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List of abbreviations and symbols
Area1oo : Nonperfused area fraction at a distance > 100 mm from
a nearest perfused vessel (-)
2 1ADC : Apparent diffusion coefficient (cm . s- )
ADCw : Apparent diffusion coefficient of water (cm2. s-1)
ATP : Adenosine triphosphate
D2O : Deuterium oxide
DPF : Differential Path length Factor (-) (= related to scattering properties
of tissue, see NIRS experiments in Chapter 7)
EPI : Echo planar imaging
FID : Free induction decay
FLASH : Fast low angle shot imaging 
FOV : Field of view
Gd : Gadolinium diethylenetriaminepenta acetic acid (Gd_DTPA)
HDO : Deuterated water, which results from proton-deuteron exchange with
D2O
[HHb] : Deoxyhemoglobin concentration (mM)
icd : Intercapillary distance (mm)
icd200 : Intercapillary distance larger than 200 mm
k : Tracer-uptake rate constant (s-1)
MRS : Magnetic resonance spectroscopy
MRI : Magnetic resonance imaging
NIRS : Near Infrared spectroscopy
NITP : A/-Imidazole-theophylline (bioreductive chemical probe)
NS : Number of scans
-2Np : Perfused capillary density (no. mm-2)
NTP : Nucleoside triphosphates: adenosine -, guanosine -, uridine - and cytidine
31triphosphate. P-MRS cannot distinguish these nucleoside triphosphates, 
because the phosphate groupes are all equivalent. Approximately 90 % of the 
NTP signal in 31P-MR spectra is due to the contribution of ATP 
Oxyhemoglobin concentration (mM)
Region of interest
Permeability of capillary endothelium (cm. s-1)
Phosphocreatine 
Phosphodiesters 
Extracellular pH 
Intracellular pH 
pH of blood
31pH as determined by P-MRS (= intracellular pH)
Inorganic phosphate
Inorganic phosphate to nucleoside triphosphates ratio. Cells with a high 
Pi/NTP ratio or low bioenergetic status have difficulties to maintain a steady 
state NTP level
PIMO : Pimonidazole hydrochloride (bioreductive chemical probe)
PFC : Perfluorocarbon compound
PME : Phosphomonoesters
[0 2 HD]
ROI
P
PCr
PDE
pHe
pHi
pHblood
pHmrs
Pi
Pi/NTP
VpCÜ2blood Carbondioxide tension in blood (mmHg)
p02blood Üxygen tension in blood (mmHg)
pÜ2electrode Üxygen tension in tissue as measured by Ü2-electrodes (polarography)
(mmHg)
pÜ2relaxo Üxygen tension in tissue as measured by 19F-MR relaxometry (mmHg)
pÜ2tissue Üxygen tension in tissue (mmHg)
PS Permeability surface-area product (ml. s-1)
Ri Spin-lattice relaxation rate (1/T1) (s-1)
SaÜ2 Hemoglobin saturation (%)
SI Signal Intensity
SIpre Signal Intensity before bolus adminstration of contrast agent
SIpost Signal Intensity after bolus administration of contrast agent
Ti Spin-lattice relaxation time (s)
T2 Spin-spin relaxation time (s)
T2* Apparent spin-spin relaxation time (s)
TBP Tumor blood perfusion (ml. s-1)
tdifmax Maximum diffusion time (s)
TE Echo time
TR Repetition time
[tHb] Total hemoglobin concentration (= [Ü2Hb] + [HHb]) (mM)
Ve Extracellular volume (ml)
Vd Distribution volume of a contrast agent (ml)
Vv Vascular volume (ml)
VÜI Volume of interest
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Introduction and outline thesis
2 Chapter 1
1.1 Physiological profiles of tumors and radiosensitivity
The physiological profile of a tumor is a term that groups different physiological parameters 
such as tumor blood perfusion, oxygenation status, pH of different blood and tissue 
compartments, and the bioenergetic status of tumor cells. But also information on the 
morphology of the vascular architecture is a crucial part of the physiological profile. The 
outcome of an anti-cancer therapy depends on the specific physiological profile of a tumor, 
and therefore the sensitivity of a tumor for a therapy is unique. In radiotherapy, tumor 
response to treatment depends among others on the local oxygen tension and indirectly on the 
supply of oxygen via blood perfusion. Poor supply of oxygen causing hypoxia is associated 
with treatment failure following radiation therapy. In the development of new treatment 
strategies and protocols, new methods for predicting the best treatment modality for the 
individual patient will help the therapist in his choice of specific protocols before the start of 
a therapy (prediction phase). In the last few years, magnetic resonance methods have become 
available, which can be used to measure different parameters of the tumor physiology (1-4). 
Most of these magnetic resonance techniques are noninvasive and can be performed on 
clinical magnetic resonance imaging (MRI) scanners.
The aim of the studies presented in this thesis is to evaluate and apply magnetic 
resonance techniques in the characterization of physiological profiles of gliomas (primary 
brain tumors) before the start of radiotherapy. This approach is applicable to various tumor 
types, but here we focus on gliomas, because these are among the most radioresistent tumors
(5).
Radiotherapy is based on the interaction of ionizing radiation with molecules of which 
the tissue is composed. This interaction may lead to ionization and/or excitation of atoms 
followed by breakage of chemical bounds. These broken molecules or free radicals are highly 
reactive and they engage in a succession of reactions that eventually leads to the restoration 
of electronic charge equilibrium. During this succession of reactions, DNA is one of the 
target molecules of interest. A majority of DNA can be successfully repaired by enzymes, but 
some DNA repair may fail, which can lead to cell death. Most of the free radicals are 
produced from water, since 70 % to 80 % of the molecules in the cell is water. In the 
presence of oxygen, a free radical R * can react with O2 to produce RO2*, which then 
undergoes further reaction ultimately to yield ROOH in a target molecule. This causes a 
change in the chemical composition of the target and makes the damage permanent. In the 
absence of O2, the free radical R * reacts mainly with protons of water and restores its 
original form. The importance of oxygen for a permanent damage to cell structures during 
irradiation was shown in experiments on cell cultures and solid tumors (6,7). Hypoxic cells 
are up to three times more radioresistent than well-oxygenated cells (6). The cell-surviving 
fraction decreased faster under oxic conditions than under hypoxic conditions as a function of 
the radiation dose. Thus, the oxygen tension in tumor tissue is one of the physiological 
parameters that determine the sensitivity of a tumor to radiotherapy. Therefore the 
introduction of noninvasive methods to measure oxygen tensions and physiological 
parameters related to tissue oxygen tension would be very valuable before the start of 
radiotherapy, and also to evaluate proposed therapy improvements.
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Figure 1.1 shows different physiological parameters, which determine the oxygen tension in 
tissue. The regional and global oxygen tension in tissue is the result of a balance between O2 
supply and O2 demand of cells (8). The O2 supply depends among others on the tumor blood 
perfusion (8) and the oxyhemoglobin concentration in red blood cells of arterial blood and 
capillaries (8). In well-perfused capillaries, the oxygen carrier hemoglobin releases O2 in 
tissue, which is influenced by the pH and oxygen tensions of the tumor microenvironment (8, 
9). In the extravascular volume, pO2tissue gradients pertinent to perfused capillaries occur, 
which decrease monotonically until hypoxic values (< 5 mmHg) (10, 11) (see also chapter 6, 
Fig. 6.6). The length of these gradients depends on O2-diffusion coefficients and O2- 
consumption rates of tumor cell populations. Tumor cells beyond these O2-gradients are 
regarded as chronically hypoxic (6, 12). These cells appear at the edge of necrotic cords (see 
chapter 3, Fig. 3.1 and 3.2). In chronically hypoxic regions, substrates (glucose, glutamine) 
for an anaerobic energy metabolism may still be supplied, but will run out by an intensified 
energy metabolism for the generation of ATP to maintain cell homeostasis. From the 
physiological and biochemical processes mentioned above, it can be deduced that tumors 
with an important fraction of large intercapillary distances may develop large populations of 
chronically hypoxic cells and necrotic areas. In addition, some microvessels transiently open 
and close in such a way that hypoxic regions may appear acutely (13, 14).
Figure 1.1 Summary of different physiological parameters, which affect the oxygen tension in tissue 
(pO2/tissue): Tumor blood perfusion (TBP), oxyhemoglobin concentration [O2Hb] in red blood cells, diffusion of 
oxygen across the vascular endothelium and in the extravascular volume (DO2), the oxygen consumption rates 
of the tumor cells (QO2). A combination of the latter parameters determines the critical O2 diffusion distances 
pertinent to perfused vessels in tumor tissue. Beyond these distances, tumor cells are regarded as chronically 
hypoxic.
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1.2 Outline of thesis
Most of the physiological and biochemical parameters, related to tissue oxygenation, can be 
assessed by magnetic resonance techniques. The MR-techniques and other methods used in 
this thesis for that purpose are summarized in Figure 1.2. A basic new experimental approach 
in these studies was to relate the MR-results to quantitative (immuno)histochemical analyses 
of the (functional) vascular architecture, the distribution of hypoxic cells and necrotic areas. 
The latter analyses permits the validation and characterization of MR-methods, and vice 
versa morphometric parameters of the vascular architecture and/or histological appearance of 
a tumor can be related to dynamic and noninvasive MR-studies of physiological and 
biochemical processes.
Most studies described in this thesis were performed on human glioma xenografts: 
surgical specimens of primary human gliomas (glioblastoma multiforme) were transplanted 
as xenografts in immuno-suppressed nude mice (15). The idea behind this approach was to 
maintain as close as possible a link with the original human tumor. Several glioma cell lines 
of human origin showed subcutaneous and intracerebral tumor growth retaining the 
morphological and cytogenetic characteristics of the original tumors (16). However, the 
development of the vasculature (angiogenesis) in human glioma xenografts is probably 
different, since the new microvessels originate from the host vessels of mouse tissue.
t
vascular extravascular compartment
Figure 1.2 Summary o f different M R and other methods, which have been used in this thesis to assess the 
physiological parameters of Figure 1.1. The five different methods and abbreviations represented in this figure, 
are explained in the text hereafter.
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The tumor blood perfusion (TBP) was measured by tracer-uptake studies. In this thesis, 
two different tracers were used: the freely diffusible tracer HDO and the diffusible 
paramagnetic contrast-agent gadolinium (Gd). In previous studies, the uptake rate of HDO in 
tumor tissue was assumed to be limited by perfusion (17, 18), which makes this tracer a good 
candidate for TBP measurements. However, with respect to toxicity and MR-sensitivity, it 
seems unlikely that this tracer can be used for clinical purposes (19). Therefore, the use of the 
clinical contrast-agent Gd was explored in addition to HDO (20-23). During the research 
describes in this thesis, we became aware that the relation between tracer-uptake rates in 
tumor tissue and tumor blood perfusion was equivocal. The tracer-uptake rates were more 
related to parameters of the functional vascular bed in a tumor, such as the perfused vasular 
density, distribution, the vasular permeabilty (P) and the total surface area of the perfused 
blood vessel (S). The P and S factor are often taken together as the permeability surface-area 
product (PS-product), which determines the diffusive transport across the capillary 
endothelium. Furthermore, the distribution volume in the extravascular space (Vd) plays a 
role, since the latter determine the time to reach equilibrium between the tracer concentration 
in the vessels and the extravascular compartment. When Vd is large, the time for equalization 
of the tracer concentration may be considerable (Figure 1.2 and chapter 2). In chapter 2, 
different pharmacokinetic models will be discussed, which have been used to relate the 
uptake rates of HDO and Gd in tumor tissue to these physiological and vascular parameters. 
The content of this chapter permits a better understanding of chapters 3 and 4. In chapter 3, 
fast dynamic Gd-uptake MRI studies with a high spatial and temporal resolution in 9L- 
glioma growing in rat brain are presented. Gd-uptake rates were spatially correlated to 
morphometric parameters of the perfused vascular architecture, such as the perfused 
microvessel density (Np) and vascular surface-area (Sp). The latter parameter was supposed to 
determine among other parameters as TBP and microvessel permeability (P), the Gd-uptake 
rate in perfused regions of the tumor (20). In addition to tracer-uptake experiments with the 
diffusible tracer Gd, changes in the concentration of freely diffusible HDO in the whole 
extravascular tumor volume (global) were analyzed in two subcutaneous human glioma 
xenografts with a different perfused vascular architecture (chapter 4). The diffusion of HDO 
across the vascular endothelium and in the extravascular space is supposed to be fast, and not 
to be hindered by the vascular permeability and morphological or physiological 
characteristics of the extracellular matrix. Therefore it is assumed that global HDO-uptake is 
perfusion-limited. This assumption was tested for our glioma xenografts in chapter 4. The in 
vivo studies were substantiated in HDO-uptake studies on 2D in vitro models. In these 
models, perfusion rates and morphometric parameters of the perfused capillaries as 
distribution and permeability were well defined, which make a comparison between these 
parameters and HDO-uptake rates possible.
The oxygen tension in tumor tissue (pO2/tissue) was probed with 19F-MR relaxometry using 
perfluoro-15-crown-5-ether (perfluorocarbon compound) as oxygen sensor (2, 24) (Figure 1.2 
and chapter 5). 19F-MR relaxometry is a noninvasive method, which permits the 
determination of local or global oxygen tensions in tumors independent of the location of the 
tumor. Most alternative methods for the measurement of tissue oxygen tensions are invasive 
and limited to superficial tumors.
19F-MR relaxometry is based on the linear relationship between spin-lattice relaxation 
rates of 19F-spins of perfluorocarbon compounds and the local oxygen tension (pO2/tissue). In 
chapter 5, the oxygen tension values obtained by this method were compared to
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polarography (Eppendorf O2-electrode measurements). Polarography is the most frequently 
used technique for direct measurements of local oxygen tension in (tumor) tissue (25, 26), 
however, this technique is invasive and studies of deep tumors are only possible with surgery. 
Thus, alternative methods are worthwhile and may be used in the prediction phase to test 
treatment modalities (chapter 7).
The bioenergetic status of a tumor is related to the supply of oxygen and nutrients for the 
energy metabolism of tumor cells. The Pi/NTP ratio is a measure of the bioenergetic status,
31and can be detected by P-MR spectroscopy. NTP is an abbreviation for nucleoside 
triphosphates, which serve as principal donors of free energy in biological systems. A large 
amount of free energy is liberated when NTP is hydrolyzed to nucleoside diphosphates 
(NDP) and inorganic phosphate (Pi). When the concentration of Pi is high relative to the NTP 
concentration, the bioenergetic status of a cell or tissue is low. The latter may occur when the 
diffusion-limited supply of oxygen and nutrients to tumor cells at a distance from perfused 
microvessels is insufficient. In chapter 6, the Pi/NTP ratio of the same heterogeneously and 
homogeneously perfused tumor lines of chapter 4, was related to the distribution of distances 
between perfused capillaries using (immuno)histochemical analyses of the perfused vascular 
architecture. When the distance between functional microvessels increases, it is expected that 
the diffusion-limited supply of oxygen and nutrients decreases simultaneously and influences 
the bioenergetic status of the tumor.
Apart from characterizing the physiological profile of tumors, advanced MR-methods may 
also be used to evaluate proposed modifications of these profiles for improved treatments.
For instance, in chapter 7, MR-techniques were used to evaluate the effects of carbogen 
breathing on the physiological profile of gliomas. Carbogen is a gas mixture of 5 % CO2 and 
95 % O2, which has been introduced to reduce hypoxia in tumors (13, 27). The ultimate effect 
of carbogen breathing on tumor physiology evolves from changes in multiple processes and 
varied in different experimental and human tumors (28, 29). Thus, the effect can only be 
understood when all relevant physiological parameters are taken into account. Near infrared 
spectroscopy (NIRS) was used to investigate relative changes in oxy- and deoxyhemoglobin 
concentrations in tumors (= Blood Oxygen Level Dependent (BOLD) effect) (30). Similar 
studies are possible with functional MRI methods (3), but the separation of perfusion and 
BOLD effects on signal intensity changes was impossible until recently (31). Oxygen tension 
changes in tumor tissue were evaluated by 19F-MR relaxometry (as described in chapter 5), 
and possible modifications of tumor blood perfusion (TBP) were analyzed by fast dynamic 
1H-MR imaging of Gd-uptake (see chapter 3). Finally, changes of the bioenergetic status and 
pH of tumor cells were analyzed by 1P-MRS (see also chapter 6). If carbogen-breathing 
results in an extension of the tissue volume supplied with oxygen, then the Pi/NTP ratio of 
tumor cells may decrease due to enhanced oxidative energy metabolism. Further, changes in 
the intracellular pH of tumor cells (pHmrs) may correlate with changes in energy metabolism 
(32).
Chapter 8 provides a summary of this work.
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Chapter 2
Pharmacokinetic models for the interpretation of 
diffusible tracer-uptake in tissue.
Boudewijn P.J. van der Sanden
12 Chapter 2
2.1 Introduction
In the context of a tumor therapy, it is important to know how efficiently blood is providing 
oxygen, nutrients and drugs to tumor tissue and how effective it is in removing waste 
products from that tissue. The supply to tissue depends on physiological processes such as: 
blood transport or blood perfusion rates in the vascular compartment, the transport across the 
vascular endothelium and finally, the diffusion from regions adjacent to perfused vessels into 
nonperfused regions of the tissue (for review see 1-3). The uptake rate of diffusible tracers in 
the extravascular volume is related to these processes and therefore this parameter may 
indirectly provide information on the oxygen, nutrient and drug supply in tissue. The problem 
is, however, how to correlate tracer-uptake rates directly to one or more of these 
physiological processes. In chapter 3 and 4 detailed information on the perfused vascular 
architecture is given, which may help to solve this problem. If tracer-uptake rates can be 
related to physiological parameters, then they may be used more efficiently as a prognostic 
tool before or during the monitoring of a therapy (4-7).
Different pharmacokinetic models have been developed to relate global or regional 
tracer-uptake rates to physiological parameters (8-10). The choice of the pharmacokinetic 
model depends on physicochemical and pharmacological properties of the tracer (e.g. size, 
charge, structure, half-time in blood, ...) and the applied MR-method for the detection of 
tracer concentation changes in the volume of interest. In this thesis, only MR-studies of 
tracer-uptake were used, which permit direct or indirect analyses of the physiological 
processes in the tumor related to perfusion and/or diffusion-limited supply with oxygen, 
nutrients and drugs.
The aim of this chapter is to give a short review of different pharmacokinetic models 
and their assumptions, which have been frequently used for the interpretation of uptake rates 
of diffusible tracers. Knowledge of these models permits a better understanding of the content 
of chapters 3 and 4.
2.2 Comparison of the freely diffusible tracer HDO with 
the diffusible tracer gadolinium
In this thesis, two diffusible tracers: HDO and the paramagnetic contrast-agent Gd_DTPA 
have been used (see Table 2.1 for physicochemical and pharmacological properties). HDO is 
considered a freely diffusible tracer that has access to the total water volume of a tissue (11). 
The term freely diffusible refers to a redistribution of tracer in the extravascular space of a 
volume of interest, which is not impaired by morphometric, and/or physiological parameters 
of the perfused vascular architecture and the extravascular space. In previous studies, the 
redistribution of HDO in tissue was assumed to be instantaneous and therefore limited by 
perfusion (11, 13-16). These characteristics make HDO a good candidate for measurements 
of blood perfusion. However, with respect to toxicity and MR-sensitivity, it seems unlikely 
that this tracer can be used for clinical purposes. Therefore the clinical contrast-agent Gd was 
also explored in addition to HDO. In this thesis, the abbreviation Gd refers to the contrast 
agent Gd_DTPA and not to the element gadolinium. In contrast to HDO, the transport of the 
larger tracer Gd across the microvessel endothelium may be hindered by the morphometric 
structure of the latter. Furthermore, the uptake of Gd is limited to the extracellular volume in 
tissue. Therefore, this agent is considered a diffusible tracer in comparison to the freely 
diffusible tracer HDO (12).
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2 2Changes in the HDO concentrations can be observed directly by H-MRS (14,15) or H-MRI
(13,16). The magnetic resonance sensitivity of 2H-spins is, however, approximately 100 times
1 2 smaller than the sensitivity of H spins (17), which makes the detection of H-spins in small
volumes with a reasonable temporal resolution presently impossible. In most 2H-MR
experiments, the global uptake of HDO in the whole tumor volume is detected by H-MRS
(see chapter 4 and ref. 14).
In studies of the Gd-uptake in tissue, the effect of this paramagnetic contrast agent on
the ^-relaxation time of 1H-spins of water is observed. An advantage of this contrast agent is
that the high MR-sensitivity of 1H-spins can be used, therefore 1H-MRI experiments with a
high temporal and spatial resolution are possible (see also chapter 3 and ref. 4, 18). A
disadvantage of this contrast agent is that changes of the tracer concentration cannot be
observed directly. However, at low concentrations ([Gd] < 0.01 M) the relationship between
the ^-relaxation rate of 1H-spins and [Gd] is linear (19). Thus, with appropriate MR-
sequences, changes in ^-relaxation time of 1H-spins can be related to changes of the [Gd]
(chapter 3 and ref. 20).
Table 2.1 Comparison of physicochemical and pharmacological properties of the two (freely) 
diffusible tracers used in this thesis: HDO and Gd. In reference (21) the structural formula of 
Gd_DTPA is given.
HDO Gd
Molecular weight (M) 18 583
Distribution volume 
in extravascular space
intra/ extracellular 
volume
extracellular volume
Diffusion coefficient (D) in 
tissue of 37o C .1X 2)
~ 1.10-5 cm2.s-1 ~ 2.10-6 cm2.s-1
Half-time in blood 
of mice and rats (t/) ^  4)
3 - 4 days 10 - 20 min
1) see chapter 4, p. 54.
2) The diffusion coefficient o f Gd in tissue of 37o C was estimated as follows (22): 
Dwater. VMwater = DGd.VMGd, (D = Diffusion coefficient, M = Molecular weight).
3) see ref. (14).
4) see ref. (23) and (24).
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2.3 Pharmacokinetic models used for the description of HDO 
and Gd-uptake in tumor tissue
Until recently, two different pharmacokinetic models were commonly used to fit to Gd- 
uptake curves as measured in tissue: 1. the single-capillary model proposed by Larsson et al 
(9) in 1990 and 2. the multi-compartment model developed by Tofts et al (10) in 1991. The 
single-capillary model is similar to the Kety model (8), which has been used for the 
interpretation of HDO-uptake curves. S.S. Kety already developed this model in 1951 for the 
theoretical description of inert gas exchange at lungs and tissue. In 1992, the single-capillary 
model and the multi-compartment model were compared and possible differences explained 
(25).
2.3.1 General model assumptions versus reality
Schematic representations of the single capillary and the multi-compartment model are given 
in figures 2.1 and 2.2. Both models make some basic assumptions related to concepts in 
tracer kinetics. The most important assumptions are the following (see 26 for a review):
1. Tumor volume of interest in the different models is defined as a volume with two 
compartments: a vascular and an extravascular compartment. The pharmacokinetic models 
presented in this chapter assume uniform dimensions and permeabilities along the 
microvessels (= vascular compartment) (9). When considering the vascular compartment in a 
growing tumor, one must take into account the existence of two different populations of 
vessels: 1. preexisting host vessels which are incorporated into the tumor tissue and 2. 
capillaries arising from neovascularization or angiogenesis (27). These newly formed 
capillaries usually show structural and functional abnormalities with regard to their spatial 
distribution, morphology, dimensions and permeability (28). In none of these models 
attention is paid to the real nature of the perfused vascular architecture of tumor tissue. In 
chapter 3 and 4, it will be shown that the proper interpretation of tracer-uptake rates in tumors 
is impossible without knowledge of the latter.
2. The different compartments contain the well-mixed tracer in a uniform concentration 
throughout the compartment. This assumption may be valid in normal tissue, however, the 
extravascular compartment or interstitial space of a tumor is not comparable to the interstitial 
volume of normal tissue (3). In solid tumors the interstitial fluid pressure is generally higher 
than in normal tissue which is due to leaky microvessels (see previous paragraph) and the 
absence of lymphatic vessels. The interstitial fluid pressure was found to increase rapidly in 
the periphery of a tumor towards a steady state, which is maintained throughout the center of 
a tumor (29). This interstitial fluid pressure may be a major cause for a heterogenous 
distribution of macromolecules, because it leads to radially outward convection that opposes 
the inward diffusion (3, 29). However, for small molecules it was shown that they could enter 
tumor tissue freely and were not selectively excluded from any region in small tumors (30). 
Therefore, any spatial restriction of the tracers used in this thesis is not expected, however, 
interstitual fluid pressure may increase the time to reach tracer equilibrium between perfused 
and nonperfused regions of the tumor.
3. It is assumed that tracer in the tumor volume of interest has arrived directly from a nearby 
capillary. Diffusion of tracer through the extravascular tumor volume from more distant 
capillaries is neglected. Therefore, the tracer-uptake should only be analyzed in regions of
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interest with a high-density of perfused capillaries. The region of interest should not include 
nonperfused tumor regions, since tracer-uptake in these regions is due to diffusion processes 
from more distant perfused microvessels and would render the models invalid. Thus, prior 
knowledge of the 2D or 3D distribution of perfused capillaries is needed (chapter 3 and 4). In 
tumor tissue, the 3D distribution of capillaries may be very heterogeneous with large 
intercapillary distances, which makes the interpretation of tracer-uptake complicated (see end 
of this chapter and chapter 4).
As implicitly outlined above, tumor tissue is not comparable to normal tissue. In 
particular, the (perfused) vascular architecture and the extracellular matrix are different. 
Existing pharmacokinetic models for the interpretation of tracer-uptake in tissue can be 
adapted to physiological and morphological characteristics of a tumor. The function 
generated by the more complicated model (the one with more variables) will always come 
closer to the measured datapoints, but the estimated values of many physiological and 
morphological parameters are difficult to verify and are not always independent. For instance, 
functional capillaries may collapse when the interstitual fluid pressure increases which results 
in a lower perfused capillary density with larger intercapillary distances (3). In this thesis, 
efforts have been made to adapt MR-methods for tracer-uptake studies in tumor tissue in such 
a way that the assumptions discussed above are valid for the interpretation of the data (e.g. in 
chapter 3, Gd-uptake rates were only analysed in voxels with predominantly perfused 
capillaries) or otherwise an alternative model or interpretation of tracer-uptake is proposed 
(see end of this chapter and chapter 4).
2.3.2 Mathematical description of pharmacokinetic models
Both in the model of Larsson and Tofts (9,10), (tumor) tissue of interest is defined as a 
volume with a vascular and extravascular compartment, see Figure 2.1 and 2.2. The tracer- 
uptake rate in the extravascular compartment is determined by a rate constant k. The changes 
of the [tracer] in the extravascular compartment in time (Ctu(t)) can be descibed as follows, 
see Equation [1] :
As pointed out in Table 2.1, the distribution volume of HDO and Gd are different in the 
vascular and extravascular compartment. The distribution of Gd is limited to the extracellular 
volume in both compartments, whereas HDO has access to the extra - and intracellular 
volumes.
When the tracer concentration in tumor tissue at the time of the bolus injection (t = 0) 
is 0, the general solution of Equation [1] is (8,9):
dC f )- = k -(C p(t)-ctu(t)) [1]
Ctu(t) : tracer concentration in extravascular tumor volume at time t 
Cp(t) : tracer blood (plasma) concentration at time t 
k : tracer-uptake rate constant
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t
Cu (t) = k.exp-kt.ò expkt .C p ( t)d r  [2]
o
Equation 2 is also known as the Kety equation (8) for tracer-uptake or saturation experiments. 
In chapter 3, p. 3G (Eq. [2]), the solution for the integral in Eq. [2] of page 14 is given.
Tissue of interest (e.g. tumor)
TBP
B
Cp ( t ) ^ Ctu(t)
1 kLarsson
vascular extravascular 
compartment
Figure 2.1 Single-capillary model of Larsson (9). The blood volume in tumor tissue (see dashed box) is 
represented by a single-capillary with uniform dimensions and permeability for the tracer. The uptake rate of the 
tracer is governed by the rate constant kLarsson and by tracer concentration difference between the vascular (Cp(t) 
and extravascular compartment (Ctu(t)), which depends among others on tumor blood perfusion (TBP).
Bolus injection
Figure 2.2 Multi-compartment model of Tofts (10). The vascular and extravascular compartment o f the tissue 
of interest (see dashed box) are shown as well as other compartments, which influence the tracer concentration 
in the vascular compartment (Kidneys and rest body). Changes of tracer concentration in compartments depend 
on exchange rate constants: kTofts, k1 and k2.
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The form of the function which describes the changes of the tracer concentration in blood 
Cp(t), depends among others on the temporal resolution of the experiment. When changes of 
the [tracer] in tissue are measured directly after bolus injection with a high temporal 
resolution (sample time < 1 s per datapoint), Cp(t) should include the first bolus passage of 
the tracer in the capillaries and a multi-exponential decay describing the clearance of the 
tracer from the blood compartment (see ref. 31 and next paragraph). The function Cp(t) is also 
called the arterial input function and is measured in an artery feeding the tissue of interest: 
e.g. the arterial input function is detected in the carotid artery when the tracer-uptake in brain 
tumors is measured. Actually, the tracer concentration changes in blood should be measured 
in perfused capillaries and not in arteries (see Figure 2.1), however, this is impossible due to 
the leak of tracer into the extravascular compartment during the first bolus passage. 
Therefore, it is assumed that arterial tracer concentration changes are equal to changes in the 
perfused capillaries. In the multi-compartment model (see Figure 2.2), the first bolus passage 
is simply neglected by assuming an instantaneous tracer redistribution in the blood 
compartment after bolus injection.
When Ctu(t) is sampled with a low temporal resolution or when it is assumed that the 
redistribution of the tracer in the blood compartment is instantaneous, Cp(t) can be 
approximated by a multi-exponential decay describing the clearance of the tracer from the 
blood compartment only. In such a case, Cp(t) is related to tracer exchanges with the 
extravascular compartments of tissues in the rest of the body with permeable capillaries (k1, 
fast exchange) and to the clearance by the kidneys (k2, slow exchange), see Figure 2.2 and 
Equation [3]. It should be noted that k1 and k2 depend on the physicochemical and 
pharmacological parameters of the tracer (see Table 2.1). For instance, the clearance of HDO 
by the kidneys is much slower than the clearance of Gd_DTPA: the half-times in blood are 3
-  4 days and 20 min, respectively. The loss of tracer in the blood compartment is described 
by a multi-exponential decay with different rate constants k1 & k2 and amplitudes A 1 and A2, 
see Eq. [3] and Figure 2.3.
Cp(t) = Ai. e k u + A2 . e k 2t [3]
Cp(t) : tracer blood (plasma) concentration at time t (mmol.ml-1)  ^ 1 
A 1, A2 : amplitudes of the fast and slow exponential (mmol.ml- )
component, respectively
k1, k2 : rate constants of the fast and slow exponential (s-1)
component, respectively
It is beyond the scope of this chapter to analyse the effect of the Cp(t) function on the 
quantification of tracer-uptake rates (k). In reference 31, this analysis was done in more detail 
for Gd-uptake studies in brain tumors (see also chapter 3). In perfused tumor regions, 
estimations of tracer-uptake rate constants were very inaccurate when a Cp(t) function was 
used which included the bolus passage. These constants were not significantly different from 
experiments where the bolus passage was not included by omitting a few datapoints of the 
Gd-uptake curve obtained during the bolus passage. This can partly be explained by the fact 
that tracer-uptake in this tumor model was mainly limited by tracer transport across the 
capillary endothelium. But, when tracer-uptake is governed by transport in the perfused 
capillaries, the shape of arterial input function may influence the uptake rate in tissue.
18 Chapter 2
In Figure 2.3, the changes of the [Gd] in time in the vascular (Cp(t)) and extravascular 
compartment (Ctu(t)) of a 9L-glioma rat model are shown (chapter 3 and ref. 31). The arterial 
input function was determined in the carotid artery and the function Ctu(t) was measured in a 
well-perfused tumor voxel, with a high-density of perfused capillaries, see legend of Figure 
2.3 for details. After bolus injection of the tracer, the Cp(t) function decreased rapidly, and 
simultaneously the tracer concentration in the extracellular volume of the tumor (Ctu(t)) 
increased. The function Ctu(t) reached a maximum and was equal to Cp(t) after approximately 
1 min, and declined afterwards until the tracer concentrations in the vascular and 
extravascular compartment of the voxel were a second time in equilibrium and decreased 
simultaneously.
In global HDO-uptake studies, changes of the tracer concentration in the total 
extravascular compartment of the tumor are not similar due among others to a different half­
time in the blood compartment (Table 2.1). After the bolus passage, the concentration of 
HDO in blood stays constant over a long time period; thus, tracer equilibrium between the 
vascular and total extravascular volume by diffusion is possible during the total measurement 
time (see end of this chapter and chapter 4, Fig.4.4D). In Gd-uptake experiments, the latter is 
only possible in well-perfused voxels during a short time interval.
time (min)
Figure 2.3 Changes of the [Gd] in time in the vascular (Cp(t)) and extravascular compartment (Ctu(t)) of a 9L- 
glioma rat model. The arterial input function Cp(t), was measured in the carotid artery and Qu(t) was detected in 
a well-perfused voxel of the tumor. The estimated rate constant k was 0.02 s-1. The following parameters of the 
arterial input function (Cp(t)) were found : A1/A2 = 2.35, k1= 0.015 s-1, k2 = 0.00117 s-1 (31).
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2.3.3 Definitions of the tracer-uptake rate constants in both 
pharmacokinetic models.
The main difference between the single-capillary model of Larsson et al (9) or Kety equation 
(8) and the multi-compartment model of Tofts et al (10) is the definition of the rate constant k 
(s-1). The rate constant k as defined by the model of Tofts (10) and Larsson (9) are given in 
Eq. [4] and Eq. [5] respectively. The different symbols of Eq. [4] - [6] are explained 
hereafter.
In the multi-compartment model (Figure 2.2), the tracer-uptake in the extravascular 
compartment of the tissue of interest is governed by the product of the capillary permeability 
(P) and the perfused vascular surface-area (S). Both parameters are combined in the so-called 
PS-product, because in most tracer-uptake studies it is difficult to separate the effect of P or S 
on the tracer-uptake rates. In the multi-compartment model it is supposed that this product is 
the rate-limiting step during tracer-uptake and not TBP.
In the single-capillary model (Figure 2.1) it is suggested that the tumor blood 
perfusion (TBP) cannot be excluded during the tracer-uptake and should be considered as 
well. The main question is: How important is the TBP in comparison with the PS-product 
during the extraction (E) of the tracer in tissue? Here, the extraction is defined as the fraction 
of the inflowing amount of tracer that leaves the vascular bed by diffusion through the 
capillary wall and is given by Eq. [6] (8, 32).
Finally, the distribution volume of the tracer (Vd) in the volume of interest has an 
inverse relationship with the uptake rate constant in both models: if  Vd is large, then it will 
take more time to reach equilibrium between the tracer concentration in the vascular and 
extravascular compartment.
PSkTofts = [4]
Vd
E.TBP
ki arsson [5]
Vd
E = 1 - exp-TBP [6]
ki-ofts : Tracer-uptake rate constant in Tofts's model (s-1)
P : Permeability of perfused capillaries (cm.s-1)
P can be defined as the linear velocity of tracer during 
the passage across the capillary endothelium 
S : Total surface-area of perfused capillaries (cm2)
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PS : Permeability surface-area product 
Here, the PS-product can be seen as a volume flow
(ml.s-1)
velocity of tracer across the capillary endothelium.
(cm3)Vd : Distribution volume of tracer in volume of interest
kLarsson : Tracer-uptake rate constant in Larsson's model (s-1)
E : Extraction of tracer during passage in capillaries (-)
TBP : Tumor blood perfusion (ml.s-1)
When PS » TBP, the extraction of the tracer is maximal during the passage in the perfused 
capillaries: E = 1 (see Eq. [6]) and no tracer would be detectable at the venous side of the 
tissue of interest. In such a case, the tracer-uptake in tissue is completely governed by the 
TBP (perfusion-limited): kLarsson = TBP/Vd. The model of Tofts (10) does not take into 
consideration such a situation.
When PS « TBP, E can be approximated by a first order Taylor expansion around PS 
= 0, which results in E = (1-(1-PS/TBP)). Substitution of E in Eq. [5] gives: kLarsson = PS/Vd, 
which is the same rate constant as defined by Tofts et al (10) in Eq. [4]. The tracer-uptake is 
now completely governed by diffusion of the tracer across the capillary endothelium (= 
diffusion-limited).
When both TBP and diffusion across the capillary endothelium influence the uptake 
rate, the situation is more difficult to describe. In Figure 3.6 of chapter 3, the relationship 
between kLarsson, TBP and the PS-product was simulated using Eq. [5] and Eq.[6]. In the 
surface plot it is shown that for perfusion-limited tracer-uptake (TBP « PS-product), the PS- 
product has no influence on the value of kLarsson. The k-value reaches a steady state when the 
PS-product becomes larger than TBP. When TBP increases the relationship between the PS- 
product and kLarsson becomes slowly linear, k is more and more dominated by the PS-product.
All physiological parameters of the pharmacokinetic models (TBP, PS-product) are 
only defined in perfused regions of the tumor. Therefore, in tumors with a heterogeneously 
perfused microvessel distribution, tracer-time curves should only be analyzed in voxels with 
perfused microvessels and not in nonperfused areas of the tumor. When TBP affects the 
tracer-uptake rate in perfused regions and the exchange of tracer between the capillaries and 
tissue is not limited by diffusion across the vascular endothelium, the model of Larsson 
should be used for the interpretation of tracer-uptake curves in all circumstances. The 
pharmacokinetic model of Tofts should only be applied for the interpretation of tracer-uptake 
studies, when clear evidence is provided that the tracer-uptake in the extravascular volume of 
tissue is controlled by tracer diffusion across the vascular endothelium (PS-product). In such 
a case, a linear relationship may exist between the perfused vascular surface-area (S) and the 
uptake rate constant, when all microvessels are highly permeable to the tracer (chapter 3). 
Diffusion-limited tracer uptake across the vascular endothelium may be favoured when 
tracers with a molecular weight larger than 20 kD are chosen.
If the tumor has a heterogeneously perfused vascular architecture with large 
nonperfused regions, and regional analyses of the tracer-uptake in perfused regions of the 
tumor are not possible, then the pharmacokinetic models cannot be fitted to the tracer-uptake 
curve. The latter may occur in global H-MRS studies of the HDO-uptake in the whole 
volume of the tumor (see chapter 4). The latter is explained in more detail in Figure 2.4.
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In this figure, tubes connected to a water tap, which regulates the perfusion rate in the whole 
system (TBP), symbolize the vascular system. The tube walls in the tissue of interest (■ ) are 
permeable to the tracer (•), which enters the extravascular volume via diffusion across the 
tube wall or vascular endothelium. In the case of normal tissue or in perfused regions of the 
tumor (case1), diffusion distances between the functional microvessels are small, thus the 
time to reach a tracer concentration equilibrium between the vascular and extravascular 
compartment is short. In Figure 2.4B, changes of the [tracer] as a function of the distance (--) 
between functional vessels in a transversal slice (- -) through the center of the tissue of 
interest are shown. The time to reach a steady state [tracer] in the vascular and extravascular 
compartment is approximately 2 s for an intercapillary distance of 50 |im. Diffusion times 
were estimated using a diffusion coefficient of 8.4. 10-6 cm2.s-1 (see chapter 4, p. 54) and a 
modified partial differential equation describing HDO diffusion in one dimension (33)). In 
heterogeneously perfused tumors (case 2), the diffusion distances between perfused regions 
may be large, and consequently the time for equalization of the tracer concentration is 
considerable (see Figure 2.4B). This is further illustrated in Figure 1C, which shows the 
changes of the [tracer] in the whole tissue volume of interest as a function of time for both 
cases. Similar curves are obtained with 2H-MRS studies of the HDO-uptake in the whole 
tissue volume (Figure 4.4B or 4.4D in Chapter 4).
In summary: When diffusion distances between functional microvessels are short, 
the tumor blood perfusion (TBP) and/or permeability surface-area product (PS-product) (see 
above) mainly dominate the time to reach tracer concentration equilibrium between the 
vascular and extravascular volume. The pharmacokinetic models described in literature and 
cited in this chapter can be used to relate tracer-uptake rates to TBP and/or PS-product. 
However, in case 2, tracer diffusion processes in the extravascular volume determine the time 
to reach [tracer] equilibrium between the vascular and extravascular compartment. Until 
recently, no pharmacokinetic models are available, which take into consideration these 
diffusion processes in the extravascular space.
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Case 1: Normal tissue/ well perfused tumors Case 2: Heterogeneously perfused 
tumors
Distance between perfused microvessels
C [tracer] in total 
tissue volume 
of both cases 
□
Î
Case 1:
Diffusion distances between functional m icro­
vessels a re  short. The TBP and PS-product govern the 
time to reach [tracer] equilibrium between the 
vascular and extra-vascular volume.
Pharm acokinetic model :
- Kety and Larsson model (single-capillary)
OR
- Tofts and Kermode (multi-compartment)
Case 2:
Diffusion distances between functional m icro­
vessels a re  large. Tracer diffusion processes in 
extra-vascular volume determine the tim e to 
reach [tracer] equilibrium between the vascular 
and extra-vascular volume 
Problem  :
- None o f the pharmacokinetic models 
take into account these trace r diffusion 
processes in the extra-vascular volume.
Figure 2.4 Comparison of physiological and morphometric parameters, which determine the tracer-uptake in 
perfused regions with short intercapillary distances (case 1) and large intercapillary distances (case 2). For 
further details see text.
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Abstract
Purpose: to spatially correlate apparent Gd-concentrations (ri[Gdj) to the 2D distribution of 
perfused microvessels, and Gd-uptake rates to morphometric parameters of the perfused 
vascular architecture in 9L-gliomas growing in rat brain.
Material and methods: Changes of r1[Gd] in time were analyzed in a slice through the 
center of ten 9L-gliomas using fast ^-measurements. At comparable locations, r1[Gd] maps 
were matched to whole tumor tissue sections with (immuno)histochemically-stained perfused 
and nonperfused microvessels, and hypoxic areas. Finally, the pharmacokinetic model of 
Larsson was fitted to r1[Gd]-time curves in voxels containing perfused microvessels, and 
kLarsson-values were spatially related to the perfused microvessel density (Np) or vascular 
surface-area (Sp).
Results: A spatial correlation was observed between r1[Gd] maps and the 2D 
distribution of perfused microvessels. In tumor voxels with perfused microvessels, a linear 
correlation was found between kLarsson-values and Np (kLarsson = [0.00029 ± 2.3.10-5 (SD)] x 
Np) or Sp (kLarsson = [0.23 ± 0.02 (SD)] x Sp). No correlation was observed between kLarsson- 
values and the total microvessel density.
Conclusion: A positive correlation exists between Gd-uptake rates and the perfused 
microvessel density or surface-area in 9L-gliomas. The latter correlation indicates that tumor 
blood perfusion far exceeds the tracer transport across the microvascular endothelium. 
Therefore, noninvasive Gd-uptake measurements may be of additional value to pathology in 
the evaluation of therapies that affect the perfused microvessel density or surface-area, such 
as anti-angiogenic therapy.
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Introduction
Information on tumor angiogenesis is important to evaluate the potential of a tumor to grow 
and metastasize (1, 2). Therefore, direct and indirect methods have been developed to analyze 
the angiogenic capacity of a tumor (1, 3-5). One of the more direct methods of assessing 
tumor vascularity is the microvessel density (MVD) technique (1, 3, 5). With this technique 
endothelial cells of all microvessels are immunohistochemically stained in biopsy specimen 
and quantification is established from regions with the highest vascular density (hot spots) by 
the pathologist. Several clinical studies have shown that increased microvessel density is 
correlated to poorer overall survival and/or increased risk for metastasis: for instance in 
patients with breast and prostate carcinoma (1, 3-6). However, these correlations were less 
obvious in other malignant lesions (7).
The MVD technique has many drawbacks such as the low reproducibility among 
pathologists (4, 8) and the inability to distinguish between perfused and nonperfused 
microvessels. The morphological appearance of the total vascular bed does not necessarily 
allow judgements on functional aspects of the tumor microcirculation (9). Microvessels, 
which are not perfused during a long time, are not expected to contribute to tumor growth or 
metastasis. Therefore, a relevant analysis of the vascular bed should include an evaluation of 
the distribution of perfused microvessels. The perfused microvessel distribution may be 
assessed noninvasively by dynamic Gd_DTPA (Gd) -enhanced magnetic resonance imaging 
(MRI). This paramagnetic contrast agent appears to accumulate in the extracellular tumor 
volume adjacent to perfused microvessels, which are permeable to this tracer (10). This 
suggests a possible role for dynamic Gd-enhanced MRI in obtaining in vivo information on 
the perfused microvessel distribution with prognostic potential.
In addition, pharmacokinetic models have been developed to examine wheter Gd- 
uptake rates are related to physiological parameters such as tumor blood perfusion (11) and 
the perfused capillary permeability surface-area product (PS-product, (12)). Information on 
Gd-uptake rates and the spatial distribution of Gd were useful in longitudinal studies of tumor 
therapy effects (13-15). The latter may be of particular importance in the follow-up of anti- 
angiogenic therapy where the effect of an agent on the angiogenesis in solid tumors may be 
analyzed noninvasively by dynamic Gd- enhanced MRI (4, 8, 16). In previous studies, Gd- 
uptake rates have been related to the microvessel density (MVD), but in most reports poor 
correlations were found (17-20). A number of factors may contribute to this. First, it was not 
possible to spatially correlate the MVD with Gd-uptake rates, because Gd-enhanced MRI was 
not used to guide biopsy of surgical specimens. Secondly, the applied MVD technique (1) 
evaluates all microvessels whereas dynamic Gd-Enhanced MRI only senses functional or 
perfused microvessels.
Therefore, the aim of this study is to see whether a spatial correlation exists between
1) apparent Gd-concentrations and the 2D distribution of perfused microvessels, and between
2) Gd-uptake rates (k-values) and morphometric parameters of the perfused vascular 
architecture, such as the perfused microvessel density (Np) and vascular surface-area (Sp). As 
a tumor model, 9L-gliomas growing in rat brain were used. The perfused vascular surface- 
area has been suggested to determine the Gd-uptake rates in perfused tumor regions together 
with other physiological parameters, such as tumor blood perfusion (TBP) and microvessel 
permeability (P) (11, 12).
For this purpose, the apparent Gd-concentration (r1[Gd]) as a function of time was 
determined using a fast dynamic MRI T1-sequence (21). Next, pharmacokinetic models were 
fitted to r1[Gd]-time curves (11, 12, 21) to estimate k-values per voxel (k-map).
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The distribution of apparent Gd- concentrations (r1[Gd]) and k-maps were spatially correlated 
to immunohistochemical images showing the 2D distribution of perfused microvessels, the 
total vascular bed (MVD technique), chronically hypoxic cells (22), and necrotic regions in 
whole tumor sections at comparable locations as the MR-slices. Staining of these cells or cell 
structures permits comparison of the total vascular bed with the perfused microvessel 
distribution, and detailed analyses of nonperfused tumor areas. Whole tumor sections were 
analyzed using a computer-controlled image-processing system connected to a (fluoresence) 
microscope (23). In this way, the reproducibility of the (immuno)histochemical analyses was 
increased and the quantification of morphological parameters was independent of the 
pathologist's choice of certain tumor regions. In MR-voxels containing functional 
microvessels, morphometric parameters of the perfused vascular architecture were related to 
Gd-uptake rates.
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Material and Methods
Animal model. Ten days before the NMR experiments, 9L-glioma cells (kindly provided by 
Dr Jeffrey A. Coderre, Brookhaven National Laboratory, Upton, N.Y., USA) were injected in 
the brain of 10 Fischer rats (CDF® (F-344)/CrlBr Charles River Laboratories, Germany). 
Cannulae (Insyte®, 0  0.7/19 mm, 24 G., Becton Dickinson Belgium) were inserted in a tail 
vein for online administration of Gd_DTPA (Magnevist®, Schering AG, Germany) solution 
in saline (dose: 0.2 mmol.kg-1, duration of bolus injection is 2 s). Rats were anaesthetized by 
subcutaneous injection of 0.1 ml of an atropine solution (Atropini Sulfas, Pharmachemie 
B.V., Haarlem, Netherlands) followed by exposure to 1.5 % enflurane in an oxygen-nitrous 
oxide (30 % O2) mixture applied through a nose cone. Body temperature was monitored with 
a rectal probe (0  3.5 mm, Hewlett Packard) and maintained at 36.5o - 37o C by a warm water 
blanket with a feed back system. The local ethical committee for animal use approved the 
experimental procedures.
M R-measurements. MR-experiments were performed on a home-built spectrometer (6.3 T) 
using a single tuned 1H-resonator with a diameter of 3 cm well adapted to the rat head. Before 
the start of Gd-uptake measurements, the tumor location and size were determined in coronal, 
sagittal and transversal slices using a fast T1-sequence (see below). In this study, the T1- 
relaxation times of water 1H-spins in tumor regions were longer than in normal brain tissue: 
thus, tumor regions were clearly delineated in T1-maps through the whole brain. Next, in a 
transversal slice through the center of the tumor, the homogeneity of the local Bo- field was 
optimized. The uptake of Gd was measured in this slice using a SNAPSHOT T1-method (24) 
with an interleaved EPI imaging sequence (21). An effective T1 value (T1*) is obtained using 
this sequence (24). The Gd-uptake experiment contained 15 T1* maps prior to the bolus 
injection (T10*) and 40 T1* maps after bolus injection (21). One SNAPSHOT ^-experim ent 
consisted of 12 images of 300 ms duration each with a flip angle of 5o, a time resolution of 
3.6 s, FOV = 30 x 30 mm, resolution 90 x 90 pixels, and slice thickness = 2 mm.
M R-data analyses. Gd-uptake rate constants (k, s-1) per voxel (k-map) were obtained 
by the following 3 steps (21). First, 15 effective ^-experim ents prior to the bolus injection 
were averaged to obtain a high SNR T10* measurement. For each voxel, a mono-exponential 
three-parameter model function (see Eq. [1]) was fitted to 12 phase corrected 1H-MR signals 
of a relaxation curve (M(t)) using the Marguardt least-squares non-linear fitting algorithm 
(25) (IDL-software 5.1, Creaso GmbH, Gilching, Germany). In this way, a T10*map was 
generated (24). In Eq. [1], - Mb is the magnetization directly after inversion and M0* is the 
effective end and/or rest magnetization, Eq. [1]:
M(t) = Mo - ( M*0 - Mb).exp-TTo [1]
Secondly, T1*-relaxation maps after bolus injection were obtained in a similar. The linear 
relationship between changes in the effective T1 relaxation rates and the average Gd- 
concentration in the extravascular volume of tumor tissue was used to calculate apparent Gd- 
concentration maps: r1[Gd] = 1/T1* - 1/T10*. The constant r1 or relaxivity ((mM.s)-1) depends 
on tissue parameters such as temperature and pH (26). These tissue parameters were 
unknown; thus, only apparent Gd-concentration maps could be calculated, which was 
sufficient in this study.
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Finally, a k-map was obtained after fitting the pharmacokinetic model of Larsson (11, 21) to 
r1[Gd] - time curves per voxel (r1[Gd](t)), see Equation [2]. The Powell minimization method 
was used for the least-squares non-linear fitting (27). In Eq. [2], the uptake rate constant k 
(s-1) as proposed by Larsson et al (11) is defined as kLarsson= TBP.E/ Vd. TBP is the tumor 
blood perfusion (ml.s-1), E (-) is the extraction fraction of the amount of tracer during bolus 
passage (E = 1 - exp (- PSp/ TBP)) and Vd is the distribution volume (ml) of the tracer, which 
equals the extracellular volume in the case of Gd (see end of material & methods). In the
extraction term (E), P is the permeability of the microvessel endothelium for the tracer (cm.s-
1 2) and Sp is the total perfused microvessel surface-area (cm ) in the volume of interest (see 
next section immunohistochemical analyses). If TBP is much larger than the PSp-product, 
then k approaches the uptake rate constant as proposed by Tofts, see (12, 28): kTofts = PSp/ Vd.
Changes of the apparent Gd-concentration in time are generally given by Eq. [2] with 
a scaling factor S (21):
+ r1 [Gd ]0.exp ~kt
[2]
r1 [Gd ](t) = ^ .
A1.k 
k -  k1
.exp -k1.t A2.k
k - k
-.exp -k?.t exp -k.t
In Eq. [2] r1[Gd]0 is the apparent Gd-concentration at t = 0, A 1, A2 and k1, k2 are amplitudes 
(mM) and rate constants (s-1), respectively, of the arterial input function Cp(t), which 
describes the bi-exponential decay of the Gd-concentration in bloodplasma (p) in a carotid 
artery during the time of the Gd-uptake experiment, see Eq. 3 and (12, 21). The fast phase of 
this bi-exponential decay (k1) is governed by Gd-exchange with the extravascular volumes in 
rest of body, and the slow phase (k2) is determined by the Gd- clearance via the kidneys (12).
Cp(t)= Ai-expk,t + A2-exp k2'f [3]
The arterial input function (Cp(t)) was determined independently in 3 rats (21). Briefly, the 
carotid arteries of 3 rats were cannulated and 20 blood samples of 60 ml per rat were taken at 
7 s intervals directly after bolus injection of Gd through the tail vein. Directly after sampling, 
blood samples were diluted in 10 ml heparine and 10 ml saline. Next, absolute Gd 
concentrations were determined using inductively coupled plasma-emission spectrometry (IL 
Plasma-200, Instrumentation Laboratory Benelux, IJsselstein, the Netherlands). The 
following parameters for the Cp(t) function of Eq. 3 were found: k1 = 0.015 s-1 ± 0.004 (SD) 
and k2 = 0.00117 s-1 ± 3.10-4 (SD) and A 1/A2 = 2.35 ± 0.2 (SD).
In reference 21, the effect of the bolus passage on estimations of uptake-rate constants 
was analyzed. A mean bolus passage was measured in a transversal slice through normal rat 
brain at a comparable location as 9L-gliomas in this study. When the bolus passage was 
included in the Cp(t) function, estimations of tracer-uptake rate constants became very 
inaccurate. These constants were not significantly different from estimations of k-values 
when the bolus passage was not included. Therefore, the first data points of the r1[Gd]-time 
curves which coincided with the bolus passage were omitted before fitting the curves to Eq. 
[2] (Figure 3.3B).
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Fluorescence microscopy. In complete transverse tumor sections morphometric analyses of 
the total vascular bed, perfused microvessels, hypoxic-/ necrotic areas and the extracellular 
volume in viable regions were performed using a computer-controlled digital-image analyses 
system connected to a (fluorescence) microscope.
Immunohistochemical staining. One day after the MR-measurements, markers for 
the detection of hypoxic cells (Pimonidazol, 20 mg in 0.1 ml saline, kindly provided by Prof. 
J. Raleigh, Dept. of Radiation Oncology and Toxicology, UNC school of medicine, Chapel 
Hill, NC, USA) and perfused microvessels (Hoechst 33342, 3 mg in 0.1 ml saline, Sigma, 
St.Louis, MO, USA) were injected via a lateral tail vein 60 min and 1 min, respectively, 
before sacrificing the rats. One minute after Hoechst injection, a complete transversal section 
of the brain containing the entire tumor as determined from T1* maps after Gd injection, was 
quickly removed and frozen in liquid nitrogen. In every tumor, 10 frozen tissue sections (5 
mm) at a location corresponding to the slice of the Gd -uptake experiment, were made using a 
cryo-microtome. Five sections, homogeneously distributed throughout the 2 mm slice of the 
MR-measurements, were used for quantitative immunohistochemical analyses of the 2D 
distribution of the total vascular bed, perfused microvessels (Hoechst) and hypoxic areas 
(pimonidazole).
The endothelium of all microvessels (= total vascular bed) was visualized with goat 
anti-collagen IV (Southern Biotechnology Associates, Birmingham, AL, USA) followed by a 
second antibody, TRITC-labeled donkey anti-goat (Jackson ImmunoResearch Laboratories 
Inc., West Grove, USA). For the staining of hypoxic areas, sections were incubated with 
rabbit anti-pimo (kindly provided by Prof. J. Raleigh, Dept. of Radiation Oncology and 
Toxicology, UNC school of medicine, Chapel Hill, NC, USA) followed by incubation with 
FITC-labeled donkey anti-rabbit immunoglobulin (Jackson ImmunoResearch Laboratories, 
West Grove, USA). Three tumor sections in between the previous 5 sections were used for 
conventional staining with eosin (cytoplasm) and haematoxylin (nuclei). Finally, NADH- 
diaphorase in the whole cytoplasm of cells was labeled in the remaining 2 sections using 
NADH and Nitro-blue-tetrazolium (NBT) (Sigma, St.Louis, MO, USA). Previous stainings 
were used to distinguish viable tumor regions from necrotic areas and to estimate the 
extracellular volume in viable regions (see end of material & methods).
Scanning and processing. Tumor tissue sections were processed in three steps: First, 
the perfused microvessels (Hoechst) were analyzed, followed by immunohistochemical 
staining of hypoxic areas and the endothelium of all microvessels. The distribution of 
necrotic areas and extracellular volume were evaluated separately. After each staining step 
sections were scanned using an extended version of the digital-image analyses system as 
described by Rijken et al (23). After processing all fields of each scan a composite image was 
reconstructed from the individual processed fields revealing the different structures. If the 
composite images of the tumor sections obtained after each step were combined, then the new 
matched image showed the 2D distribution of perfused microvessels, hypoxic areas and the 
total vascular bed simultaneously.
Finally, the fluorescent rim of the Hoechst dye around perfused microvessels due to 
Hoechst diffusion into adjacent tissue was deleted by image processing. In this way, the 
perfused surface-area of microvessels (see below) was not overestimated.
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Data analyses.
Matching o f r[G d] maps with immunohistochemical images. For each tumor, a 
representative immunohistochemical image showing the 2D distribution of perfused 
microvessel and hypoxic cells approximately half-way the 2 mm MR-slice, was used for 
matching with a ri[Gd] map obtained one minute after bolus injection. This particular ri[Gd] 
map was used, because rats were sacrificed one minute after injection of the fluorescent 
perfusion marker Hoechst. During the interactive matching (= shifting and rotating of the 
r1[Gd] maps relative to the immunohistochemical images) using IDL-software (IDL 5.1, 
Creaso GmbH, Gilching, Germany), prior knowledge on orientations of 1) the r 1[Gd] maps 
obtained in Gd-uptake studies, and 2) the tumor sections during histochemical processing was 
used.
To enable further analyses, an MR-lattice was generated consisting of voxels with a 4 
times lower spatial resolution than in original r1[Gd] maps using IDL-software (the new 
voxel volume was approximately 1 mm ). In a further study, the 2D distribution of r 1[Gd] in 
tumor slices will be spatially correlated to the distribution of metabolites as measured by 
spectroscopic imaging, therefore the spatial resolution of both experiments was tuned. In 
addition, the analyzes of correlations between k-values and morphometric parameters in large 
voxels are less sensitive to a mismatch of the Gd-enchanced MRI with histology than in small 
voxels.
Subsequently, each voxel of the MR-lattice was labeled. With help of the 
representative immunohistochemical image different categories of voxels were assigned as 
follows:
- Pr = voxels with perfused microvessels at the rim of the tumor.
- P = voxels with perfused microvessels inside the tumor.
- PH = voxels with perfused microvessels and hypoxic areas inside the tumor.
- HN = voxels with hypoxic- and necrotic areas only.
It should be noted that the distribution of perfused microvessels and hypoxic cells may 
slightly differ between the representative tumor section of the MR-slice and the 4 other 
sections homogeneously distributed throughout the MR-slice. For instance, a MR-voxel of 
category P, as assigned with use of the representative section may contain hypoxic cells in the 
other sections. All 5 tumor sections were used for estimations of morphometric parameters of 
the perfused vascular. For each voxel of category P and PH, correlations between these 
morphometric parameters and Gd-uptake rate constants (k-map) were analyzed (see next 
paragraph). The latter is important because r1[Gd]-time curves were fitted to pharmacokinetic 
models with parameters such as TBP and PSp-product, which are only defined in voxels with 
perfused microvessels. Voxels of category Pr were not included, because a large volume 
fraction in these voxels coincide with 'normal' brain tissue. A detail of an 
immunohistochemical image overlaid with a rotated and shifted MR-lattice is shown in 
Figure 3.3A, with assignments for the different voxel categories and voxel numbers.
Estimations o f the (perfused) microvessel density, the perfused microvessel length density 
and the total perfused surface-area. For each voxel of category P and PH the following 4 
morphometric parameters were estimated: 1. perfused microvessel density (Np, no.mm-2); 2. 
the total microvessel density (= density of perfused and nonperfused microvessels (N, 
no.mm-2)); 3. the perfused microvessel length density (Lp, mm.mm-3), and 4. the total 
perfused
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2 3surface-area density (Sp, cm .mm- ). The microvessel density parameters Np and N were 
defined as the mean of the perfused and total microvessels density per 5 tumor sections 
homogeneously distributed throughout a voxel. The perfused microvessel length density and 
surface-area density were estimated using a stereological algorithm (29). Briefly, for an 
estimation of Lp per voxel, the sum of the major axis (a) divided by the minor axis (b) (= 
eccentricity of ellipse) of all cross-sectional areas of perfused microvessels in all 5 tumor 
sections was divided by the total sum of areas per section in which microvessels were 
analyzed (At), see equation: Lp = Sa/b / S At. Five whole tumor sections were used for the 
calculations of Lp, because pilot studies revealed that the values of the latter were not 
significantly different when 10 or 20 tumor sections were taken. Furthermore, a model was 
developed to test the stereological algorithm for the estimation of Lp on our digital-image 
analyses system. The error in the estimation of Lp was approximately ± 15 %. In addition, 
analyses of Lp in different regions of the normal rat brain were comparable to estimations of 
Lp in previous studies (30) (results to be published elsewhere).
Next, the value of Sp was estimated after determination of the median radius (r) of all 
perfused microvessels per 5 tumor sections (= median of minor axis b divided by 2), using 
the following equation: Sp = (2.p. r. Lp)/ 100. The perfused microvessels were approached as 
cylinders with uniform dimensions. For each voxel of category P and PH, the relationship 
between Np or Sp and kLarsson values was analyzed using Graphpad software (Graphpad 
PRISM version 2, San Diego, USA).
Estimations o f the extracellular volume in perfused tumor regions. The following 3 
steps resulted in an estimated distribution volume of Gd (Vd) in perfused voxels. First, the 
extracellular regions were segmented from the cells stained by NADH-diaphorase applying a 
threshold operation in digitized images. Secondly, the extracellular volume (Ve) was 
estimated in perfused voxels using the following equation: Ve » 1 - (surface-area cells/ 
sample area). Finally, per perfused voxel the extracellular volume was corrected for the 
vascular volume (Vv) using the parameters defined in the previous paragraph (vascular 
volume per voxel volume is approximately: Vv » p.r .Lp). The value of Vd equals Ve -  Vv, 
and is assumed to be a maximum estimate of the Gd distribution volume in in vivo studies, 
because some cell shrinkage may occur during the quick-freeze of tumors.
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Results
Matching of r^Gd] maps with immunohistochemical images.
Examples of this matching for two tumors are shown in Figure 3.1 and 3.2. The r1[Gd] maps 
as obtained 1 min after bolus injection of Gd (Figure 3.1 A and 3.2A) were matched with 
immunohistochemical images showing the 2D distribution of perfused microvessels, the total 
microvessel bed and hypoxic regions (Figure 3.1C and 3.2C). In all tumors a positive 
correlation was observed between the distribution of the apparent Gd-concentration and the 
perfused microvessel distribution. Tumor regions with no Gd uptake appeared to be 
chronically hypoxic or necrotic. Necrotic areas were found in regions enclosed by hypoxic 
cells (results not shown here).
Figure 3.1 and 3.2 A) The distribution of the apparent Gd-concentration (ri[Gd]) for two representative 
tumors in a transversal slice (2 mm) through the center of the tumor 1 min after bolus injection of Gd. B) k- 
maps, calculated using the Larsson model. C) Representative tumor sections at comparable locations as MR- 
slices showing the 2D distribution of the total vascular bed (red structures), perfused microvessels (blue 
structures) and hypoxic areas (green structures). The immunohistochemical image of Figure 3.2C matches the 
delineated area in Figure 3.2A.
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In Figure 3.3A, a detail of an immunohistochemical image is shown which was overlaid with 
an MR-lattice as determined after matching with a ri[Gd] map. A pharmacokinetic model 
proposed by Larsson was fitted to changes of r 1[Gd] in time per voxel (11, 21), resulting in a 
k-map (Figure 3.1B & 3.2B). In Figure 3.3B, an example is shown of a fitted r1[Gd]-time 
curve as measured in a well-perfused voxel of category P.
Analyses of correlations between G d-uptake rates and param eters of the perfused 
vascular architecture.
With the help of immunohistochemical images, only voxels containing perfused microvessels 
(categories P and PH) were selected for a comparative study between kLarsson-values and 
parameters of the perfused vascular architecture (Figure 3.4 and 3.5). In previous studies, Gd- 
uptake rates were related to the microvessel density (MVD, (17, 18)). In our study, it 
appeared that Gd-uptake rates or kLarsson-values (s-1) have a linear relationship (Figure 3.4A) 
with the perfused microvessel density (Np) in voxels of category P and PH in transversal 
slices through the center of 10 9L-gliomas. However, no clear relationship was found 
between kLarsson-values and the density of all microvessels (perfused and nonperfused vessels, 
N) (Figure 3.4B).
In a next step, analyses of the perfused vascular density were extended to estimations 
of the perfused vascular surface-area per voxel (Sp). The latter parameter is expected to have 
a stronger correlation with Gd-uptake rates, when TBP is much larger than the PS-product 
(see definition of kLarsson and kTofts). Before Sp can be calculated, the length density (Lp, 
(mm.mm-3)) per voxel was estimated using a stereological algorithm (29). The lenght density is 
comparable to the perfused microvessel density Np when microvessels are arranged parallel 
to each other and perpendicular to cross-sectional areas of the voxels (29). If the microvessels 
are bent and twisted throughout the voxel volume, then Lp is always larger than Np. In tumor 
voxels of category P and PH of all 9L-gliomas the following linear correlation was found 
after least-squares regression analyses (n = 86, R = 0.95): Lp = [4.6 ± 0.3 (SD)] x Np. The 
large slope value (> 1) indicates that perfused microvessels were tortuous in the different 
voxels.
Finally, the perfused length density (Lp) and a median radius of all perfused 
microvessels (r) in the 5 tumor sections per MR-voxel were used to estimate the perfused 
vascular surface-area density (Sp) in P and PH voxels. The kLarsson-values were found to be 
linearly related to the estimated perfused surface-area density (Sp) (Figure 3.5). This 
correlation was slightly better than the correlation between Gd-uptake rates and the perfused 
microvessel density (Np) as shown in Figure 3.4A, see goodness of fit (R - values) in legends 
of Figures 3.4A and 3.5. The median radii which were used for the estimations of Sp varied 
between 3.6 and 6.5 mm. The distribution of the perfused microvessel radii was not 
homogeneous, however the percentage of radii larger than 2 times the median radius did not 
exceed 5 %. Thus, significant groups of large microvessel radii were not observed and are not 
expected to influence considerably the estimations of Sp.
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Figure 3.3 A) A detail o f an immunohistochemical image (see Figure 3.2B) overlaid with a MR-lattice. The 
different voxel categories: Pr, P, PH and HN are denoted. The light grey structures correspond to perfused 
microvessel (see also Fig. 3.1C and 3.2C) and dark grey structures in PH and H voxels are hypoxic cells. B) A 
ri[Gd]-time curve (* dashed line) of voxel no. 26 (category P, see black arrow) is fitted to the Larsson model 
(solid line). The nonlinear regression analyses resulted in a kLarsson value of 0.012 ± 0.0026 (SD) s-1. The error 
bars indicate the 95 % confidence interval.
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Figure 3.4 A) Analyses o f the 
correlation between Gd-uptake rates 
(kLarsson-values, s-1) and the perfused 
microvessel density (Np, no. mm-2) or 
B): the total microvessel density 
(perfused and nonperfused (N, no. mm- 
2)) in voxels of category P ( ) and PH 
(□ )  (see Figure 3.3A) of 10 9L-glioma 
rat models. The solid line in Fig. 3.4A 
indicates the results o f the least-squares 
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Figure 3.5 The correlation between kLarsson-values (s-1) (y-axis) and the perfused vascular surface-area (Sp, 
cm2.mm-3) per voxel o f categories P (■) and PH (□ )  (see Figure 3.3A) in 10 9L-gliomas. The solid line 
indicates the results o f the least-squares linear regression analyses of the data (n = 86, R2 = 0.72): kLarsson (s-1) = 
[0.23 ± 0.02 (SD)] x Sp. The dashed lines show the 95 % confidence intervals.
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Discussion
Tumor growth and metastasis is associated with angiogenesis (1, 2, 4). The angiogenic 
capacity of a tumor has been related to the total microvessel density (MVD), but information 
on this morphometric parameter does not necessarily allow judgements on functional aspects 
of the tumor microcirculation. Microvessels, which coincide with chronically hypoxic areas 
or necrotic regions, may not contribute to tumor growth or metastasis. Fast dynamic 1H-MRI 
studies of the Gd-uptake in tumor tissue have potential to gain insight into the distribution of 
perfused microvessels in tumor tissue slices or to provide knowledge on the perfused vessel 
density or vascular surface-area. Before dynamic Gd-enhanced MR-imaging can be 
recognized as a valid technique for analyses of functional microvessels, it will need extensive 
comparison with other techniques.
In this study, Gd-uptake rate constants were compared to immunohistochemical 
analyses of morphometric parameters of the perfused vascular architecture. This is possible 
when changes of the ^-relaxation time of water protons as a function of time due to the 
uptake of Gd in the extracellular volume are directly related to Gd-concentration changes. 
Fast dynamic SNAPSHOT ^-m easurem ents permit direct analyses of the apparent Gd- 
concentrations as a function of time, which can be related to morphometric and physiological 
parameters of the perfused vascular architecture by fitting pharmacokinetic models to Gd- 
uptake curves (11, 12). Measurements of Gd-uptake rates are also possible with T1-weighted 
fast MRI sequences (31-33), but these results are less accurate than those obtained with the 
fast T1-method. For instance, changes of signal intensities in T1-weighted fast MR images 
depend on the pulse angle a  (and so RF-inhomogeneity), the MR-sequence (TR, RF- 
spoiling), and the T1, T2 and T2* relaxation times. In reference experiments, the T2 and T2* 
relaxation times differ from those in the experiments after Gd-injection, and depend on the 
time after injection. However, the calculation of r1[Gd] changes using T1 maps before and 
after tracer administration are independent of the previous acquisition parameters and T2, T2* 
relaxation times (34).
The immunohistochemical analyses, which has been applied one day after the MR- 
experiments, seems to detect nearly all functional microvessels, since in regions with 
nonperfused microvessels chronically hypoxic cells (diffusion-limited oxygen-supply) and 
necrotic areas were detected. Microvessels, which transiently open and close in such ways 
that a hypoxic region appears acutely were not observed. In such a case, the Hoechst signal 
would show overlap with hypoxic cells and/or isolated areas of non-hypoxic cells would 
occur in hypoxic regions around nonperfused microvessels. Thus, it seems safe to presume 
that the immunohistochemical method allows a proper evaluation of functional aspects of the 
tumor microcirculation.
The distribution of apparent Gd-concentrations in whole transversal tumor slices was 
found to be spatially correlated to the 2D perfused microvessel distribution in a representative 
tumor section of that slice. In a next step, Gd-uptake rates were found to be linearly related to 
the perfused microvessel density, and perfused microvessel surface-area in voxels containing 
perfused microvessels. The linear relationship between kLarsson and the perfused vascular 
surface-area indicates that the Gd-uptake rate is not affected by variations in vascular 
permeability (P) and/or tumor blood perfusion (TBP). In the present study, the molecular 
weight of Gd is probably not large enough to discriminate between more or less leaky tumor 
microvessels; all microvessels were highly permeable to Gd. The heterogeneity of the 
vascular permeability may be assessed by contrast agents with a molecular weight larger than 
20 kD (35-37).
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In previous fast dynamic MRI-studies of the Gd-uptake, two different pharmacokinetic 
models were used to fit to changes of the apparent Gd-concentration in time, namely: the 
multi-compartment model of Tofts (12, 38) and the single-capillary model of Larsson (11). If 
Gd-uptake rates are not affected by variations in tumor blood perfusion, then the kLarsson may 
be approached by the Gd-uptake rate constant as defined by Tofts (12, 28) (kTofts). The uptake 
rate constant kTofts has a linear relationship with tracer transport across the vascular 
endothelium (PSp-product) and an inverse relationship with the distribution volume of the 
tracer in the volume of interest. In such a case, the slope of Figure 3.5 equals the apparent 
vascular permeability (P) divided by the distribution volume of the tracer per voxel (Vd). The 
use of the term apparent vascular permeability is preferable, since Gd-uptake rates were 
obtained from homogeneously and heterogeneously perfused voxels. In heterogeneously 
perfused voxels, the tracer may have arrived from nearby capillaries, and may have arrived 
by diffusion through the extracellular volume from more distant perfused microvessels, 
which overestimates the calculations of the vascular permeability. The distribution volume 
(Vd) of Gd in perfused voxels was approximately 25 ± 1.5 (SD) % and equals the 
extracellular volume corrected for the vascular volume, which varied between 1.5 ± 0.5 (SD) 
% and 2.4 ± 0.7 (SD) %. Thus, consequently the cellular volume fraction is close to 73 %, 
which is comparable to mean values found by K. Donahue et al in a mammary 
adenocarcinoma model (39). The apparent microvessel permeability (P) in voxel categories P 
and PH can now be calculated using the estimated Vd value and the slope of Figure 3.5: P =
6.10-5 cm.s-1.
The vascular permeability for Gd and/or the PSp-product was measured previously in 
gliomas growing in the rat brain (40, 41). However, the values found in these studies cannot 
be compared directly to estimations of the vascular permeability or PSp-product in the present 
study, because the PSp-product was estimated using a simple graphical method of Patlak et al 
(42). The latter method assumes that the reflux of Gd from the tumor interstitium back into 
the microvessels can be neglected (unidirectional two-compartment model). However, in our 
study, changes of the Gd-concentration in the extravascular volume of the tumor were not 
linear during the time of the Gd-uptake experiments. This means that the reflux of Gd from 
the tumor interstitium back into the microvessels should be taken into account, see the 
models of Tofts or Larsson (11, 12). In studies on the quantitation of blood-brain barrier 
permeability in patients with multiple sclerosis lesions using a comparable MR-method and 
pharmacokinetic model as applied in this study, permeability constants in a range of 0.4 -
1.7.10-5 cm.s-1 were found (12). These values are smaller than our estimations of the 
permeability of the blood-brain barrier in 9L-gliomas, which may be explained among others 
by differences in the disruption of the blood-brain barrier.
The linear relationship between Gd-uptake rates and the perfused vascular surface- 
area indicates that Gd-uptake rates are not affected by variations in tumor blood perfusion 
(TBP). The relationships between Gd-uptake rates, PSp-product and TBP are now analyzed 
using the single-capillary model of Larsson (11). In this way, information can be obtained on 
the range of TBP values, which may affect the linear relationship between kLarsson and PSp- 
product. Estimates of the vascular permeabilty in this paper and the tracer distribution volume 
in voxels of vital tumor regions permit simulations of these relationships (Figure 3.6). In 
these simulations, the TBP was varied between 0 and 4 times the maximum PSp-product 
found in the present study (= product of the apparent vascular permeability and the maximum 
Sp value). In addition, information on the range of kLarsson values was used, since kLarsson 
values larger than 0.021 s-1 were not detected in perfused voxels. In Figure 3.6, it is shown 
that the relationship between kLarsson and the PSp-product becomes slowly linear when
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the TBP is larger than the PSp-product. Thus, the linear relationship between kLarsson and Sp 
can only be explained when the TBP is larger than the PSp-product in the different voxels.
PSp- product (cm3. s-1)
Figure 3.6 Surface-plot of correlations between the permeabilty surface-area product (PSp-product, x-axis), 
tumor blood perfusion (TBP, y-axis) and Gd-uptake rate constants (kLarsson, z-axis) using the definition of the 
rate constant k as proposed by Larsson et al (11): kLarsson = E x TBP/Vd. The distribution volume (Vd) of the 
tracer in the extracellular volume of perfused voxels (1 mm3) was 25 % in these simulations.
Pratical applications: If Gd-uptake rates in voxels with perfused microvessels are governed 
by the perfused vascular surface-area or indirectly by the perfused vascular density, then 
quantification of these Gd-uptake rate constants may help to monitor noninvasively the effect 
of an anti-angiogenic therapy (8, 16). The latter therapy should not decrease the TBP in such 
a way that it becomes equal to or smaller than the PSp-product, but should only have an effect 
on the number of perfused microvessels or vascular surface-area. Furthermore, the early 
enhancement of Gd in apparent Gd-concentration maps was found to spatially correlate to the 
perfused microvessel distribution. This information may be used in the prediction phase 
before radiotherapy or chemotherapy, since both treatments depend among others on the 
delivery of oxygen and drugs, respectively, via functional microvessels. Nonperfused 
hypoxic tumor regions were not enhanced in r1[Gd] maps, and therefore these maps provide 
additional information on tumor areas which depend on oxygen and drug supply by diffusion 
(see the immunohistochemical analyses of chronically hypoxic cells). Therefore, areas in 
r1[Gd]-maps which are not enhanced may be less sensitive to radiotherapy (42) or 
chemotherapy.
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Conclusions. In whole tumor sections through the center of 9L-gliomas in the rat brain, a 
spatial correlation was found between the apparent Gd-concentration and the 2D distribution 
of perfused microvessels. In perfused voxels, the Gd-uptake rates were linearly related to the 
perfused microvessel density and vascular surface-area. The latter relationship indicates that 
Gd-uptake rates do not depend on variations of the tumor blood perfusion and vascular 
permeability. Therefore, quantification of Gd-uptake rates has potential to monitor 
noninvasively the effect of a therapy on the perfused microvessels density or vascular 
surface-area.
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Abstract
The aim of this study is to evaluate the existence of a possible relationship between global 
HDO-uptake rates and the diffusion geometry of human glioma xenografts in nude mice.
HDO diffusion times in the whole extravascular tumor volume were estimated by 
combining quantitative 1H-MR diffusion imaging and morphometrical analyses of intercapillary 
distances in 2 tumor lines with a different perfused vascular architecture. HDO-uptake was 
measured independently using H-MRS. Uptake time constants (t) were compared to 
estimations of maximum HDO diffusion times (tdifmax).
Tumors with a homogeneously perfused capillary distribution showed a mono­
exponential HDO uptake. The tdifmax was comparable to t's  of HDO-uptake curves: tdifmax varied 
between 74 and 368 s and the range of t's  was 115 - 370 s. Heterogeneously perfused tumors 
had a bi-exponential HDO uptake with tdifmax in between the t's of the fast and slow uptake 
phase.
These findings indicate that the global HDO uptake is related to the perfused capillary 
distribution in human glioma xenografts. That HDO-uptake rates indeed can depend on the 
perfused capillary distribution was substantiated in experiments with 2D models. In these 
models with a diffusion-limited HDO-uptake, HDO-uptake curves could be approximated by 
curves derived from 2D HDO-diffusion simulations.
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Introduction
Tumor blood perfusion can determine among other physiological parameters the sensitivity of a 
tumor to radiotherapy and/or chemotherapy. Manipulations of tumor blood perfusion (TBP) may 
enhance the sensitivity of a tumor for a particular treatment. Therefore, information on TBP can
help to select the most suitable treatment modality.
2 2 2 H-magnetic resonance spectroscopy ( H-MRS) and imaging studies ( H-MRI) of HDO
uptake and HDO clearance in tumor tissue have frequently been used for the determination of
TBP (1-8). 2H-MRI has been used to study regional HDO-uptake and TBP (3, 5 ,8), whereas 2H-
MRS has been used to analyse the global HDO-uptake in the whole tumor volume (1, 2, 4, 7).
Generally the time to reach tracer concentration equilibrium between the vascular - and
extravascular compartment is supposed to be instantaneous and TBP can be derived from HDO-
uptake rates using the Kety model (9). However, the assumption that HDO uptake is perfusion-
limited has to be verified for every application (10).
The HDO uptake may become diffusion-limited at high perfusion rates (10) and/or in 
tissue with a significant fraction of large intercapillary distances. The Kety model as well as 
other kinetic models (11-13) which were used for the interpretation of tracer-uptake studies 
include tracer diffusion through the vascular endothelium per unit tissue volume (permeability 
surface-area product (9, 12, 13), but ignore tracer diffusion in the extravascular space. In normal 
and tumor tissue, the permeability surface-area product for HDO is sufficiently high relative to 
TBP (14). In addition, diffusion distances between capillaries in normal tissue are small 
(approximately 50 mm (15, 16)), so that the characteristic time of HDO diffusion is short in 
comparison to the capillary transit time of the tracer (perfusion-limited uptake, (8)). However, in 
tumors with extended hypoxic and necrotic areas a significant fraction of large intercapillary 
distances exist, which may decrease the time to reach tracer equilibrium by diffusion between 
the perfused and nonperfused regions. Tracer diffusion distances between perfused capillaries in 
the whole tumor volume have never been analyzed so far.
Detailed information on the pattern of tracer delivery is important in the context of 
radiotherapy and chemotherapy. The lack of O2 or chemotherapeutic agents in tumor tissue can 
be due to the presence of regions with low TBP or of nonperfused regions, characterized by 
large diffusion distances between perfused capillaries. In the first case, an increase of the tumor 
oxygenation or drug delivery may be achieved by an improvement of the TBP. However, such a 
treatment modulation will not be effective in the second case (17).
The aim of this study is to investigate the existence of a possible relationship between 
HDO-uptake rates and HDO diffusion times in the extravascular space of two different human 
glioma xenograft lines with a homogeneously and heterogeneously perfused vascular 
architecture. HDO diffusion times were estimated combining quantitative 1H-MR diffusion 
imaging (18) and two-dimensional morphometrical analyses of intercapillary distances between 
perfused capillaries in complete transverse tumor sections (19). Maximum HDO-diffusion times 
were related to time constants of HDO-uptake curves as measured independently with 2H-MRS. 
A linear correlation was found between the maximum HDO-diffusion times and the time 
constants of the HDO-uptake. To obtain a better understanding of the relation between HDO- 
uptake rates and HDO diffusion times in the extravascular volume, HDO-uptake curves of 2D 
models with anisotropic capillary distribution were compared to curves derived from two­
dimensional HDO diffusion simulations. As models we used blood filters, which contained 
bundles of parallel, perfused capillaries and which showed diffusion-limited HDO uptake. 
Intercapillary distances were varied and the effect on HDO-uptake rates was studied by H- 
MRS. A good approximation of HDO-uptake curves in all blood filters was obtained by the 
simulation of 2D HDO diffusion.
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Material and Methods
In  vivo studies.
Animal model. Two tumor lines (E49 and E98), with a different perfused vascular architecture 
and derived from two different primary human gliomas, were grown subcutaneously in the hind 
limb of athymic mice (Balb/c nu/nu, BonholdGard Denmark). The E49 line was more 
heterogeneously perfused than the E98 line (20). Cannulae (Neoflon 0  0.6/19mm, 24 G) were 
inserted in a tail vein for online administration of D2O. Mice were anaesthetized by exposure to 
1.5 % enflurane in an O2/N2O (3:7) mixture applied through a nose cone. Their body 
temperature was monitored with a rectal probe (36 G, Hewlett Packard) and maintained at 36.5o
- 37o C by a warm water blanket with a feedback system. In 2H-MRS experiments and in 
immunohistochemical analyses 10 E49 tumors and 9 E98 tumors were analyzed. In 1H-MR 
diffusion experiments the same tumor lines but different tumors were used: 8 E49 tumors and 6 
E98 tumors. The local ethical committee for animal use approved the experimental procedures.
Quantitative 1H-M R diffusion imaging experiments. 1H-MR diffusion experiments were 
performed on a horizontal-bore SISCO 200/400 spectrometer (4.7 T) with a 220 mT.m-1 
gradient insert (rise time = 300 |is). A single 2.0 cm diameter, inductively coupled surface coil 
tuned to the proton frequency (200.1 MHz) was used for both RF transmission and reception. 
Before the diffusion experiments sagittal 1H-SE images were made for the positioning of a 
coronal slice in the center of the tumor parallel to the surface coil. The following acquisition 
parameters were used: TR = 1.5 s, TE = 23 ms, matrix size 256 x 64, FOV 5 x 5 cm and slice 
thickness = 1.5 mm.
An adiabatic double spin-echo sequence (21) was used for the measurement of apparent 
diffusion coefficients of water in tumors, using the following acquisition parameters: TR = 2.5 s, 
TE = 65 ms, matrix size = 256 x 128, FOV = 2.5 x 2.5 cm and slice thickness = 1.5 mm. Signal 
excitation was performed with a non-selective adiabatic half passage pulse (pulse length = 1.0 
ms) (22) while frequency selective refocusing was achieved with a pair of adiabatic full passage 
(AFP) pulses (23) (pulse length = 2.0 ms). Diffusion weighting was introduced by a pair of 
halfsine shaped gradients around each AFP pulse (gradient pulse length 8 = 5 ms, separation of 
the gradients A = 19 ms). Apparent diffusion coefficients of water (ADCw) were obtained by 
fitting 5 separate diffusion measurements (b = 2.(2/ p)2.g2.G2.82.(A - 8/4)) : 33, 179, 441, 821, 
1317 s/cm , where g is the gyromagnetic ratio and G the maximum gradient amplitude) with a 
mono-exponential curve (18).
Data analyses. Per tumor, a mean ADCw (mADCw) for all voxels of the ADCw map was 
calculated. For calculations of the maximum diffusion time (see Eq. [3]) an average ADCw value 
of all tumors was used. The average ADCw is defined as the average of all mean ADCw values 
of both tumor series.
2 2H-Magnetic Resonance Spectroscopy. 2H-MRS measurements were performed on a vertical- 
bore Bruker spectrometer (4.7 T) employing a home-built 1H/2H double tunable 3-turn solenoid 
coil with an inner diameter of 13 mm. The solenoid coil was fitted with a Faraday shield to 
eliminate spurious signals from normal tissue adjacent to the tumor. Mice, with human glioma 
xenografts, were excluded if host tissue was partially present in the volume sampled by the 
solenoid (tumor weight < 0.3 g) and when tumors did not fit completely in the solenoid (tumor 
weight > 0.9 g). H-MRS spectra were obtained with a one-pulse sequence using a flip angle of
HDO uptake and diffusion geometry in glioma xenografts 53
10o, TR = 766 ms and number of scans = 64. An i.v. bolus injection of 0.1 ml PBS D2O solution 
was given after the acquisition of the third of 100 serial 49-s H-MR spectra.
The HDO concentration in blood plasma after an i.v. bolus injection of 0.1 ml PBS HDO 
solution was analyzed by cannulating the carotid arteries of 3 mice. Starting one min after 
injection, 8 blood samples (20 |il) were taken at 10 min intervals. The samples were diluted in 
600 ^l saline. The HDO concentration in the diluted blood samples was determined with in-vitro 
H-MRS using a standard HDO solution for calibration.
Data analyses. 2H-MR spectra were obtained after applying zero filling and exponential 
line broadening (10 Hz) to the free induction decay. The HDO peaks were fitted to Lorentzian 
lineshapes with NMR1 software (New Methods Research, Inc., Syracuse, NY, USA). Relative 
HDO amount changes in time were estimated from HDO peak integrals. Next, HDO-uptake 
curves were fitted to a minimum number of exponential terms. The F-test was used to 
distinguish between mono-exponential or bi-exponential HDO uptake, see Eq. [1] and [2], using 
Graphpad software (Graphpad PRISM version 2.0, San Diego, USA). In Eq. [2] A and B are 
defined as weight factors belonging to the exponential components with the largest (k1) - and 
smallest rate constant (k2), respectively. After fitting the HDO curves to Eq [1] or [2] the HDO 
peak integrals were normalized to the value of A or to the sum of the A and B value.
f(A,k;t) = A.(1-e kt ) [1]
f(A, B,k] ,k2 ;t)) = A.(1-e klt)+B.(1 - e-k2t) [2]
The parameter t  = 1/k is called the time constant of mono-exponential uptake curves and equals 
the time (s) at which the amount of tracer corresponds to 63 % of its final value (= 0.63*A). Per 
tumor with mono-exponential or bi-exponential HDO uptake, values of t  (or weighted mean 
values of t 1 and t 2) were compared to estimations of maximum HDO diffusion times (tdifmax, see 
Eq. [3] and Figure 4.5). This approach was validated in model studies (Table 4.2).
Fluorescence Microscopy and two dimensional morphometrical analyses of perfused 
vascular architecture. In complete transverse tumor sections morphometrical analyses were 
employed, using a computer-controlled digital image analyses system connected to a 
fluorescence microscope. A detailed description of this method is given by Rijken et al (19). 
Briefly, after the H-MRS experiments, a 0.05 ml solution of PBS (phosphate buffered saline, 
pH=7.4) containing a fluorescent perfusion marker Hoechst 33342 (15 mg/kg, Sigma chemical 
company, St.Louis, USA), was injected i.v. via a lateral tail vein. One minute after injection the 
mice were killed and tumors were quickly removed and frozen in liquid nitrogen preventing the 
redistribution of the dye. The tumor was cut in halves: one half was used for the analyses of 
perfused capillaries and the other half was used for classical histological staining with eosin 
(cytoplasm) and haematoxylin (nuclei). Fifteen frozen tissue sections (5 mm) at random loca­
tions were made using a freeze microtome. Sections were incubated at room temperature for 15 
min with collagen Type IV polyclonal antibody (rabbit serum, Euro-Diagnostics BV, Oss, The 
Netherlands), a marker for the basal lamina of capillaries. Next, the sections were incubated with 
a second antibody, goat anti rabbit immunoglobulin labelled with Tritc (Tago-Inc., Birlingame, 
USA).
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The complete transverse tumor sections were analyzed in the fluorescence microscope using a 
digital image processing system. Each section was scanned twice on a computer-controlled 
motorized stage of a fluorescence microscope using two different excitation/emission filters. 
After processing all fields of each scan, a composite image was reconstructed from the 
individual processed fields revealing the perfused capillaries (Hoechst image) and the total 
capillary bed (Collagen image) in separate scans. When both images were combined, the new 
matched image showed the perfused - and nonperfused capillaries (see Figure 4.4A and 4.4C). 
In the next step the fluorescent rim of the Hoechst dye around perfused capillaries due to 
Hoechst diffusion into adjacent tissue was deleted by image processing.
Data analyses. For each perfused vessel a domain (defined in ref. (24)), i.e. the area of 
tumor tissue which is supposed to be supplied by the nearest perfused vessel, was determined in 
matched images containing only the perfused capillaries. As a consequence, one domain 
contains one perfused capillary and may contain nonperfused capillaries and avascular regions. 
Line networks as shown in Figure 4.1 represent the contours of these domains. Contours of 
domains (= lines in between perfused capillaries) were used to estimate intercapillary distances 
(icds), which were defined as the shortest distance between neighbouring perfused capillaries, 
crossing the contour lines perpendicularly (e.g. see arrow in Figure 4.1). Note that neighbouring 
perfused capillaries have adjacent domains. Thus, intercapillary distances were not determined 
between perfused capillaries which did not have adjacent domains.
A mean intercapillary distance (micd) was calculated for the largest icds found between 
perfused capillaries (micdmax) in all 15 sections per tumor, as verified in matched fluorescence 
images showing the perfused - and nonperfused capillaries. Half of the micdmax was used as an 
estimate of maximum diffusion distances between perfused capillaries adjacent to nonperfused 
regions (see Eq. [3]). Nonperfused tumor regions are defined by a small number of large icds in 
comparison with perfused regions, which contain a large number of small icds (see Figure 6.2 
on page 96). If mean icds would have been used, then diffusion distances in the whole tumor 
volume were underestimated since approximately 70 % of the icds are shorter than 100 mm 
(perfused regions) but the small number of large icds determine HDO diffusion times from 
perfused into nonperfused regions. Note that global HDO-uptake measurements are sensitive to 
HDO diffusion processes in the whole tumor volume. For capillaries at the edge of a tumor 
section the shortest distance between perfused capillaries and the edge was taken as diffusion 
distance rather than half the intercapillary distance.
Estimation of maximum HDO-diffusion times between perfused capillaries.
Mean maximum intercapillary distances per tumor (micdmax, see previous paragraph) obtained 
from 2D data sets of 15 tissue sections and the average water ADC (avADCw) were used to 
estimate maximum HDO-diffusion times (tdifmax). The Einstein equation for 2D diffusion, as 
given by Vaupel et al (26), was used for rough estimations of maximum diffusion times in tumor 
tissue slices, Eq. [3]:
~ (micd max___
tdifmax . . _
4.avADCw
[3]
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Figure 4.1 Detail of a matched digitized fluorescence image of a scanned tumor section. The black structures are 
cross-sectional areas of perfused capillaries. The grey lines, determined by the computer, are exact mid-lines 
between the vessel walls and represent the contours of vascular domains. These lines were used for the 
determination of the shortest distances (= intercapillary distances) between vessel walls (see black lines). The arrow 
indicates a shortest distance between two perfused capillaries.
Model studies
Model. Six blood filters were used as two-dimensional diffusion models (Pan H-10, Asahi 
Medical CO., LTD. Japan). Filters consisted of ~ 150 parallel perfused capillaries with a mean 
radius of 0.15 ± 0.01 mm and length of 10 ± 0.1 cm in a cylindrical volume of 10.4 ± 1 ml. The 
side ports for the counter flow were blocked; the tracer could only enter and leave the cylinder 
by the capillaries. The membranes of the capillaries (thickness ~5 |im) consisted of 
polyacrylonitril with pores which were highly permeable to small molecules such as HDO, but 
which excluded molecules with molecular weights larger than 24 - 25 kDa. The perfused 
capillary distribution in the blood filters was changed by blocking the capillaries at the inlet of 
the filter with plastic cylinders precisely fitting in the capillaries. Only filters with a comparable 
capillary distribution at the inlet (= capillary distribution used in the diffusion simulations) and 
in the cylindrical volume of the filter (= volume of interest during the 2H-MRS experiments) 
were selected for 2H-MRS experiments.
Blood filters were incorporated in an open system, see Figure 4.2A. The reservoir at the
inlet of the pump contained a 10 % HDO solution in demi water (v/v). The water flow velocity
in the system was determined by the pump (Fluid Metering Inc., Oyster Bay, NY, USA) which
was able to generate constant flow velocities varying between 0.23 ml.s-1 and 4.5 ml.s-1. The
flow velocities were calibrated with an in-line device (Fluid Metering Inc., Oyster Bay, NY,
USA). In most experiments the flow velocity was 2.46 ml.s-1. At this flow velocity the mean
capillary transit time of HDO molecules is 0.4 s (approximately the volume of capillaries (1 ml)
divided by 2.46 ml.s-1). The experiments were performed at room temperature: 20 ± 0.3o C. The
temperature was measured with a rectal probe in the reservoir at the inlet of the pump. At this
-5 2 -1temperature the self-diffusion coefficient for water is ~ 2.10- cm .s- (27, 28).
Deuterium Magnetic Resonance Spectroscopy (2H-MRS). The 2H-MRS experiments 
were performed on a 4.3 T, 7.5 cm diameter vertical-bore magnet equipped with an SMIS 
spectrometer (SMIS ltd. Guildford U.K.) employing a homebuilt double tunable 1H/2H Helm­
holtz coil with a diameter of 2 cm and a length of 3 cm.
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The Helmholtz coil was situated around the middle of the blood filter to measure the HDO- 
uptake in the extracapillary volume of the blood filter (see Figure 4.2B).2
H-MRS spectra were obtained with a one-pulse sequence with the following acquisition 
parameters: flip angle = 10o, TR = 1250 ms, number of scans = 2. Data were analyzed as 
described in the first 4 sentences of the paragraph data analyses of in vivo H-MRS studies.
Simulation of diffusion. Photographs of the 2D capillary distribution at the inlet of 
normal and modified blood filters were digitized using a digital-image processing system (19). 
The Cartesian coordinates of the capillaries were determined and set into a 2D matrix with a grid 
size of 53 x 53 pixels. At this size the cross-sectional area of one capillary corresponds to one 
pixel. An octagon approximated the circular boundary of the filter inlet. For a constant supply of 
tracer, the 2D diffusion of HDO was simulated by solving Fick's law numerically using Matlab® 
(see appendix and ref. 29). The sum of all pixels was taken per time step and represented the 
total amount of HDO in the volume of interest per time unit, similar to H-MRS experiments. 
The HDO concentration gradients at the edge of the filter were set to zero since there was no 
diffusion to the outside of the filter. For the simulation of diffusion the following assumptions 
were made:
1. The diffusion coefficient was independent of time and location.
2. Capillaries were considered perfectly parallel in the cylindrical volume of the filter. In this 
way, HDO-uptake experiments can be compared with 2D diffusion simulations.
3. The HDO concentration in the capillary was considered independent of the distance from 
the inlet of the filter.
4. The diffusion of HDO molecules across the capillary membrane was supposed to be 
isotropic and not to be hindered by the porous structure of the wall.
5. Axial diffusion in the extracapillary space of the filter was not taken into consideration. For 
HDO-uptake experiments the Helmholtz coil was situated in the middle of the blood filter 
minimizing the effect of axial diffusion since a loss of tracer at the outlet of the volume of 
interest is compensated at the inlet.
A Magnet (4.3 T) B
Helmholtz
t
Figure 4.2 Schematic representation of the setup for model studies (Figure 4.2A). The reservoir at the inlet of the 
pump contained a 10 % HDO solution in demi water (v/v). The Helmholtz coil was situated around the middle of the 
blood filter (see Figure 4.2B).
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Results
In  vivo studies 
Analyses of the w ater apparent diffusion coefficients (ADCw) in tum or tissue.
An example of a ADCw map of a coronal slice through the center of a tumor (E49) is shown in 
Figure 4.3. The signal intensity per voxel is directly related to the ADCw. Tumors from both 
lines showed an ADCw range from 4.10-6 cm2.s-1 to 14.10-6 cm2.s-1. No significant difference 
was observed between the mean ADCw of both tumor lines (paired t-test, p = 0.07). For further 
calculations, an average ADCw value (8.4.10 '6 ± 2.4 .10-6 (SD) cm2.s-1) derived from mean 
ADCw values of all tumors of both lines was used.
Figure 4.3 A representative 
water apparent diffusion 
coefficient (ADCw) map of a 
slice through the center of an 
E49 tumor. The intensities are 
directly related to ADCw 
values, which varied from 
6.10-6 cm2.s-1 to 9.3.10-6 cm2.s-1 
in this example.
M orphometrical analyses of the 2D perfused vascular architecture and intercapillary 
distances.
In comparison to skeletal muscle, human glioma xenografts have asymmetrical intercapillary 
distance (icd) distributions with a long tail of large icds (see 25 and Figure 6.2, chapter 6). 
Composite digital fluorescence images of scanned tumor sections and corresponding HDO- 
uptake curves of 2 representative tumors of each line are displayed in Figures 4.4. The perfused 
capillaries are shown in white. Tumor E49, no.5 represents one of the least perfused tumors in 
this study: a large area in the center of the tumor was not perfused (Figure 4.4A). This tumor had 
a bi-exponential HDO uptake, see Figure 4.4B. E98 tumor in Figure 4.4C had a more 
homogeneously perfused vascular architecture with a mono-exponential HDO uptake (Figure 
4.4D). Note that the time scale in Figure 4.4D is different from Figure 4.4C. In general, E49 
tumors had a more heterogeneously perfused vessel distribution than E98 tumors. Most E49 
tumors were found to have larger maximum intercapillary distances than E98 tumors (Table 4.1, 
column 3).
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Figure 4.4 Digitized and processed fluorescence images of a coronal section through the center of two 
representative E49 (4.4B) and E98 tumors (4.4C) showing perfused capillaries (white structures) with the 
corresponding HDO-uptake curves of the whole tumor (Figure 4.4B and 4.4D). In the HDO-uptake curve, data 
points represent normalized integrals of HDO peaks, and the solid line is the result of a least-square bi-exponential 
regression analyses of the data. All values reported hereafter are means ± SE. The results o f the regression analyses 
are (Fig. 4.4B, bi-exp.: F-ratio = 9.8 and p = 1.3. 10-4): R2 = 0.96, A = 80 ± 10 %, B = 20 ± 2 %, k1 = 1.4. 10-3 ± 4.10­
4 s-1, k2 = 1.7. 10-4 ± 5. 10-5s-1. The results of the regression analyses in Fig. 4.4D are: mono-exp. , R2 = 0.88, k = 1.1. 
10-2± 1.2 10-3 s-1.
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Comparison between maximum diffusion times and the time constants of the HDO-uptake 
curves.
HDO diffusion times for maximum icds as estimated using Eq. [3] are given in column 4 of 
Table 4.1. The time constants t, t 1 and t 2 (s) for mono-exponential or bi-exponential HDO 
uptake as obtained after fitting to Eq. [1] or [2] are included in columns 5 and 6, respectively. 
For mono-exponential HDO-uptake curves, t  had the same order of magnitude as tdifmax, 
especially for the E98 tumors: no. 12 - no. 16. Most E98 tumors showed a mono-exponential 
uptake and most E49 tumors a multi-exponential HDO uptake. For bi-exponential HDO-uptake 
curves, t f a x  was in between t 1 and t 2. The correlation between tdifmax and t  or the weighted 
mean of t 1 and t 2 ( tw) is further illustrated in Figure 4.5.
For multi-exponential HDO-uptake curves, the HDO concentration in tumor tissue was 
not in equilibrium with the HDO concentration in blood after 80 minutes. However, 8 blood 
samples taken at 10 min intervals from the carotid arteries of 3 mice, starting one minute after 
bolus injection of D2O, showed a steady state HDO concentration for all samples (results not 
shown).
Table 4.1 Comparison between estimated maximum diffusion times (td,fmax) and time constants of HDO-uptake 
curves in E49 and E98 tumors of different weight (w). In column 4, maximum diffusion times (tdlfmax) are calculated 
using micdmax (column 3) and the average ADCw of 8.4.10-6 cm2.s-1, see Eq.[3]. In column 5 and 6, time constants 
for mono-exponential (t) or multi-exponential HDO-uptake curves (t 1 and t 2 ) are given, see further details in text. 
All values are depicted with their SE.
Table 4.1
no. w (g) micdmax (|im) tdifmax (s) t  or t 1 (s) t 2 (s)
E49 1 0.35 1783± 78 237 370 ± 10
2 0.42 1800± 66 241 249 ± 15 1115± 200
3 0.36 1820± 80 246 117 ± 17 685± 111
4 0.42 3000± 57 670 99 ± 91 567± 170
5a) 0.63 3775 ± 53 1060 714 ± 20 5882± 386
6 0.90 2911± 68 631 161 ± 22 1904± 244
7 0.41 1893± 86 267 123 ± 19 1381± 176
8 0.34 2784± 110 577 116 ± 23 974± 118
E98 11 0.64 997 ± 40 74 172 ± 20
12b) 0.27 1267± 63 119 89 ± 12
13 0.37 1549± 80 179 226 ± 25
14 0.90 2223 ± 89 368 363 ± 29
15 0.87 1633± 65 198 175 ± 16
16 0.68 1100± 55 90 115 ± 10
17 0.82 1405 ± 70 147 81 ± 7 649 ± 71
18 0.90 2042± 102 310 150 ± 17 1462± 117
a) see Figure 4.4A, b) see Figure 4.4C
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Figure 4.5 Plot of the correlation between time constants of mono-exponential HDO-uptake curves (t, s) or 
weighted mean time constants (tw, s) o f bi-exponential HDO-uptake curves and the estimated tdlfmax (s) for the tumor 
lines E49 ( ) and E98 ( ) (One square represents one tumor). In the case of bi-exponential uptake, the weight 
factors A and B (see Eq. (2)) were used for calculations of the tw (= (A*t1+ B*t2)/(A+B)). The line indicates the 
results of the least-squares linear regression analyses (R2 = 0.92): time constant = 1.5 ± 0.12 (SD) * tdlfmax. The 
regression line was forced to go through zero. The dashed line shows the 95 % confidence intervals. Error bars 
reflect SE.
Model studies 
M easurements of the HDO uptake in the middle of unmodified blood filters.
In order to validate the blood filters as models for diffusion-limited HDO uptake, the HDO 
uptake in the middle of filters was measured at different flow velocities: 0.91, 1.55 and 2.46 
ml.s-1. The rate constants of HDO-uptake curves (k) at these flow velocities in e.g. filter 3 were
0.021 ± 0.001 (SE), 0.027 ± 0.0003 and 0.028 ± 0.002, respectively. In all filters, the HDO- 
uptake rate constants for the largest flow velocities were not significant different, because the 
HDO-uptake rates were limited by diffusion. The largest flow velocity was used in the following 
studies.
Comparison of the time constants of HDO-uptake curves with maximum diffusion times of 
HDO in unmodified blood filters.
Comparable to the procedure used for the in vivo studies, the rate constants of HDO-uptake 
curves were compared to maximum diffusion times of HDO in the extracapillary volume of 
unmodified blood filters. The maximum diffusion time (tdifmax) was estimated using the mean 
maximum intercapillary distance (micdmax) in unmodified blood filters with mono-exponential 
HDO-uptake curves. Mean maximum inter capillary distances of the unmodified blood filters 
(see Table 4.2, column 2) were in between mean maximum intercapillary distances found in 
human glioma xenografts, which varied between 997 mm and 3775 mm.
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The maximum diffusion times (tdifmax) in Table 4.2 have the same order of magnitude as the time 
constants (t). Note that the time constant of mono-exponential HDO-uptake curves equals the 
time at which the amount of tracer corresponds to 63 % of the final amount in the steady state. 
For example, blood filter 2 had an time constant of 26 s, which indeed corresponds to the time at 
which the amount of tracer is 63 % of the amount in the steady state, see Figure 4.6B. The 
amount of tracer reached a steady state approximately 100 s after injection, which corresponds 
roughly to the estimated tdifmax in Table 4.2.
Table 4.2 Comparison of estimated maximum HDO diffusion times (td,fmax) with time constants of mono­
exponential HDO-uptake curves (t) o f different unmodified blood filters, see in vivo experiments. The temperature 
was 20o C during the experiments, thus the HDO diffusion coefficient is approximately 2.10-5 cm2.s-1 (27,28). The 
system flow velocity is 2.46 ml.s-1.
blood filter micdmax ± SE (mm) "tdifmax (s) t  ± SE (s)
1 1500± 465 70 21 ± 1.1
2a) 1620± 818 82 26 ± 2.6
3 1735± 595 94 36 ± 2.5
4 1900± 760 113 53 ± 4.2
a) see Figure 4.6A and 4.6B.
Effect of modifications of the capillary distribution in blood filters on HDO-uptake curves 
and comparison with simulations of the 2D diffusion.
In Figure 4.6A and 4.6C an example is shown of the anisotropic capillary distribution in an 
unmodified (Figure 4.6A) and a modified blood filter (Figure 4.6C) with the corresponding 
HDO-uptake curves displayed in Figures 4.6B & 4.6D, respectively. The linear flow velocity in 
the modified filter was increased by approximately a factor two due to the blocking of one half 
of the capillaries. This had no effect on the HDO-uptake curve, as expected from a diffusion- 
limited model. The HDO-uptake rate in the modified blood filter (Figure 4.6D) was even slower 
than the HDO-uptake rate in the unmodified filter (Figure 4.6D). In the modified filter the 
number of small diffusion distances decreases and the number of large diffusion distances 
increases. Upon the introduction of large diffusion distances in modified filters, the HDO-uptake 
curves became multi-exponential, see Figure 4.6D. The curves derived from 2D diffusion 
simulations (solid lines in Figure 4.6B and 4.6D) correspond well to the HDO-uptake curves in 
all blood filters. However, diffusion simulations gave a faster HDO uptake at the beginning of 
the curve for all filters.
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Figure 4.6 Examples of HDO-uptake experiments with an unmodified (Figure 4.6A) and a modified blood filter 
(Figure 4.6C). The effect o f capillary distribution on the HDO uptake is shown in Figure 4.6B and 4.6D. 2D 
simulations of diffusion (— ) correspond well to the HDO-uptake curves (A), see text. The temperature was 20o C 
during the experiments, and the system flow velocity was 2.46 ml.s-1 in both cases.
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Discussion
To our knowledge this is the first study that relates HDO-uptake in tumors to morphometric 
analyses of the perfused vascular architecture. An (immuno)histochemical method was used to 
analyse the 2D distribution of perfused capillaries in whole tumor sections. A main question in 
this matter is whether this method, immediately applied after the MR-experiments, detects all 
functional capillaries during the HDO-uptake experiments or underestimates the number of 
perfused capillaries due to subpopulations of capillaries with very slow and irregularly perfusion 
rates? In the latter case, intercapillary distances between perfused capillaries would have been 
overestimated as well as HDO diffusion times. However, in complementary studies in which the 
2D distribution of perfused capillaries and hypoxic cells were analyzed simultaneously (30, 31), 
evidence is provided that the histochemical method virtually detects all functional capillaries. 
These analyses showed that a continuous rim of hypoxic cells occurred at a certain distance from 
perfused regions, which indicated that these cells are chronically hypoxic (diffusion-limited O2 
supply). Capillaries which transiently open and close in such a way that hypoxic region appear 
acutely were not observed. In such a case, the Hoechst signal would show overlap with hypoxic 
cells and/or isolated areas of nonhypoxic cells would occur in hypoxic regions around 
capillaries, which were not perfused with Hoechst. In addition, the 2D distribution of perfused 
capillaries in complete tumor sections was found to match to the 2D distribution of the contrast 
agent Gd_DTPA in comparable slices (30, 31). Gd_DTPA accumulates in tumor regions 
adjacent to perfused capillaries. Thus, it seems safe to assume that the histochemical method 
virtually detects all functional capillaries.
In the present study, heterogeneously and homogeneously perfused human glioma 
xenografts were used to analyse in more detail the relationship between maximum HDO 
diffusion times and time constants of HDO-uptake curves. As long as there is no histological or 
physiological evidence for the existence of multiple tumor tissue compartments in the volume of 
interest, which are more or less accessible to HDO, one has to consider maximum diffusion 
distances for an estimation of maximum diffusion times.
In  vivo studies
The tumors of both lines showed a rather homogeneous water apparent diffusion coefficient 
(ADCw) map. The range of ADCw values and the average ADCw of both lines is in good 
agreement with ADCw values found by others in different tumor models (32-34). Histological 
features might limit the HDO diffusion in the extravascular space of the tumor. However, 
histological analyses of eosin and haematoxylin stained tumor sections did not reveal any 
histological barrier in human glioma xenografts, which may limit the diffusion of HDO.
In addition, the interstitial fluid pressure might also affect the free diffusion of HDO 
(35). However, Dvorak et al (36) showed that small fluorescent molecules can enter tumor tissue 
freely and are not selectively excluded from any region in small tumors (0  < 1 cm, weight < ~ 1 
g). In a preliminary study we found that small bioreductive chemical probes such as N- 
imidazole-theophylline and pimonidazole distribute homogeneously in our tumor model within 
80 min after injection (= approximately the total time of HDO-uptake measurements) (30, 31). 
Thus, a possible restriction of HDO diffusion in the extravascular space due to interstitial fluid 
pressure is not expected.
The average ADCw and mean maximum icds were used for estimations of the maximum 
HDO-diffusion time per tumor. A linear correlation was found between tdifmax and (weighted 
mean) time constants of mono-exponential or bi-exponential HDO-uptake curves. Mono­
exponential HDO-uptake curves were mainly found in tumors with a homogeneously perfused 
capillary distribution.
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Tumors with a heterogeneously perfused capillary distribution showed a multi-exponential HDO 
uptake. The latter could not be explained by changes of the HDO concentration in the blood 
compartment, because 1 min after bolus injection the HDO concentration remained constant 
during the total experiment time. Maximum HDO-diffusion times and time constants were 
obtained from two independent series of experiments. The linear correlation between tdifmax and 
time constants as well as the observed differences of HDO-uptake in homogeneously and 
heterogeneously perfused human glioma xenografts indicate that the time constants are related 
to the perfused capillary distribution and to diffusion processes in the tumor. However, we 
cannot completely exclude that spatial and temporal variability in perfusion rates contribute to 
the uptake curves, because perfusion rates were not measured directly in capillaries. The 
following arguments provide some further support for the notion that diffusion processes play a 
significant role in the uptake kinetics of HDO in our glioma xenografts.
Until now, no methods are available to measure perfusion rates in individual capillaries 
noninvasively, with the exception of microscopic analyses of red blood cells velocities (37). The 
latter study can be used to gain a rough appreciation of mean capillary transit time of HDO 
molecules in perfused capillaries, if  one assume that the linear velocity of HDO molecules in 
perfused capillaries is supposed to be determined by the linear velocity of red blood cells. These 
velocities of red blood cells were found to vary between 0.08 to 0.4 mm.s-1 in capillaries of 
human glioma xenografts (37). Capillary path lengths in tissue-isolated mammary carcinoma 
measured from the entrance of the capillary mesh to the exit ranged from 0.5 to 1.5 mm (15). 
Thus, red blood cells with a linear velocity varying between 0.08 and 0.3 mm.s-1 have a mean 
capillary transit time of approximately 5 s for a capillary path length of approximately 1 mm, 
which is similar to the mean capillary transit time of HDO molecules as estimated by Eskey et al 
(8). In the case of perfusion-limited tracer-uptake this mean capillary transit time must be longer 
than HDO-diffusion times. This will occur in perfused tumor regions with short icds, a situation 
that can be encountered both in regional and global HDO-uptake measurements.
For regional HDO-uptake experiments Eskey et al (8) approximated HDO-diffusion 
times in perfused regions of tissue-isolated mammary adenocarcinoma using a modified Einstein 
diffusion equation (comparable to Eq. [3]). The mean distance between perfused capillaries in 
their tumor model was approximately 50 |im (15). For the determination of their mean 
intercapillary distance, Less et al (15) used a polymer infusion technique and icds were 
measured in well-perfused regions only. The icds in perfused regions of our tumor model were
similar to icds found by Less et al (15). Eskey et al (8) assumed an HDO diffusion coefficient
-5 2 -1
( D h d o )  of 1.10" cm .s- in tumor tissue (comparable to the average ADCw in this study). Thus, 
the HDO-diffusion time was approximately 0.5 s, which, indeed, is much shorter than the 
estimated mean capillary transit time of 5 s.
In global HDO-uptake measurements the HDO-uptake may become perfusion-limited in 
homogeneously perfused tumors with short icds. Studies of the two-dimensional perfused 
capillary distribution in complete sections of RIF-1 tumors and GH3 prolactinomas (a generous 
gift from Dr. Paul McSheehy, CRC Biomedical Magn. Reson. Research Group, St.George's 
Hospital Medical School, London) show that these tumors have a homogeneous perfused 
vascular architecture with short icds. The mean intercapillary distance of both tumors is 51 ± 7 
mm, and the mean maximum intercapillary distance is 338 ± 43 mm which is much shorter than 
those determined for human glioma xenografts in this study. These tumors may have a 
perfusion-limited HDO-uptake, because the estimated maximum diffusion time of HDO 
molecules in the total tumor volume is approximately 8.5 s, which is comparable to the 
estimated mean capillary transit time of HDO molecules.
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Human glioma xenografts in this study showed an asymmetrical frequency histogram of icds 
with a significant tail for long distances (see 25 and Fig. 6.2). The estimated mean capillary 
transit time of HDO molecules is much shorter than the maximum HDO-diffusion times and 
time constants of HDO uptake in the whole tumor volume, which indicate that global HDO- 
uptake rates are merely related to the distribution of perfused capillaries. Thus, diffusion-limited 
HDO-uptake may be related to diffusion-limited delivery of oxygen and nutrients. Indeed this
31was corroborated by P-MR spectroscopy studies on exactly the same tumors (ref. 25 and 
chapter 6). In this study a decrease of the bioenergetic status of the whole tumor was found to be 
linearly related to an increase of the percentage of intercapillary distances larger than 200 mm.
Model studies
The aim of the model studies was to show that in the case of diffusion-limited HDO-uptake, the 
latter is related to the distribution of perfused capillaries as deduced from the comparison of 
HDO-uptake curves with 2D diffusion simulations.
Diffusion simulations showed a somewhat faster HDO-uptake rate at the beginning of 
the curve in all filters. Discrepancies between HDO-uptake experiments and simulations may 
have the following causes: a) In simulations, the HDO diffusion from perfused capillaries was 
supposed to be isotropic, but the thickness and porous structure of capillary membranes may 
influence freely tracer diffusion. b) In 2D diffusion simulation the 2D capillary distribution at 
the filter inlet was used, whereas 2H-MRS measurements were performed halfway through the 
filter. Small variations in icds and capillary distributions between both sites may explain the 
discrepancy. Discrepancies cannot be explained by perfusion-limited uptake in the first part of 
HDO-uptake curves. In that case the HDO-uptake rate would have been faster in modified filters 
in comparison with unmodified filters, because the linear flow velocity of HDO molecules in 
perfused capillaries of modified filters was two times larger than the linear flow velocity in the 
capillaries of unmodified filters.
Although blood filters are not exactly comparable to human glioma xenografts, the 
multi-exponential HDO-uptake curves were related to heterogeneous capillary distributions in 
both experiments. Simulations of the 3D diffusion of HDO in tumors was not possible, because 
information of the 3D perfused vascular architecture was not available. In in vivo studies, 
estimations of HDO diffusion times were obtained using a 2D dataset of intercapillary distances. 
The linear correlation between maximum HDO diffusion times and time constants of HDO- 
uptake curves suggest that diffusion processes cannot be neglected during global HDO-uptake 
studies in human glioma xenografts. Values of maximum diffusion times and time constants 
would not have been comparable when the HDO-uptake rates were purely limited by perfusion.
Conclusions. In human glioma xenografts a significant fraction of relatively large intercapillary 
distances was found. For the interpretation of global HDO-uptake curves as monitored with 2H- 
MRS, diffusion of HDO in the extravascular volume of these tumors have to be taken into 
account. Therefore, tracer-uptake studies at high spatial and temporal resolution (see ref. 31 and 
38 or chapter 3) may give a better estimate of tumor blood perfusion than time-resolved HDO- 
uptake experiments of the whole tumor; especially if tracer-uptake rates are only measured in 
perfused tumor regions with a high perfused capillary density and short intercapillary distances.
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Appendix
When the diffusion coefficient (D) is independent of time (t) and location (x), Fick's law for one 
dimension can be written as:
du(x,t) _ d2u(x,t) rA1]
a t ' a x2 r ]
In Eq. [A1], u(x,t) represents the HDO concentration at location (x) and at time (t). The 
numerical solution of Eq. [A1] in one dimension (Crank-Nicholson scheme) using a forward 
time-centred space scheme (FTCS) (29) is:
n+1
At
D
2
/  n+1 O n+1 . n+1 ) . /  n O( u j+1 - 2-üj +Uj-1 ) + (ui+1~2-' nj  - n n  li + Ui-1)
A x
[A2]
nu
2
In Eq. [A2], time is indicated by the superscript n and location by the subscript j. Rewriting Eq. 
[A2] with the same time terms on both sides and defining the constant g as: g = {D.At}/ {2.Ax } 
with At as the time step and Ax as the distance step, we get:
u"/1 ~YUj+i- 2.unj+1 + unj+j]  = Uj+Y-luj+r2.unj + Uj-i] [A3]
For a stable iteration scheme the constant g has to be smaller than A. Eq. [A3] can be rewritten 
in matrix form, see e.g. term in brackets at time n + 1:
n+1 n+1Uj+1-2-Uj n+1+ Uj-1 _
2 1 0 0
1 -2 1 0
0 1 -2 1
n+1Uo
n+1U1
n+1Uk
_ A .U ‘n+1 rA4]
The vector Un+1 in Eq. [A4] correponds to the distribution of the HDO concentration in one 
dimension at time n+1. In 2 dimensions, this vector U becomes a matrix U (see Eq. [A8] and 
[A9]). In 2D HDO-diffusion simulations the matrix U at time = 0 contains the perfused capillary 
distribution, as shown, e.g., in Figure 4.6A and 4.6C. At time = 0 the distribution of the HDO 
concentration correponds to the perfused capillary distribution and is maximum in these 
capillaries. At every time step (n+1) a new matrix (Un+1) is calculated showing the changes of 
the HDO concentration distribution around perfused capillaries due to radial diffusion. The 
HDO concentration in the capillaries is reset to the maximum values at every time step, 
corresponding to a constant supply of HDO. In general, Eq. [A3] in matrix form becomes Eq. 
[A5]:
(1-rA).un+1_(1+rA ).un [A5]
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For j = 0 the diffusion outside the blood filter (j = -1) cannot take place, so boundary conditions 
have to be introduced. The concentration gradient between location j = -1 and j = 1 is set to zero; 
this means that: u-1 = u1. Using Eq. [A4] for j = 0 gives u-1 - 2.u0 + u 1; with u-1 = u1 we obtain
2.u1 - 2.u0. The matrix A becomes, Eq. [A6]:
A =
-2  (2) o o .:
1 - 2  1 0 ..
: 0 1 - 2  1
.. 0 1 (2) -2
[A6]
In 2 dimensions Eq. [A1] is transformed as follows:
9u(x,y,t)
dt
= D. d2u(x,y,t) + d2u(x,y,t) [A7]
The Crank-Nicholson algorithm is changed using the alternating-direction implicit method 
(ADI). This method divides each time step into two steps of duration At/2. In the first At/2 step 
the diffusion in the x-direction is calculated under the influence of concentration gradients in the 
y-direction and vice versa. Following Eq. [A5] in matrix form we obtain:
1 T
(1- 2gA). Un+2 = (1+2gA).( Un) [A8]
i
(1 - 2gA).( Un+1 )T = (1+2gA). Un+2 [A9]
In Eq. [A8] and [A9] transposed matrices are used for changing the multiplication with matrix A 
from x- to y-direction. In Eq. [A8] the result of diffusion in the x-direction (Un+%) after time step 
A t/2 under influence of the y-direction (Un)T is calculated. The matrix Un is known. Next, in Eq. 
[A9] the result of diffusion in the y-direction (Un+1)T after time step A t/2 under influence of the 
x-direction (Un+%) is calculated.
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Abstract
Purpose: The aim of this study was to characterize and to validate noninvasive 19F-magnetic 
resonance relaxometry for the measurement of oxygen tensions in human glioma xenografts 
in nude mice. The following three questions were addressed: 1. When perfluorocarbon 
compounds (PFCs) are administrated intravenously, which tumor regions are assessed by 19F- 
MR relaxometry? 2. Are oxygen tensions as detected by 19F-MR relaxometry (pÜ2/relaxo) 
comparable to Eppendorf Ü2-electrode measurements (pÜ2/electrode)? 3. Can 19F-MR 
relaxometry be used to detect oxygen tension changes in tumor tissue during carbogen 
breathing?
Methods and Materials: Slice-selective 19F-MR relaxometry was carried out with 
perfluoro-15-crown-5-ether as oxygen sensor. The PFC was injected i.v. 3 days before the 
F-MR experiments. Two data sets were acquired before and two after the start of carbogen 
breathing. The distribution of PFCs and necrotic areas were analyzed in 19F-Spin Echo (SE) 
density MR-images and T2-weighted 1H-SE MR-images, respectively. One day after the MR- 
investigations oxygen tensions were measured by oxygen electrodes in the same slice along 
two perpendicular tracks. These measurements were followed by (immuno)histochemical 
analyses of the 2D distribution of perfused microvessels, hypoxic cells, necrotic areas and 
macrophages.
Results: The PFCs mainly became sequestered in perfused regions at the tumor 
periphery; thus, 19F-MR relaxometry probed mean oxygen tensions in these regions 
throughout the selected MR-slice. In perfused regions of the tumor, mean pÜ2/relaxo values 
were comparable to mean pÜ2/electrode values and varied from 0.03 to 9 mmHg. Median 
pÜ2/electrode values of both tracks were lower than mean pÜ2/relaxo values, because low 
pÜ2/electrode values that originate from hypoxic and necrotic areas were also included in 
calculations of median pÜ2/electrode values. After 8-min carbogen breathing the average 
pÜ2/relaxo increase was 3.3 ± 0.8 (SEM) mmHg and 2.1 ± 0.6 (SEM) after 14 min breathing.
Conclusions: We have demonstrated that PFCs mainly became sequestered in 
perfused regions of the tumor. Here, mean pÜ2/relaxo values were comparable to mean 
pÜ2/electrode values. In these areas, carbogen breathing was found to increase the pÜ2/relaxo 
values significantly.
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Introduction
It has been shown that the oxygen tension of tumor tissue is an important physiological 
parameter during radiotherapy treatment (1-3). Hypoxic tumor cells are approximately three 
times more radioresistant than well-oxygenated cells (1). Therefore, modulations of the 
oxygen tension in tumor tissue may enhance the sensitivity of tumor cells for radiotherapy. 
For example, breathing of carbogen (95 % O2, 5 % CO2) has been introduced to decrease the 
fraction of chronically hypoxic cells (4-6). The combination of carbogen breathing with the 
administration of nicotinamide has produced a significant increase in local control of 
advanced laryngeal tumors (7).
A method to assess local or global oxygen tensions in tumor tissue would be valuable 
and may be used to predict the outcome of a treatment modality. Polarography (Eppendorf 
O2-electrodes) is the most frequently used technique for direct measurements of local or 
global oxygen tensions in tumor tissue (pO2/electrode) (8, 9). Although oxygen electrodes are 
small, polarographic measurements are invasive and studies of deep tumors are difficult or 
even impossible without surgery.
F-magnetic resonance relaxometry ( F-MR relaxometry) using perfluorocarbon 
(PFC) compounds is a noninvasive technique, which permits the determination of local or 
global oxygen tensions in tumors (pO2/relaxo) independent of the location of the tumor (10-17). 
This technique is based on the linear relationship between the spin-lattice relaxation rates 
( 1 /T1) of 19F-spins in PFCs and the local oxygen tension in tumor tissue. In most 19F-MR 
relaxometry studies PFCs are administered intravenously a few days before the MR- 
measurements (11-15). After approximately 3 days PFCs had accumulated in tumor tissue 
and in the reticulo-endothelial system of liver and spleen, and PFCs were not detectable in 
blood plasma (11, 15, 18).
Before 19F-MR relaxometry can be used as an indicator of absolute oxygen tensions or 
oxygen tension changes in tumor tissue, it will need extensive comparison with more 
established techniques such as polarography. A proper comparison between both techniques 
is possible when the distribution of PFC compounds is spatially correlated to the approximate 
location of the O2-electrodes. In addition, it is necessary to know how the distribution of the 
PFCs and the location of the O2-electrode tracks are spatially correlated to the distribution of 
perfused, hypoxic and necrotic tumor areas. The extent of the latter areas determine local or 
global oxygen tensions in tumors, and can be used to explain possible differences of pO2 
values as probed by both methods. Furthermore, validation of pO2/relaxo values with pO2/electrode 
values is of interest, because pO2/relaxo values are derived from T1-relaxation rates of 19F-spins 
in perfluorocarbon compounds and in principle these relaxation rates may also depend on 
other physiological and histological parameters.
The aim of this paper is to characterize and to validate in vivo 19F-MR relaxometry as 
a tool to measure oxygen tensions and changes in oxygen tensions noninvasively in human 
glioma xenografts. The following questions were addressed: When perfluorocarbon 
compounds (PFCs) are administrated intravenously, which tumor regions are assessed by 19F- 
MR relaxometry? How are the pO2/relaxo values related to pO2/electrode values? Finally, can 19F- 
MR relaxometry be used to detect oxygen tension changes in tumor tissue during carbogen 
breathing?
To answer these questions the 2D distribution of perfluorocarbon compounds in 19F- 
MR-images was compared to the 2D distribution of perfused microvessels, hypoxic regions,
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macrophages (18) and necrotic areas using histochemical analyses (19) and T2-weighted 1H- 
MR images, respectively. In a previous study (18), it had been suggested that PFCs are taken 
up by macrophages, and therefore the distribution of the latter was also compared to the PFC 
distribution. For each tumor, both pO2/relaxo and pO2/electrode values were sampled in comparable 
slices through the center of tumors and oxygen tensions changes were measured during 
carbogen breathing.
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Materials and Methods
Animal model. Human glioma xenografts (line E49) were grown subcutaneously in the 
hindlimbs of 13 athymic mice (Balb/c nu/nu, BonholdGard, Ry, Denmark) (20). In pilot 
studies on the feasibility of slice-selective 19F-MR relaxometry measurements of oxygen 
tensions in 2 homogeneously perfused human glioma xenograft lines (E98, E106) (20)) and a 
heterogeneously perfused line (E49), the PFC uptake was only sufficient for slice-selective 
19F-MR relaxometry measurements in tumor line E49. Tumor volumes (cm3) of the latter line 
were estimated from the formula: (p / 6) x abc, where a, b and c are orthogonal diameters as 
measured with calipers. Mice were anaesthetized with 2 % enflurane in an oxygen-nitrous (25 
% O2) gas mixture applied through a nose cone. For experiments with carbogen breathing the 
oxygen-nitrous gas mixture was switched to carbogen (95% 02/5% CO2) and the percentage 
of enflurane was kept constant. The flow velocity was 1 l.min-1 in all experiments and the 
composition of gas mixtures was analyzed on-line at the inlet of the nose cone with a gas 
monitor (Datascope Multinex, Datascope Corp. Paramus, NJ, USA). All experiments were 
started 5 minutes after the beginning of carbogen breathing. The 5-min pre-breathing time 
was based on results of near-infrared spectroscopy experiments, which showed that after 5 
min the oxyhemoglobin concentration was close to a steady state (21). Body temperature was 
monitored with a rectal probe (36-gauge wire, Hewlett Packard) and maintained at 36.5o - 37o 
C by a warm water blanket with a feedback system. The anesthesia and temperature controls 
were similar for the in vivo 19F-MR relaxometry studies and the polarography measurements 
(see next sections); thus, possible effects of e.g. anesthesia on the results of both experiments 
were comparable. The local ethical committee for animal use approved the experimental 
procedures.
19F-MR relaxometry. 19F-MR relaxometry measurements were performed on an SMIS 
spectrometer interfaced to a vertical bore magnet (4.3 T) employing a home-built 1H/19F 
double tunable solenoid ( 0  13 mm).
In vitro experiments. An in vitro calibration curve (1 /T1 (s-1) versus p02 (mmHg)) 
was generated using an inversion-recovery T1-sequence with a 180o adiabatic full passage 
inversion pulse (22) and a 90o hard excitation pulse. The PFC emulsion (40% (v/v) perfluoro- 
15-crown-5-ether, HemaGen/PFC, St. Louis, MO, USA) was bubbled for 60 minutes with 5 
different gas mixtures (O2/N2) containing 0 %, 10 %, 21 %, 48 % and 100 % O2. During the 
T1 measurements gas mixtures were led smoothly over the emulsion to maintain p02 levels. 
The temperature of the emulsion was monitored online and was kept at 37o C using the same 
feedback system and rectal probe as mentioned in the previous paragraph. For low pO2 values 
the T1-relaxation time of F-spins is relatively long; thus, a different array of delay times 
between inversion and excitation pulse was used for correct measurements of the different T1- 
relaxation times. For the gas mixtures containing 0 % and 10 % O2, the 8 delay times of 
inversion (TIs) varied between 0.2 and 6 s, and for the other gas mixtures the TIs ranged from
0.2 to 3 s. The in vitro calibration curve was determined from 3 independent measurements.
In vivo experiments. Three days before the NMR experiments 0.15 ml of the 40% 
(v/v) PFC emulsion was injected via a tail vein (dose: 4.2 g/kg). For the appropriate 
positioning of a coronal slice for 19F MR relaxometry studies through the center of the tumor 
parallel to the solenoid coil, multi-slice coronal T2-weighted 1H-spin echo images (SE 
images) were acquired (TR=1 s, TE=0.06 s, number of scans = 2, matrix size = 128 x 128, 
FOV 15 x 15 mm, slice thickness 1.5 mm). Simultaneously, these T2-weighted 1H-SE images 
were used for analyses of the necrotic area distribution in comparable slices as observed in
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in vivo 19F-MR experiments. The water diffusion coefficient was found to be larger in 
necrotic areas than in vital tumor areas (23) which may result in higher signal intensities in 
T2-weighted 1H-SE images. Next, 19F-SE density images were obtained at the same position 
as the H-SE images using the following parameters: TR = 8 s, TE = 0.03 s, NS = 2, matrix 
size = 64 x 64, FOV = 15 x 15 mm and slice thickness 4 mm. The 19F-SE density images 
were used for analyses of the 2D distribution of PFCs in similar slices as used in in vivo F- 
MR relaxometry studies.
In vivo 19F-MR relaxometry studies were performed with a slice-selective inversion- 
recovery T1-sequence with similar acquisition parameters as used in the T 1 sequence for the 
determination of the in vitro calibration curve. The pulse width of the 90o sinc excitation 
pulse was optimized for a slice thickness of 4 mm. Eight TIs were used between 0.8 and 8 s, 
TR = 12 s, NS = 4, total measurement time 384 s. Two T1 measurements were performed 
before carbogen breathing and subsequently two during carbogen breathing.
To obtain an in vivo 1 /T1 value for the calibration curve at p02 = 0 mmHg, four independent 
in vivo experiments in mice were performed. T1-values of F-spins before and every 6-min 
after the killing of mice were determined with the slice-selective inversion-recovery T1- 
sequence as described earlier. Mice were killed by switching off the oxygen supply and 1 min 
afterwards the total supply of anesthesia was stopped. Experiments on dead mice were 
finished when T1-values of 19F-spins reached a steady state. The temperature of the skin 
adjacent to tumor tissue was monitored on line and was kept at 36o- 37o C using the same 
feedback system and rectal probe as mentioned above. Note that the T1-relaxation time of 19F- 
spins is not only related to the oxygen tension in tissue, but also to tissue temperature. 
Therefore, temperature control is important in all experiments.
Data analyses. From 3 independent in vitro measurements the calibration curve ( 1/T 1 
(s-1) versus p02 (mmHg)) was obtained by linear regression analyses with Graphpad software 
(Graphpad PRISM, version 2.0, San Diego, USA). As the intercept value of the calibration 
curve at p02= 0 mmHg, the mean 1 /T1 as measured in 4 dead mice was applied. This 
calibration curve was used to convert in vivo T1-relaxation rates (R1) of 19F-spins to p02/relaxo 
values. The standard errors of the intercept value and the slope of the calibration curve were 
propagated in the calculations of the SEMof absolute mean p02/relaxo values per tumor slice in 
experiments without carbogen breathing (n = 2) or were propagated in calculations of the SE 
of changes in the p02/relaxo values after 8 and 14 min carbogen breathing. For carbogen 
breathing experiments the average p02/relaxo changes of all tumors (n = 13) was analyzed with 
a paired t-test.
Polarographic measurements of the oxygen tension in tumor tissue.
One day after the 19F-MR experiments invasive p02 measurements were performed with a 
computerized polarographic system (KIMOC 6650, Eppendorf, Hamburg). The details of this 
technique have been described previously (8, 24). Briefly, the intratumoral pO2 was 
registered with a polarographic needle (p02electode) with a diameter of 300 mm. The sensitive 
membrane-covered cathode has a diameter of 17 mm resulting in a hemispherical measuring 
volume with a diameter of approximately 50 mm around the tip of the electrode (25).
In order to reduce the resistance of the skin during the insertion of O2-electrodes in 
tumors, a small hole was made in the skin adjacent to tumor tissue using a needle with a 
similar diameter as the O2-electrodes. Tissue compression artifacts were minimized with 
forward movements of the 02-electrode (500 mm) immediately followed by a backward step 
of 200 mm (26).
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Tumor oxygenation measurements were performed along two perpendicular tracks in the 
comparable tumor slices as used in the slice selective F-MR relaxometry. Per track 12 
individual pÜ2/electrode data points were measured. The drift was < 0.4 %. min-1. PÜ2/electrode 
values of a track were omitted, when the tumor started bleeding after insertion of the 0 2 - 
electrode. The raw data of the pÜ2/electrode measurements were exported from the KIMOC 
device into a personal computer for statistical analyses.
Data analyses. Per tumor slice the median pÜ2/electrode value of both tracks was 
calculated (n = 24). Next, in the same slice the mean of the pÜ2/electrodevalues was calculated 
from these sample points, that coincided with the PFC distribution in the perfused tumor rim 
(n = 2). These values appeared to be the first and maximum values of the sampled data points 
in both tracks, therefore this physiological parameter was denoted as the mean maximum 
pÜ2/electrode value. Both the median pÜ2/electrode value and the mean maximum pÜ2/electrodewere 
compared to the absolute mean pÜ2/relaxo values.
Fluorescence microscopy and (immuno)histochemical analyses of the 2D distribution of 
perfused microvessels, hypoxic- / necrotic areas and macrophages. In complete transverse 
tumor sections morphometric analyses of perfused microvessels, hypoxic- / necrotic areas and 
macrophages were performed using a computer-controlled digital-image analyses system 
connected to a (fluorescence) microscope. Üne day after the polarographic measurements 0.3 
ml of a suspension was injected i.p. which contained the following chemical compounds: 0.5 
ml dimethylsulphoxide, 4.5 ml heated peanut oil and 70 mg of the hypoxia marker 7(-)[4'-(2- 
nitroimidazol-l-yl)-butyl]-theophylline (NITP, a generous gift of Dr. R. Hodgkiss, CRC Gray 
Laboratory, Mount Vernon Hospital, Northwood, Middlesex, UK). Two hours after 
administration of the hypoxic marker NITP, a 0.05 ml solution of saline (0.9 %, pH=7.4) 
containing a fluorescent perfusion marker Hoechst 33342 (15 mg/kg, Sigma, St.Louis, MÜ, 
USA) was injected i.v. via a lateral tail vein. Üne minute after Hoechst injection, mice were 
rapidly killed by dislocation of their neck, and tumors were quickly removed and frozen in 
liquid nitrogen preventing the redistribution of fluorescent perfusion marker Hoechst. Tumors 
were cut in halve: one half was used for quantitative immunohistochemical analyses of 
perfused microvessels, the total microvascular bed, hypoxic areas and the 2D distribution of 
macrophages. The other half was used for classical histological staining with eosin (cyto­
plasm) and haematoxylin (nuclei). For each tumor half, three frozen tissue sections (5 mm) at 
comparable locations as the slices in 19F-MR relaxometry experiments were made. The 
staining with eosin and haematoxylin was used to distinguish viable tumor areas from 
necrotic areas.
Immunohistochemical analyses. The different cells and cell structures were analyzed 
in four steps: the perfused microvessels were analyzed first followed by the 
immunohistochemical staining of hypoxic areas, the endothelium of all microvessels and 
macrophages. After each staining step, sections were scanned using an extended version of 
the digital image analyses system as described by Rijken et al (19). After processing all fields 
of each scan a composite image was reconstructed from the individual processed fields 
revealing the different structures. If the composite images of the tumor sections obtained after 
each step were combined, then the new matched image showed the 2D distribution of 
perfused microvessels, hypoxic areas, the total microvascular bed and macrophages.
For the staining of hypoxic areas, sections were incubated with rabbit anti­
theophylline (Sigma, St. Louis, MÜ, USA) followed by incubation with FITC-labeled donkey 
anti-rabbit immunoglobulin (Jackson ImmunoResearch Laboratories, West Grove, USA).
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The endothelium of all microvessels was first stained with monoclonal rat anti-mouse 
antibody ME 9F1 (27), followed by the second and third antibody TRITC-labeled goat anti­
rat immunoglobulin and donkey anti-goat immunoglobulin (Jackson ImmunoResearch 
Laboratories, West Grove, USA). In different tumor sections, but adjacent to sections with 
hypoxic cell staining, the macrophages were stained with monoclonal rat antibody to mouse 
macrophage (clone F4/80, rat IgG-2b, Caltag laboratories, Burlingame, CA, USA). The 
second antibody was rhodamine-labeled rabbit anti-rat IgG (Cappel-Organon Technika, 
Durham, NC, USA). In the same sections as used for the analyses of the macrophage 
distribution the basal lamina of the tumor vasculature was stained with collagen type IV poly­
clonal antibody (goat antitype IV collagen, Southern Biotechnology Associates, Birmingham, 
AL, USA) and donkey anti-goat immunoglobulin labeled with FITC (Jackson 
ImmunoResearch Laboratories, West Grove, USA).
Data analyses. Per tumor section the 2D distribution of macrophages, perfused 
microvessels, hypoxic and necrotic areas was compared to the 2D distribution of PFC 
compounds in F-SE density MR-images and the 2D distribution of high intensity regions in 
T2-weighted 1H-SE MR-images, respectively. Per tumor section the hypoxic fraction and the 
necrotic fraction were calculated. Both parameters are defined as the total hypoxic or necrotic 
area per total tumor section area. Next, an average necrotic and hypoxic fraction was 
calculated for all tumors (n = 13).
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Results
19Calibration curve for oxygen tension measurements by F-MR relaxometry.
In vitro 19F-MR relaxometry measurements of the PFC emulsion (40% (v/v) at a temperature 
of 37o C for 5 different oxygen tensions (p02, mmHg) resulted in the following calibration 
curve, see Eq. [1]:
-L  =  0.44 + 0.0028. pO2 [1]
The standard error (SE) of the intercept value (0.44 (s-1)) is 2.3 %, and the SE of the slope 
(0.0028 (s.mmHg)-1) is 1%. The 1/T1 value obtained from the in vivo 19F-MR relaxometry 
studies on 4 dead mice was 0.41 ± 0.02 (SEM) s-1. This 1 /T1 value is not significantly 
different from the intercept value of the in vitro measurements. For calculations of absolute 
mean pÜ2/relaxo values in the following sections this value of 0.41 s-1 was used as intercept. It 
should be noted that the intercept is not needed for calculations of changes in the pÜ2/relaxo 
values.
19Comparison of the 2D distribution of PFCs in F-SE density MR-images and high 
intensity areas in T2-weighted 1H-SE MR-images with the 2D distribution of perfused 
microvessels, hypoxic - / necrotic areas and macrophages.
Three days after intravenous injection of PFCs the 2D distribution of PFCs in 19F-SE density 
images correspond mainly to the 2D distribution of perfused microvessels in Hoechst images, 
see e.g. tumors no. 10 and 11 in Figure 5.1A and 5.1B. All tumors were well perfused in the 
periphery and no perfused microvessels were detected in the center. The nonperfused regions 
in Hoechst images correlated with high intensity areas in T2-weighted 1H-SE MR-images 
(Figure 5.1B and 5.1C). A detailed analysis of such a nonperfused area is shown in Figure 5.2 
for tumor no. 10. In eosin and haematoxylin stained sections these areas appeared necrotic 
(Figure 5.2B). The average necrotic fraction of all 13 tumors was 0.5 ± 0.06 (SEM) (-). In 
only 5 of the 13 tumors NITP labeled cells (~ hypoxic cells) could be detected. The average 
hypoxic fraction of these 5 tumors was 0.01 ± 0.0013 (SEM) (-). In general, a thin layer of 
NITP labeled cells surrounded extensive necrotic cords, see e.g. tumor no. 2 in Figure 5.3A 
and 5.3B. For this tumor line comparable results were obtained with another hypoxic marker 
pimonidazole hydrochloride (PIMO) (P. Rijken M.Sc., oral communication, November 
1997). In only one tumor a small isolated group of macrophages was observed in the perfused 
tumor rim (results not shown) of which the 2D distribution did not correlate with the 
distribution of PFCs.
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Figure 5.1A shows the PFC distribution in 19F-SE density MR-images of a slice through the center of tumors 
no. 10 and no. 11. Figure 5.1B displays the 2D perfused microvessel (white structures) distribution in 
fluorescence microscopic Hoechst images of comparable slices and Figure 5.1C shows the 1H-signal intensities 
in T2-weighted 1H-SE MR-images in similar slices as the 19F-MRI studies. Detailed analyses of the delineated 
area in Figure 5.1B are given in Figure 5.2.
A
Figure 5.2 Representative results of 
histological analyses of nonperfused regions 
in tumor no. 10 are shown in this Figure. An 
area of Figure 5.1B delineated by the 
rectangle is analyzed in more detail in Figure 
5.2 A and 5.2B. Figure 5.2 A shows the 
distribution of perfused microvessels (white 
structures) and in 5.2B the results of the 
haematoxylin (nuclei) and eosin (cytoplasm) 
staining (HE) are displayed. The light gray 
colors correspond to necrotic areas (N) and 
the more dark gray colors are related to 
perfused tumor areas (P) in Figure 5.2A.
B
N
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Comparison of median pO2/electrode values with absolute mean pO2/relaxovalues in tumor 
tissue slices.
Low S/N ratios in 19F-MR spectra of PFCs in the whole tumor did not permit voxel-selective 
T1-measurements or local p02/relaxo studies within a reasonable time (11). Absolute mean 
pO2/relaxo values were measured in perfused regions of the tumor throughout the whole MR- 
slice (see previous paragraph), and ranged from 0.03 to 49.7 mmHg (see Table 5.1). In tumor 
no. 4 with a mean p02/relaxo value of 49.7 mmHg an important region with low 1H-signal 
intensities was found near the center of the tumor in T2-weighted 1H-SE MR-images, 
probably corresponding to extravasation of hemoglobin. In this region the blood oxygen 
tension directly effects the T1-relaxation time of F-spins of PFC compounds, which may 
result in high pO2/relaxo values.
Polarographic measurements were done in two perpendicular tracks located within the 
slices, as measured in the corresponding in vivo 19F-MR relaxometry studies. For tumor no. 
10 a fluorescence microscopic image (Hoechst image) of the perfused microvessel 
distribution is displayed in Figure 5.4A including the approximate locations of the tracks.
The pO2/electrode values obtained during the stepwise movement of the Eppendorf electrode in 
one track are shown in Figure 5.4B. The p02/electrode values decreased from the periphery of 
the tumor to the center. Median p02/electrode values of tumors denoted by asterisks in Table 5.1 
varied from 0.4 to 3.3 mmHg. Four of the 13 tumors started bleeding during the insertion of 
O2-electrodes and data were not further evaluated. Tissue injuries related to the Eppendorf 
electrode measurements were only observed in two of 9 remaining tumors, but this did not 
influence the (immuno)histochemical analyses in whole tumor sections, since p0 2 /electrode 
values were locally sampled in two tracks.
For the tumors studied by both methods the median pO2/electrode values were generally 
lower than the mean p02/relaxo values (Figure 5.5). However, when the mean maximum 
pO2/electrode values which originated from the tumor periphery were compared with mean 
pO2/relaxo values, a much closer correlation between both data sets was observed as indicated 
by the solid line in Figure 5.5 (= approaching the line of identity). Finally, no relationships 
were found between necrotic and hypoxic fractions and mean pO2/relaxo values or median
pO2/electrode values.
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Figure 5.3 A detailed analysis of hypoxic and 
necrotic areas of tumor no. 2 are depicted in A and 
B, respectively. Three different (cell) structures 
were labeled in A: perfused microvessels (P, blue), 
endothelium of all microvessels (red) and hypoxic 
cells (H, green). Hypoxic cells appear at a distance 
of 100 - 150 mm from perfused microvessels. 
Differences between the staining of nuclei 
(haematoxylin) and cytoplasm (eosin) in necrotic 
regions and areas with viable tissue are shown in B. 
The perfused and viable tissue regions (P) have a 
more uniformed nuclei staining than necrotic 
regions (N).
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Table 5.1 In vivo 19F-MR relaxometry measurements of absolute mean pO2/reiaxo values (mmHg) and changes 
in pO2/reiaxo values relative to baseline (ApO2/reiaxo, mmHg) after 8 and 14 min carbogen breathing. In tumors 
denoted by an asterisk the oxygen tension was also measured by polarography (Figure 5.5). The values in 
column 3 are means ± SEM The values in column 4 and 5 are mentioned with their SE.
No. Volume (cm3) mpO2/relaxo ApO2/relaxo ( 8 min) ApO2/relaxo ( 14 min)
1* 0.70 8.8 ± 0.6 2.8 ± 4.3 0.2 ± 3.0
2* 1.10 0.3 ± 1.0 2.3 ± 3.4 0.7 ± 3.7
3* 0.60 8.6 ± 0.6 4.1 ± 5.1 0.9 ± 4.1
4 0.41 49.7 ±  2.5 15.1 ±  11 1.7 ±7.2
5* 0.56 0.8 ± 0.4 2.7 ± 4.3 3.5 ± 5.0
6* 0.65 2.8 ± 0.9 0.5 ± 3.5 2.1 ± 4.0
7* 0.30 0.03 ± 3.0 5.3 ± 3.7 1.2 ± 3.5
8 0.31 9.1 ± 0.2 9.3 ± 5.8 6.6 ± 3.1
9 0.40 8.4 ± 0.1 5.0 ± 4.0 5.4 ± 3.6
10* 0.41 8.7 ± 0.9 2.8 ± 3.4 0.4 ± 3.7
11* 0.34 0.9 ± 0.4 0.03 ± 3.7 1.3 ± 3.5
12 0.37 13.5 ± 1.4 5.9 ± 3.6 0.1 ± 3.6
13* 0.39 3.1 ± 0.5 0.6 ± 4.9 3.5 ± 5.6
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19In vivo F-MR relaxometry studies of the oxygen tension changes in tumor tissue 
during carbogen breathing.
Changes in the pO2/reiaxo values were measured in complete tumor tissue slices. Table 5.1 
presents the pO2/relaxo changes in slices through the center of 13 tumors after 8 and 14 min 
carbogen breathing. After 8-min carbogen breathing a small increase of the pO2/relaxo tensions 
relative to baseline was observed in 12 of the 13 mice. The pO2/relaxo changes were rather 
heterogeneous and varied from 0.03 to 15 mmHg. The average oxygen tension increase 
(DpO2/relaxo) of all tumors (except tumor no. 4) = 3.3 ± 0.8 (SEM) mmHg and was 
significantly different from zero (p < 0.01). In 9 of 13 mice the increase of the pO2/relaxo values 
reduced after 14-min carbogen breathing: these values relative to baseline varied from 0.1 to
6.6 mmHg. The average DpO2/relaxo was 2.1 ± 0.6 (SEM) mmHg, which still was significant 
different from zero (p < 0.05), but was not significant different from changes after 8 min 
carbogen breathing (p > 0.05).
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Figure 5.4 A fluorescence microscopic image (Hoechst image) of the 2D distribution of perfused microvessels 
(white structures) in a slice through the center of tumor no. 10 is shown in A.The length of the white bar 
corresponds to 1 mm. In the same Figure 5.4A, the approximate locations of two perpendicular tracks of the O2- 
electrode are displayed. Figure 5.4B shows the individual p02/electrode values (mmHg) of track no. 2 (y-axis) as 
obtained during the stepwise movement of the Eppendorf electrode from the periphery of the tumor to the center 
(x-axis) (stepsize 0.3 mm, total length of track 3.6 mm).
Figure 5.5 Comparison between 
absolute mean pÜ2/relaxo values 
(mmHg) per tumor tissue slice and 
median pÜ2/electrode values ± SEM 
(dashed line) or mean maximum 
pÜ2/electrode values ± SEM (solid line) 
as detected in 2 perpendicular tracks 
in comparable slices (Figure 5.4). 
The lines indicate the results of least- 
squares linear regression analyses 
(R2 = 0.96, solid line and R2 = 0.95, 
dashed line) using Graphpad PRISM 
software (version 2.0, San Diego, 
USA). Both lines were forced to go 
through the origin during the 
regression analyses. Detailed 
analyses of tumor no. 10 denoted by 
an asterisk (*) are given in Figure 
5.4.
mean pO2/reiaxo (mmHg)
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Discussion
In contrast to polarographic measurements, 19F-MR relaxometry of perfluorocarbon 
compounds permits noninvasive oxygen tension measurements independent of the location of 
the tumor. However, this new method does not allow direct analyses of the oxygen tension: 
local oxygen tensions are derived from T1-relaxation rates of 19F-spins in the perfluorocarbon 
compounds. These relaxation rates may also depend on other physiological and histological 
parameters, and therefore pO2/relaxo values have been compared to pO2/electrode values in this 
study. In addition to 19F-MR relaxometry and polarographic studies, the spatial distribution of 
PFC compounds over the tumor was determined and correlated to the location of the oxygen 
electrodes in tumor tissue, and to the distribution of perfused microvessels, hypoxic and 
necrotic areas. In this way, a proper comparison between both techniques becomes possible, 
because the tumor areas from which the measured pO2/relaxo and pO2/electrode values originate 
are known.
Calibration curve.
The relationship between the T1-relaxation rates (1 /T1) of 19F-spins in perfluoro-15-crown-5- 
ether and oxygen tensions was determined under strict temperature control, because T1- 
relaxation rates of PFCs also have an inverse relationship with temperature (11). The 
intercept and slope value of the calibration curve of the neat perfluoro-15-crown-5-ether 
obtained in this study were larger than the values reported elsewhere (11). This may be due to 
a number of differences in experimental conditions, such as the ways to control temperature 
and to maintain O2 levels during the in vitro 19F-MR relaxometry examinations. In the present 
study the intercept values obtained from in vitro studies and F-MR experiments on dead 
mice were not significantly different using the same temperature control system. These results 
indicate that the temperature of the tumors and the emulsion was comparable and differences 
in physiological properties such as, salt concentrations, pH, presence of proteins and PFC 
concentrations do not influence the T1-relaxation rates of PFCs (16, 28). A simultaneous 
determination of tissue temperature and tissue oxygen tensions would be necessary to exclude 
the effect of temperature differences on T1-relaxation rates of PFCs. This is possible with 
PFCs, which have two or more resonances in 19F-MR spectra (14), but this cannot be done 
with perfluoro-15-crown-5-ether, which has 20 equivalent fluorine atoms resonating at a 
single frequency. The correlation between the pO2/relaxo and pO2/electrode data in this study 
suggest that the calibration curve is reliable and can be used to convert in vivo 1 /T 1 values of 
F-spins of PFCs to in vivo p02/relaxo values.
19In vivo F-MR relaxometry studies and polarographic measurements of oxygen 
tensions in tissue slices of human glioma xenografts.
Dardzinski and Sotak (11) used a fast MR-imaging technique to measure voxel-selective T1- 
relaxation rates of perfluoro-15-crown-5-ether or local oxygen tensions. In the present study, 
low signal to noise ratios in 19F-MR spectra of PFCs in the whole tumor did not permit to 
perform such studies within a reasonable time. The signal to noise ratios were lower, because 
the amount of administrated perfluoro-15-crown-5-ether had to be 2.4 times smaller than the 
dose used in the studies reported by Dardzinski and Sotak (11). Their dose was lethal to nude 
mice in our study. In addition, the permeability of microvessels for perfluoro-15-crown-5- 
ether in RIF-1 tumors may be larger than the permeability of microvessels in the glioma
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xenograft line used in the present study. Intertumoral variations of microvessel permeability 
for perfluoro-15-crown-5-ether were also observed in different glioma xenograft lines (results 
not shown).
Three days after intravenous administration, the perfluorocarbons became mainly 
sequestered in the well-perfused rim of the human glioma xenografts as observed in 19F-SE 
density MR-images and histological analyses. In a previous study these histological analyses 
of the 2D perfused vascular architecture have been validated by fast dynamic 1H-MR imaging 
studies of contrast-agent uptake (29). One minute after bolus injection, the 2D distribution of 
the contrast agent in 1H-MR images was found to be similar to the distribution of perfused 
microvessels 1 min after the injection of the fluorescent marker Hoechst. In the present study, 
the PFC distribution did not spatially correlate with the distribution of macrophages; thus, 
these cells as suggested by Longmaid et al (18) do not take up PFCs. The long-term retention 
of PFCs in perfused regions indicate, however, that they are firmly bound to tissue or cell 
structures in perfused regions of the tumor rather than redistributed in the whole tumor 
volume. The latter hypothesis could not be tested with (immuno)histochemical methods 
applied in the present paper, since analyses at the subcellular level were not possible. Mason 
et al (15) suggested also that PFCs became sequestered in well-perfused regions of Dunning 
prostate tumors, but did not provide any evidence for this suggestion. In this study and 
probably in the study of Mason et al (15), absolute mean p02/relaxo values and changes in 
p0 2 /relaxo tensions are mainly measured in perfused regions of tumors.
However, in the evaluation phase before radiotherapy oxygen tension measurements 
in chronically hypoxic areas appear of greater interest than pO2 measurements in perfused 
regions of tumors. In immunohistochemical analyses of chronically hypoxic cells with the 
bioreductive chemical probe NITP, a thin layer of NITP labeled cells was found adjacent to 
extensive necrotic cords in a few human glioma xenografts. In some tumors hypoxic cells as 
detected by NITP were even absent. In general, hypoxic areas were much smaller than 
perfused tumor regions that contain most of the PFCs. Therefore oxygen tension 
measurements in hypoxic areas using 19F-MR relaxometry seems not possible in the tumor 
line used in the present study. Other human glioma xenograft lines showed larger areas with 
NITP labeled cells (Paul Rijken M.Sc., oral communication, November 1998). In these tumor 
models intratumoral injections of PFCs is an attractive alternative compared to i.v. 
administration of PFCs to assess tissue p02 in hypoxic regions (15, 17). However, also in this 
approach hypoxic areas may not be included, as these cannot be selected beforehand.
In the well-perfused tumor rim, the mean oxygen tensions as measured by 19F-MR- 
relaxometry (pO2/relaxo) were comparable to the mean of the maximum pO2/electrode values of 
both tracks that originate from the same perfused tumor rim. The absolute mean oxygen 
tension values in perfused regions were found to be relatively low in both analyses. Others 
also obtained low oxygen tension values in animal tumor models using polarographic or 19F- 
MR relaxometry measurements (8, 13, 17, 30-34). Recent phosphorescence quenching 
microscopic analyses of pO2 profiles in human colon adenocarcinoma xenografts with a 
spatial resolution of 10 mm showed that the p0 2  near perfused microvessels was 
approximately 14 mmHg and decreases monotonically until hypoxic values (< 5 mmHg) at a 
distance of 70 - 80 mm away from the nearest capillary wall (35). The mean p02 along the 
distance of 80 mm was approximately 8.4 mmHg, which is comparable to maximum p02/relaxo 
and pO2/electrode values as measured in the perfused rim of the glioma xenograft line in this 
study. Although, 02-consumption rates of tumor cells and 02-diffusion coefficient may not be 
similar in human glioma xenografts, these results suggest that slice-selective 19F-MR
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relaxometry measurements of PFCs sequestered in the perfused rim of tumors probe a mean 
oxygen tension of O2 profiles pertinent to perfused microvessels. The same is probably true 
for polarographic analyses of oxygen tensions, because the sample area of the O2-electrode 
has approximately a diameter of 50 mm (25). Therefore, the mean maximum pO2/electrode 
values in the perfused tumor rim were comparable to mean pO2/relaxo values. If the median 
pO2/electrode value of both tracks was calculated, then this value was lower than the mean 
pO2/relaxo value, since low pO2/electrode values which originated from hypoxic and necrotic areas 
were also included in calculations of the median pO2/electrode values.
Effect of carbogen breathing on the mean pÜ2/reiaxo values in tumor tissue slices.
In this study, 19F-MR relaxometry measurements of intravenously injected PFCs did not only 
permit the determination of oxygen tensions in perfused areas, but also oxygen tension 
changes. A small but significant increase of the pO2/relaxo values was observed after 8 and 14 
min carbogen breathing. In 9 of the 13 mice this increase tended to become smaller after 14- 
min carbogen breathing. If oxygen tension changes in perfused areas may cause 
radiosensitization, then maximum radiosensitivity is expected within the first 8 min after the 
start of carbogen breathing. 19F-MR relaxometry measurements alone cannot give an 
explanation for this small decrease of pO2/relaxo values during carbogen breathing, but we may 
speculate that this has to do with the redistribution of O2 by diffusion in tumor tissue after the 
start of carbogen breathing and/or the time to establish a new equilibrium between the 
increased O2-supply and demand.
In the context of radiotherapy the detection of oxygen tension changes in chronically 
hypoxic areas are of greater interest. Perhaps the use of fluorinated bioreductive chemical 
probes may assess oxygen tension changes in chronically hypoxic regions noninvasively by 
F-MR spectroscopy, although MR-sensitivity may limit their proper detection (36-39).
Conclusions. If perfluorocarbon compounds are administrated 3 days before the slice- 
selective 19F-MR relaxometry experiments, then oxygen tensions and oxygen tension changes 
during carbogen breathing are mainly measured in perfused regions of the tumor throughout 
the whole MR-slice. In these regions, mean pO2/relaxo tensions have been validated by 
polarographic measurements. The effect of carbogen breathing on the oxygen tension in 
perfused areas was small but significant and tended to decrease with time.
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Abstract
The relationship between the bioenergetic status of human glioma xenografts in nude mice
31and morphometric parameters of the perfused vascular architecture was studied using P- 
magnetic resonance spectroscopy (MRS), fluorescence microscopy and two-dimensional 
digital image analyses. Two tumor lines with a different vascular architecture were used for 
this study. Intercapillary distances and nonperfused area fractions varied greatly between 
tumors of the same line and tumors of different lines. The inorganic phosphate-nucleoside 
triphosphate (Pi/NTP) ratio increased rapidly as mean intercapillary distances increased from 
100 |im to 300 |im. Two morphometric parameters - the percentage of intercapillary distances 
larger than 200 ^m (icd200) and the nonperfused area fraction at a distance larger than 100 |im 
from a nearest perfused vessel (areai00) - were deduced from these experiments and related to 
the Pi/NTP ratio of the whole tumor. It is assumed that an aerobic to anaerobic transition 
influences the bioenergetic status: i.e. the Pi/NTP ratio increased linearly with the percentage 
of icd200 and the areai00.
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Introduction
31Phosphorus magnetic resonance spectroscopy ( P-MRS) studies of the bioenergetic status of 
tumors have been compared directly with tumor tissue pÖ2 (1) and with several physiological 
parameters that affect pÖ2 in tumor tissue, such as the intravascular concentration of 
oxyhaemoglobin (2) and tumor blood perfusion (3). 31P-MRS has been demonstrated to be 
sensitive to tumor size (4, 5), with an increase in tumor size being supposed to have a 
negative influence on perfusion- and diffusion limited oxygen delivery and nutrient (6). The 
global bioenergetic status of a tumor, expressed as the Pi/NTP ratio, depends on the balance 
between the oxygen and nutrient supply, and the consumption rates of the tumor cells, which 
is related to the type of energy metabolism. This balance between supply and consumption 
determines the critical diffusion distances for oxygen and nutrients in tumor tissue. The total 
oxygen supply and nutrient supply depends on the tumor microcirculation and on the 
diffusion geometry.
The purpose of this study was to investigate the existence of a possible relationship 
between the global bioenergetic status and the diffusion geometry of human glioma 
xenografts in nude mice. A two-dimensional morphometrical analyses of the perfused 
vascular architecture of complete transverse tumor sections was performed. Morphometric 
parameters such as the percentage of large intercapillary distances and the fraction of 
nonperfused areas in a tumor section area are related to the diffusion limited oxygen delivery 
and nutrient delivery. Critical diffusion distances for oxygen and nutrients per perfused vessel 
can be estimated using a Krogh model (7-12). For example, the mean critical oxygen 
diffusion distance in gliomas using a Krogh model is approximately 100 |im. When tumor 
cells have an aerobic energy metabolism, changes in the percentage of intercapillary distances 
larger than approximately 200 |im are expected to effect the global bioenergetic status 
(Pi/NTP ratio). This indeed was observed. In addition, the mean fraction of the nonperfused 
tumor area at a distance larger than ~ 100 |im from the edge of a nearest perfused vessel was 
also found to be related to the global bioenergetic status of a tumor.
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Material and Methods
Animal model. The same tumors of chapter 4, with a homogeneously (E98, n=10) and 
heterogeneously perfused vascular architecture (E49, n=14) were used in this study. The local 
ethical committee for animal use approved the experimental procedures.
31In vivo P-magnetic resonance spectroscopy. MRS measurements were performed on a 
vertical-bore Bruker spectrometer (4.7 T) employing a home-built 1H/31P double tunable 
three-turn solenoid coil with an inner diameter of 13 mm. The solenoid coil was fitted with a 
Faraday shield to eliminate spurious signals from normal tissue adjacent to the tumor. Mice 
with human glioma xenografts were excluded if host tissue was partially present in the 
volume sampled by the solenoid (tumor weight < 0.3 g) and when tumors were too large to fit 
completely in the solenoid (tumor weight > 0.9 g).
The mice were anaesthetized with a flow of 1.5 % enflurane in an oxygen-nitrous 
oxide (3:7) mixture applied through a nose-cone. Body temperature was monitored by a rectal 
probe (36-gauge wire, Hewlet Packard) and maintained at 36.5o - 37o C by a warm water
31blanket with a feedback system. P-MR spectra were obtained with a one-pulse sequence 
with a hard pulse of 12 m  (optimized for maximum signal intensity) and a pulse repetition 
time of 5 s. The number of scans was 320.
31As the P-MRS experiments were carried out with an interpulse delay shorter than
31three times the Ti of the P spins of the Pi (i.e. approximately 4 s), the area of the Pi peak is 
not strictly proportional to its concentration (13). However, all in vivo spectra were run with 
the same acquisition parameters and in this group of tumors little effect is expected on the 
calculations of the Pi/NTP ratio at a pulse repetition time of 5 s.
Fluorescence Microscopy. After the MRS experiments, 0.05 ml solution of phosphate- 
buffered saline (PBS, pH=7.4) containing a fluorescent perfusion marker, Hoechst 33342 
(15mg.kg-1, Sigma, St.Louis,MO, USA), was injected i.v. via a lateral tail vein. One minute 
after injection, the mice were killed and tumors were quickly removed and frozen in liquid 
nitrogen, preventing the dye from diffusing too far into tissue. The tumor was cut in two 
halves: one half was used for the analyses of the perfused vascular architecture and the other 
half was used for classical histological staining with eosin (cytoplasm) and haematoxylin 
(nuclei).
Fifteen frozen tissue sections (5 ^m) at random locations were made using a freeze 
microtome. Sections were processed at room temperature by a 15-min incubation with 
collagen Type IV polyclonal antibody (rabbit serum, Euro-Diagnostics, Oss, The 
Netherlands), a marker for the basal lamina of the tumor vasculature. Next, the sections were 
incubated with a second antibody, goat anti-rabbit immunoglobulin labelled with Tritc (Tago, 
Birlingame, CA, USA).
The whole tumor sections were analyzed in the fluorescence microscope using a 
digital-image processing system. A detailed description of this method is given by Rijken et 
al (14). Briefly, each section was scanned twice on a computer-controlled motorized stage of 
a
fluorescence microscope using two different excitation-emission filters. After processing all 
fields of each scan, a composite image was reconstructed from the individual processed 
fields, revealing the perfused vessels (Hoechst image) and the total vascular bed (collagen 
image) in separate scans. When both images were combined, the new matched image showed 
the perfused and nonperfused vessels.
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In the next step, the fluorescent rim of Hoechst dye around perfused vessels, due to Hoechst 
diffusion into adjacent tissue, was deleted by image processing. In Hoechst images only, 
vascular areas are slightly overestimated.
Data analyses.
31P-MR spectra. Zero filling and the convolution difference technique with line broadenings 
of 30 and 1000 Hz were applied to the free induction decay (FID). The peaks of the a,b,g- 
NTP, Pi and, when present, phosphocreatine (PCr) were fitted to Lorentzian line shapes with 
NMR1 software (New Methods Research, Syracuse, NY, USA). The integral of the Pi peak 
and the sum of the integrals of the a,b,g-NTP peaks were used in the calculation of the 
Pi/NTP ratio.
Calculation of the pHmrs. The pH was deduced from the chemical shift of the Pi signal 
with respect to the chemical shift of the PCr signal, or the a-NTP signal in the absence of a 
PCr resonance. A modified Henderson-Hesselbach equation was used, with the following 
parameters: pK = 6.75, a (acid shift) = 3.29, b (base shift) = 5.7 (15, 16).
Vascular morphology of perfused vessels.
The percentage of intercapillary distances > 200 \im (icd200). For each perfused vessel, a 
domain (17), i.e. the area of tumor tissue which is supposed to be supplied by the nearest 
perfused vessel, was determined in matched images. As a consequence, one domain contains 
one perfused vascular structure, and may contain nonperfused vascular structures and 
avascular regions. With the help of an image analyses system, line networks in Figure 6.1 
represent contours of these domains. The shortest distance between neighbouring perfused 
vascular structures was used as an estimation of the icd. Note that neighbouring perfused 
vascular structures have adjacent domains. Thus, intercapillary distances were not determined 
between perfused vascular structures that did not have adjacent domains. Calculations of 
distances were started from perfused vessel walls. Icds obtained by a domain analyses are 
always larger than icds between perfused vessels, measured in perfused regions only (18). For 
each tumor, the frequency distribution of the icds was determined for all values calculated in 
the 15 tumor sections (Statistica, StatSoft, Tulsa, OK, USA). The percentage of intercapillary 
distances > 200 |im (icd200) was obtained from the cumulative frequency distribution for the 
whole tumor.
The fraction of the nonperfused tumor area at a distance larger than 100 \im from a nearest 
perfused vessel (areai00). In matched images, a circle with a radius of 100 |im was drawn 
around every perfused vessel. For each tumor section, the tumor area outside the circles was 
determined and divided by the total tumor section area. Next, a mean nonperfused area 
fraction at a distance > 100 |im from a nearest perfused vessel was calculated for all 15 tumor 
sections.
The morphological parameter - the percentage of icd200 - is probably less sensitive to 
the total nonperfused area than the parameter area100. Only a few long icds (> 200 |im) may 
be responsible for the determination of a large nonperfused area. In other words, the weight of 
a few long icds in comparison with all icds is of less importance than the weight of the 
nonperfused areas in relation to the total tumor area.
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Analyses of the relationship between the Pi/NTP ratio and the morphometric 
parameters.
Linear regression analyses was performed between the morphometric parameters, mentioned 
above, and the Pi/NTP ratios using Graphpad (Graphpad PRISM version 2.0, San Diego, 
USA). The goodness of the fit (R ), the 95% confidence intervals and the p-value of the slope 
are given, i.e. test result of the significant difference of the slope from zero. Values presented 
in the text are means ± standard deviations (SD).
A B
ppm
1 mm
ppm
Figure 6.1 Matched digital images of a scanned tumor section at the centre of an E49 tumor no. 4 (A) and E98
31no.15 (C) with the corresponding P-MR spectra of the whole tumor (B and D). The perfused vessel structures 
are situated in a vessel domain delineated by the lines. Peak assignments of 31P-MR spectra in B and D: 1, 
phosphomonoesters; 2, Pi; 3, phosphodiesters; 4, PCr; 5, g-phosphate of NTP; 6, a-phosphate of NTP; 7, p- 
phosphate of NTP. The tumors depicted in this figure are similar to the tumors of Figure 4.4 in chapter 4.
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Results
Comparison of vascular morphometric analyses of perfused vessels between the tumor 
lines (E49, E98) and host tissue.
In Figure 6.2, a frequency histogram of the icds is given for a single tumor and host tissue, i.e. 
skeletal muscle of the hindlimb. Tumor tissue showed an important tail of long icds in 
comparison with host tissue. Icds larger than 200 mm were not observed in host tissue; thus, 
the percentage of icd200 = 0. The mean icd of host tissue was 35 ± 21 mm, which was much 
smaller than the mean icds per tumor for both lines, which varied between 102 ± 255 mm 
(E98, no. 6) and 526 ± 613 mm (E49, no. 23) (Figure 6.3). In skeletal muscle of the hindlimb, 
the mean area100 was 0.07 ± 0.02 (-) and is smaller than the mean area100 values found for the 
tumor line E49 & E98, which varied between 0.09 ± 0.02 (E98, no.1 & no. 6) and 0.84 ± 0.02 
(E49, no. 23) (Figure 6.5).
Figure 6.2 Example of a 
frequency histogram of 
intercapillary distances in tumor 
tissue (E49, no.13) (□ ) and skeletal 
muscle (host tissue) ( ). The 
percentage of cases per icd-interval 
of 20 mm (x-axis) is depicted on the 
y-axis. The figure is truncated at icds 
> 600 ^m. The maximum icd of 
no.13 is 1918 ^m.
icd (m m)
31Vascular morphometric analyses of perfused vessels and P-MRS.
31The integral of the peaks in the P-MR spectra reflects the quantity of phosphorylated 
metabolites (a,p,g-NTP, Pi, PCr, PME, PDE) in viable tumor cells (19), in the volume 
sampled by the solenoid (approximate tumor volume). The Pi/NTP ratio is accepted as an 
indication of the energy status of cells (1, 2), where NTP is broken down to NDP and Pi by 
the action of NTPases during cellular activities.
31There was little or no contamination by PCr and NTP signals from muscle tissue. P- 
MR spectra of tumors with similar weights showed PCr-peaks smaller than NTP-peaks, 
except some well-perfused tumors, e.g. E98 no. 15 (Figure 6.1). An example of the domain 
analyses for two different tumor sections of E49 no.4 and E98 no.15 is shown in Figure 6.1A
31& 6.1C with the corresponding P-MR spectra of the whole tumors (Figure 6.1B and 6.1D). 
In Figure 4.4, the HDO-uptake curve of the same tumors is shown. Tumor E49 no. 4 showed 
a large nonperfused area in the centre, whereas tumor E98 no.15 showed a homogeneously 
perfused vessel distribution. The tumors had the following values for the morphometric
102 Chapter 6
parameters: no. 4, percentage of icd200 = 22, mean area100 = 0.52 ± 0.07; no. 15, percentage of 
icd200 = 7 and mean area100 = 0.12 ± 0.04. The Pi/NTP ratio of no. 4: i.e. 0.45, was higher 
than the ratio of no. 15: i.e. 0.17.
Pi/NTP ratio and the mean intercapillary distance.
Figure 6.2 shows that a frequency distribution of icds in tumor tissue is not a normal 
distribution. An important tail of large icds (> 200 |im) was found in all tumors (results not 
shown here). Standard deviations were mostly larger than mean icds, with the exception of 
most E98 tumors, which showed a more homogeneously perfused vessel distribution. 
Therefore, the mean icd can only be used as a rough indication for differences in the icd 
distribution between tumors. In Figure 6.3, the mean icd per tumor for both lines is related to 
the Pi/NTP ratio. The Pi/NTP ratio showed the largest changes between a mean icd of 
approximately 100 |im and approximately 300 |im; the Pi/NTP ratio increased around a mean 
icd of approximately 200 |im.
Figure 6.3 Plot of the Pi/NTP 
ratio (-) vs the mean icd (^m) per 
tumor for the lines E49 (□ ) and 
E98 ( ). One square represents 
one tumor.
micd (mm)
Pi/NTP ratio and the percentage intercapillary distance greater than 200 ^m.
In Figure 6.4, the relationship between the Pi/NTP ratio and the percentage of icd200 is shown 
for the tumor lines E49 and E98. A linear relationship was found with a goodness of the fit 
(R2) = 0.70. The slopes of the regression lines from both tumor lines were not significantly 
different (p > 0.01). The pooled slope was significantly different from zero (p < 0.0001). No 
relationship was found between the Pi/NTP ratio and the percentage of icds > 100 |im and the 
percentage of icds > 300 |im (results not shown here). The Pi/NTP ratio for the host tissue 
(hindlimb skeletal muscle) was 0.09 ± 0.01 and the percentage of icd200 = 0. The datapoint of 
the host tissue is depicted in Figure 6.4, but was not used in the regression analyses. The 
energy metabolism in muscle tissue cells probably differs from the energy metabolism in 
glioma tumor cells, so a direct comparison is not allowed.
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Pi/NTP ratio and the nonperfused area fraction at a distance larger than 100 ^m from a 
nearest perfused vessel (areai00).
In Figure 6.5, the relationship between the Pi/NTP ratio and the mean area100 is shown. For 
both tumor lines, there was a linear relation between the Pi/NTP ratio and the area100: R =
0.76. The slopes of the linear regression lines of the tumor lines E49 & E98 were not 
significantly different (p > 0.01), but the pooled slope was significantly different from zero (p 
< 0.0001). No relationship was found between the Pi/NTP ratio and the mean area50 and the 
mean area150, as expected from the results obtained for icds as shown in the previous 
paragraph.
The goodness of the fit in Figure 6.5 was slightly better than in Figure 6.4, i.e. the 
morphometric parameter mean area100 showed a better correlation with the Pi/NTP ratio than 
the percentage of icd200. The datapoint of the host tissue was lower than the datapoints of the 
different tumors and was not used in the regression analyses (see previous paragraph).
pH mrs and morphometric analyses of perfused vessels.
pHmrs (approximate pHi) was independent of the percentage of icd200 and the area100 over a 
large range of values (results not shown). All tumors showed a single Pi peak corresponding 
to pHmrs values from about neutral (pH ~ 7.0 ± 0.1) to basic (pH ~ 7.3 ± 0.1). There were two 
exceptions in the E49 line: tumor no. 16 showed a split Pi peak, corresponding to pH values 
of 7.3 ± 0.2 and 6.8 ± 0.1; Tumor no. 23 had pHmrs values of 7.12 ± 0.1 and 6.7 ± 0.1. The 
tumors had the following values for the morphometric parameters: no. 16, percentage of 
icd200 = 37, mean area100 = 0.63 ± 0.19; no. 23, percentage of icd200 = 43 and mean area100 =
0.84 ± 0.1.
% ivd > 200 m m (%)
Figure 6.4 Plot of the correlation between the Pi/NTP ratio (-) and the percentage of intercapillary distances 
larger than 200 mm (icd200 (%)). The line indicates the results of least-squares linear regression analyses (R2 = 
0.70) of the data for the tumor lines E49 (□ ), E98 (■): y = 0.18 ± 0.04 + 0.01 ± 0.002 x x. The dashed lines 
show the 95% confidence intervals. One square represents one tumor. The Pi/NTP ratio (▲) for the host tissue 
(skeletal muscle hindlimb) is 0.09 ± 0.01 and the percentage of icd200 = 0. The datapoint of the host tissue was 
not used in the regression analyses.
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Figure 6.5 Plot of the correlation between the Pi/NTP ratio (-) and the mean area100 (-) for the tumor lines E49 
(□ ) and E98 (■). The line indicates the results of least-squares linear regression analyses (R2 = 0.76) of the data 
for the tumor lines E49 (□), E98 (■): y = 0.17 ± 0.03 + 0.59 ± 0.07 x x. The dashed lines show the 95% 
confidence intervals. One square represents one tumor. The Pi/NTP ratio (▲) for the host tissue (skeletal muscle 
hindlimb) is 0.09 ± 0.01 and the area100 = 0.07 ± 0.02. The datapoint of the host tissue was not used in the 
regression analyses.
31In vivo P-MRS and vascularity of glioma xenografts 105
Discussion
The relationship between the Pi/NTP ratio and the morphometric parameters.
In this study, the perfused vascular architecture of complete transverse tumor sections was 
analyzed by two-dimensional morphometric analyses. Two morphometric parameters were 
evaluated: (a) the percentage of large intercapillary distances and (b) the nonperfused area 
fraction. These were compared with the bioenergetic status of the whole tumor. To our 
knowledge this is the first study, which has related morphometric analyses of the perfused 
vascular architecture directly to the global bioenergetic status of the same tumor, measured by 
31P-MRS.
A domain analyses was used for the calculation of intercapillary distances. A domain 
included nonperfused vascular structures and avascular regions. Polymer infusion techniques 
can provide similar morphometric information about icds, but only of perfused regions (18). 
Morphometric analyses of only well perfused regions will probably fail to correlate with the 
bioenergetic status of the whole tumor, because avascular and nonperfused vascular regions 
will have a negative impact on the global bioenergetic status if these regions are hypoxic and 
are lacking nutrients.
The total bioenergetic status (Pi/NTP ratio) of a tumor depends on the balance 
between the oxygen supply and nutrient supply and the consumption rates of the tumor cells, 
which is related to the type of energy metabolism in the different tumor cells. This balance 
between supply and consumption determines the critical diffusion distances for oxygen and 
nutrients in tumor tissue. The total oxygen supply and nutrient supply depends on the tumor 
microcirculation and on the diffusion geometry. This study was restricted to the analyses of 
the relationship between the diffusion geometry of a tumor and its bioenergetic status. The 
Pi/NTP ratio was found to increase rapidly between a mean icd of approximately 100 |im and 
approximately 300 ^m (Figure 6.3). This is in agreement with preliminary histological 
analyses of critical oxygen diffusion distances in tumor sections, using a bioreductive 
chemical probe for hypoxic cells (20). With use of the bioreductive chemical probe NITP (N- 
imidazole-theophylline, a generous gift of Dr R Hodgkiss, Gray Laboratory, England) and the 
perfusion marker Hoechst, hypoxic areas and perfused vessels were stained simultaneously in 
the same tumor section. The distances between perfused vessels and hypoxic areas varied 
from approximately 50 |im to approximately 150 |im, with a mean distance of 113 ± 46 |im. 
This correspond to a mean icd of approximately 200 |im. The complete study will be 
published separately. The mean critical oxygen diffusion distance of appraximately 100 |im 
was used as a cut off value in the definition of the morphometric parameters, i.e. the 
percentage of icds > 200 |im (icd200) and the nonperfused area fraction at a distance > 100 |im 
from a nearest perfused vessel.
At a mean distance of approximately 100 |im from a perfused vessel, the probability 
of an aerobic to anaerobic transition is high. A main question in this study was whether this 
transition could influence the global bioenergetic status of a tumor? Are there sufficient 
tumor cells with an aerobic energy metabolism, depending on oxygen for an efficient NTP- 
production or may other substrates such as glucose assure the NTP-production by an 
intensified (an)aerobic glycolysis ?
In vitro studies on tumor cells (21, 22) and ex vivo studies on perfused tumours (23) 
showed the effect of a reduced oxygen supply on the oxidative phosphorylation or the inhibi­
tion of oxidative phosphorylation (24).
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Pianet et al (21), Gerweck et al (22) and Eskey et al (23) found in vitro and ex vivo, that the 
reduction of the oxygen tension has little influence on the NTP/Pi ratio in the presence of high 
glucose concentrations. They argued that (an)aerobic glycolysis is capable of maintaining the 
energy status. In vivo (DS sarcoma), Vaupel et al (25) reported that after reduction of the 
tumor blood flow the amount of NTP remains nearly constant. These findings were explained 
by an intensified glycolysis due to the recruitment of glucose from the interstitial reservoir of 
the tumor. Only for tumors with a median oxygen tension below 10-15 mmHg was NTP 
depletion observed. These conditions were found for tumor masses larger than 1.5 % of the
31body weight. Okunieff et al (26) observed with P-MRS for large tumors (murine fibro­
sarcoma FSaII, approximately 2.5 % of the body weight) that i.p. injection of glucose had a 
positive effect on tumor energy metabolism, and no significant effect on the energy 
metabolism of small tumors (approximately 0.7 % of the body weight).
What can we expect in our glioma tumor model? For a given consumption rate and 
diffusion coefficient of oxygen and glucose, critical diffusion distances can be estimated 
using the Krogh model. The consumption rate of oxygen and glucose is related to the energy 
metabolism of cells. Histochemical evaluation of this metabolism in rat C6 gliomas (27) 
revealed that the energy production is more dependent on aerobic glycolysis than on oxidative 
phosphorylation: enzymes of the energy-producing tricarboxylic acid cycle and the electron- 
transport system were reduced, although still present. Rhodes et al (28) found for human 
gliomas in vivo, using Positron Emission Tomography (PET), a metabolic uncoupling 
between the regional oxygen consumption and glucose consumption. The latter is indicative 
of an increased aerobic glycolysis. In order to determine the importance of the mitochondrial 
oxidative phosphorylation vs aerobic glycolysis, the in vivo determination of the oxygen and 
glucose consumption is important. Mean oxygen and glucose consumption rates for 
macroscopic tissue volumes of human high-grade gliomas (PET derived data) were estimated 
to be approximately 0.5 |imol.g-1.min-1 for oxygen and approximately 0.5 |imol.g-1.min-1 for 
glucose (11). The mean consumption rate of oxygen and glucose was found to be equal in 
high-grade gliomas, which means an increased aerobic glycolytic activity and/or an increased 
activity of the pentose phosphate shunt for DNA synthesis (27) in comparison to normal brain 
tissue.
Rough estimations of the oxygen and glucose Krogh radii is possible, using mean 
consumption rates, mean concentrations in perfused vessels and constant diffusion 
coefficients (Figure 6.6). The Krogh radii are approximately 100 |im for oxygen and 
approximately 200 |im for glucose (7, 9-12). In vivo, a large distribution of Krogh radii will 
be found, depending on: (a) the distance in a perfused capillary from the inlet, because the 
pO2 and the glucose concentration in a capillary decreases between the inlet and outlet; (b) 
further, the energy metabolism and the related consumption rates of tumor cells may be 
heterogeneous, i.e. cell regions with aerobic and anaerobic energy metabolism may exist. 
However, the mean critical oxygen diffusion distance in Figure 6.6 corresponds well to the 
mean distance between perfused vessels and hypoxic areas as determined by the use of the 
bioreductive chemical probe NITP. In addition, the percentage of icd200 and the mean area100 
were linearly related to the Pi/NTP ratio, whereas no relationship was found between the 
Pi/NTP ratio and higher or lower values than the cut off value of approximately 100 |im used 
in the definition of both morphometric parameters.
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The results lead to the following hypothesis: the linear relationship between the Pi/NTP ratio 
and the morphometric parameters in Figure 6.4 and 6.5 is due to a slowly changing metabolic 
steady state: (aerobic) glycolysis + oxidative phosphorylation -> anaerobic glycolysis, in 
which the glioma cells attempt to maintain NTP synthesis by the anaerobic glycolysis during 
a progressively decreasing glucose supply. At an intercapillary distance of approximately 200 
mm, the probability of an aerobic to anaerobic transition is high and consequently will affect 
the local bioenergetic status of glioma cells, which consume oxygen. The relationships found 
between the Pi/NTP ratio and the morphometric parameters possibly indicate that the 
diffusion-limited supply of oxygen is a major determinant of tissue oxygenation in our glioma 
tumor model.
As a next step, in vivo and/or in vitro measurements of the oxygen consumption rates 
of tumor cells in human glioma xenografts, used in this study, will be performed and related 
to critical diffusion distances of oxygen in vivo.
Figure 6.6 Plot of the relative 
values of the pO2 (%) (-D-) and 
[glucose] (%) (-▲ -) in glioma tissue 
(y-axis) and their Krogh radii r (x- 
axis) for one perfused vessel (x = 0) 
calculated with use of the following 
parameters: Oxygen (9,10,12): mean 
pO2 = approximately 70 mmHg 
(mean pO2 vessel), mean 
consumption rate gliomas (11):
0.011 ml.g-1.min-1, radius of tissue 
cylinder: 0.0105 cm, Krogh's 
diffusion constant: 2.5 x 10-8 ml.cm-
1.min-1.mmHg-1. Glucose (7,9): 
mean [glucose]: approximately 5.5 x 
10-3 mmol.ml-1, mean consumption 
rate gliomas: 5 x 10-4mmol.g-1.min1, 
radius of tissue cylinder: 0.031 cm, 
diffusion coefficient: 1.2 x 10-4 
cm2.min-1. For both calculations the 
mean radius of vessels is 4 ^m.
pH mrs.
Two tumors (E49, nos 16 and 23) with 36% extracellular volume, estimated from the eosin- 
and haematoxylin-stained tumor sections, showed a split Pi peak. These tumors had the 
highest values for the percentage of icd200 and the mean area100. For no.16, the percentage of 
icd200 = 37 and the mean area100 = 0.63. For no.23, the percentage of icd200 = 43 and the 
mean area100 = 0.84. Stubbs et al (29) suggested that a split Pi peak is quite possible when the 
contribution of extracellular Pi is 35% or more. The pH across the plasma membrane would 
have to be > 0.3-0.4 pH units. Gerweck et al (30) showed for murine fibrosarcoma cells 
(FSaII) that the pHi is relatively resistant to changes in pHe above 6.9. Below a pHe of 6.9 a 
pH gradient is maintained with pHi being consistently more basic than pHe by ± 0.35 pH 
units.
Krogh radius (m m)
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The results of Gerweck et al (30) and Stubbs et al (29) agree with our findings: for tumor nos 
16 and 23 the mean pHe is 6.8 ± 0.1 and 6.7 ± 0.1 and the mean pHi is 6.8 + 0.35 = 7.2 and
6.7 + 0.35 = 7.1.
No relationship was found between the pHmrs and the morphometric parameters. 
Spatially resolved bioluminescence and fluoroscopic imaging studies of pH values in tumor 
tissue showed a relationship with the distribution of perfused and nonperfused areas (31), but 
global pHmrs measurements failed in this study.
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Abstract
The aim of this study was to evaluate the effect of carbogen breathing on the physiological 
profile of human glioma xenografts. Near infrared spectroscopy was used to investigate changes 
in oxy- and deoxyhemoglobin concentrations in tumor blood. Oxygen tension changes in tumor 
tissue were evaluated by 19F-MR relaxometry, using perfluoro-15-crown-5-ether, and 
modifications of tumor blood perfusion (TBP) were analyzed by fast dynamic 1H-MR imaging 
of Gd_DTPA uptake. Finally, changes of the bioenergetic status and pH of tumor cells were 
analyzed by 31P-MRS.
After 5 to 8 min carbogen breathing the average oxygen tension increase in tumor tissue 
was 4.6 ± 1.3 mmHg, which is in agreement with an increase of the oxyhemoglobin 
concentration in tumor blood (D[O2Hb] = 9.2 ± 3 mM). However, simultaneously the TBP was 
reduced, the bioenergetic status was diminished and pH was decreased.
As 100 % O2 breathing alone did not result in a detectable increase of oxyhemoglobin in 
tumor blood, the increase of the tumor oxygenation by carbogen appears to be mediated by its 
CO2 content. This component may cause a nutrient-limited decrease of oxidative energy 
metabolism, indirectly via a steal-effect and/or by inhibition of the glycolytic rate resulting from 
tissue acidification.
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Introduction
The hypoxic cell fraction in tumor tissue plays an important role in the sensitivity of a tumor to 
radiotherapy (1,2). The oxygen tension in tumor tissue depends on the balance between the 
oxygen supply and the oxygen consumption rate of the tumor cells. This balance determines the 
critical O2 diffusion distances pertinent to perfused vessels in tumor tissue. Tumor regions 
beyond this critical distance are regarded as chronically hypoxic (3, 4). A fraction of perfused 
vessels may have intermittent blood perfusion. These vessels transiently open and close in such 
a way that hypoxic regions may appear acutely (3, 4).
Breathing of carbogen (95% 02/5% CO2) in combination with nicotinamide and/or 
perfluorocarbon compounds has been introduced to decrease the fraction of chronically - and 
acutely hypoxic cells. (3-5). This treatment modality has produced a drastic improvement in 
local control of advanced laryngeal tumors (6). Carbogen is thought to reduce chronic hypoxia 
by increasing the amount of dissolved oxygen in blood plasma and by saturating hemoglobin 
with oxygen (5, 7). This is expected to extend the tissue area supplied with oxygen by diffusion 
from perfused vessels and hence reduce the number of chronically hypoxic cells (3), provided 
that no changes occur in the tumor blood perfusion (TBP) and the O2 consumption of tumor 
cells. In addition, the acidification of blood and tissue due to the C02-component of carbogen 
may cause increased systemic blood pressure and vasodilation of microvessels possessing 
responsive smooth musculature, which can change tumor blood perfusion (8-10). Tissue 
acidification may also inhibit the glycolytic rate of cells (11,12).
Although the effect of carbogen breathing on arterial blood gases appears comparable in 
different animal models (S. Robinson and M. Stubbs, personal communications), the effect on 
tumor blood perfusion and oxygenation was found to vary between different experimental and 
human tumors (13) and also intratumoral variations were observed (14). As tumors may contain 
residual normal host vessels supplied with responsive smooth musculature, the vasodilating 
effect of the CO2-component on TBP may depend on the proportion of such host vessels in 
tumor tissue (9, 13). In addition, the vasodilating effect of the C02-component on TBP is also 
determined by the configuration of the tumor vascular bed in relation to the vasculature of host 
tissue (8-10). If the tumor vasculature runs in parallel to the vasculature of the host, then 
carbogen breathing may increase the blood perfusion in host tissue at the expense of the tumor 
blood perfusion; the so-called steal-effect (10). Thus, differences in tumor implantation sites and 
the extent of neovascularization are among the factors determining the effect of carbogen on 
TBP.
As the ultimate effect of carbogen breathing on tumor physiology evolves from changes 
in multiple processes, this effect can only be understood when all relevant factors are taken into 
account. Therefore, the aim of this study was to perform a comprehensive analysis of the effects 
of carbogen breathing on the physiological profile of human glioma xenografts.
The changes of oxyhemoglobin concentrations in tumor and arterial blood were studied using 
near infrared spectroscopy (NIRS) (15, 16) and blood analyses. The effect of carbogen breathing 
on the tumor tissue oxygenation was evaluated by 19F-MR relaxometry, using perfluoro-15- 
crown-5-ether as oxygen sensor (17). Changes in the tumor blood perfusion were analyzed by 
fast dynamic 1H-MRI studies of the gadolinium diethylenetriaminepentaacetic acid (Gd_DTPA) 
uptake in the extracellular volume of the tumor (18). Finally, the effect of carbogen breathing on 
the bioenergetic status (Pi/NTP ratio) and on the intracellular pH of tumor cells was studied by 
P-MR spectroscopy (19). If carbogen breathing results in an extension of the tissue area 
supplied with oxygen, then the Pi/NTP ratio of tumor cells may decrease due to an enhanced 
oxidative energy metabolism. Changes in the intracellular pH of tumor cells (pHmrs) may 
correlate with changes in energy metabolism (11, 12).
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Material and Methods
Animal model. Human glioma xenografts (line E49) established from human tumor material 
were grown subcutaneously in the hindlimbs of athymic mice (Balb/c nu/nu, BonholdGard 
Denmark) (20). Mice were anesthetized with a flow of 2 % enflurane in an O2/N2O (30 % O2) 
gas mixture applied through a nose cone. To study the effect of carbogen breathing the O2/N2O 
gas mixture was switched to carbogen (95% O2/5% CO2) or to other O2/CO2 gas mixtures in 
NIRS experiments (see below). The percentage of enflurane was kept constant during, and after 
the switch. The flow velocity was 1 l.min- in all experiments and the composition of gas 
mixtures was analyzed on-line at the inlet of the nose cone with a gas monitor (Datascope 
Multinex, Datascope Corp. Paramus, N.J., USA). All experiments (except NIRS) were started 5 
minutes after the beginning of carbogen breathing. The 5 min pre-breathing time was based on 
results of the NIRS experiments, which showed that after 5 min the oxyhemoglobin 
concentration ([O2Hb]) and deoxyhemoglobin concentration ([HHb]) were close to a steady 
state. Body temperature was monitored with a rectal probe (36-gauge wire, Hewlett Packard) 
and maintained at 36.5o - 37o C by a warm water blanket with a feedback system.
The following experiments were done on different groups of mice. The tumor line and 
implantation site were the same among these groups. Therefore average changes of blood and 
tissue parameters per experiment on a mouse series can be compared. The tumor weights varied 
from 0.6 to 0.9 g in all mice studied. The local ethical committee for animal use approved the 
experimental procedures.
Blood gas analyses. The effect of carbogen breathing on blood gases was analyzed by 
cannulating the carotid artery of 5 nude mice. Three 150 |il arterial blood samples were taken at 
the following times: 1) before carbogen breathing, 2) 8 min - and 3) 16 min after the start of 
carbogen breathing. Changes in the free oxygen tension in blood (pO2blood), free CO2 tension in 
blood (pCO2blood) and pH in blood (pHblood) were analyzed with the Blood Gas Manager 1312 
(Instrumentation Laboratory, USA), and the total hemoglobin concentration ([tHb]) and 
hemoglobin saturation (SaO2) were measured with the CO-oximeter 482 (Instrumentation 
Laboratory, USA).
Near Infrared Spectroscopy. Near infrared spectroscopy is based on the oxygen-dependent 
absorption of near infrared light by hemoglobin (15), with different absorption characteristics 
for oxyhemoglobin and deoxyhemoglobin. Therefore, relative changes of the oxyhemoglobin 
and deoxyhemoglobin concentration in the blood volume of tissue can be followed 
simultaneously during e.g. carbogen breathing. This technique cannot measure absolute 
concentrations of both chromophores.
Fourteen mice with tumors were placed in closed tubes with an inlet near the head of the 
mice for the introduction of different O2/CO2 gas mixtures and an outlet near the mouse's tail for 
on-line gas analyses with a gas monitor (see above). Tumors were placed without any 
compression through a hole in the tube wall adjusted to the tumor diameter. The fiber optodes 
of the NIRS instrument (Radiometer Medical A/S, Denmark) were placed on the surface of the 
subcutaneous tumors with an inter-optode distance of ~ 1 cm and an angle of ~ 90o between the 
input- and output optode. Using this configuration the volume of tissue probed by NIRS has a 
banana-shaped form with a penetration depth of approximately 10 mm (21). The tumor 
diameters in this study varied from 10 to 12 mm; thus, only a very small percentage of the 
photons originated from underlying muscle tissue and overlaying skin.
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If the chromophore signal intensities were in a steady state under condition of basal anaesthesia 
(see first paragraph animal model), then different O2/CO2 gas mixtures were generated on-line 
using a gas blending system (H. Wosthoff, Bochum, Germany). The CO2 content of the gas 
mixtures was increased in steps of 1 % with 5-min intervals, and the mixture was led through 
the tube with a flow velocity of 1 l.min-1. In three animals the effect of 100 % O2 breathing on 
the NIRS signals was analyzed with the same flow velocity.
Data analyses. In the last minute of each time interval of 5 min, when the chromophore 
signal intensities were in a steady state, the mean apparent concentration changes of the 
chromophores (^M) were calculated (22). Absolute quantification of concentration changes per 
tissue volume were not possible because, the differential path length factor (DPF (-)) was not 
known for tumor tissue. This factor is related to the scattering properties of tissue (22). In this 
paper, the term concentration changes refers to apparent concentration changes and is equal to 
real concentration changes multiplied with the differential path length factor for tumor tissue. 
The sum of oxyhemoglobin concentration ([O2Hb]) and deoxyhemoglobin concentration 
([HHb]) changes is a measure of the total hemoglobin concentration changes ([tHb]) in the 
region seen by the optodes. At constant blood hemoglobin concentrations this will reflect total 
blood volume changes (22). Concentration changes were analyzed with a paired t-test.
19F-MR relaxometry. In vivo 19F-MR relaxometry measurements were performed on 13 
tumors using an SMIS spectrometer interfaced to a vertical bore magnet (4.3 T) and employing 
a home-built 1H/19F double tunable solenoid (0  13 mm). A detailed description of this method 
is given in ref. 23 and chapter 5. Briefly, 3 or 4 days before the NMR experiments 0.15 ml of 
the 40% (v/v) perfluoro-15-crown-5-ether emulsion (HemaGen/PFC, St. Louis, MO) was 
injected via a tail vein (dose: 4.2 g/kg).
For the appropriate positioning of a coronal slice for slice-selective 19F-MR relaxometry 
measurements through the center of the tumor, multi-slice coronal 1H-Spin Echo (SE) images 
were acquired (TR = 1 s, TE = 0.06 s, NS = 2, matrix size = 128 x 128, FOV 15 x 15 mm, slice 
thickness 1.5 mm). Next, 19F-SE density images were obtained at the same position as the 1H- 
SE images using the following parameters: TR = 8 s, TE = 0.03 s, NS = 2, matrix size = 64 x 
64, FOV = 15 x 15 mm and slice thickness 4 mm. The 19F-SE density images were used for 
analyses of the 2D distribution of PFCs in similar slices as used in in vivo 19F-MR relaxometry 
studies.
In vivo 19F-MR relaxometry was performed using a slice-selective inversion-recovery 
T1-sequence with a 180o adiabatic full passage inversion pulse (24) and a 90osinc excitation 
pulse, optimized for a 4 mm thick slice. Eight inversion delay times were used between 0.8 and 
8 s, TR = 12 s, NS = 4, total measurement time 384 s. Two T1 measurements were performed 
before carbogen breathing and subsequently two during carbogen breathing.
Data analyses. An in-vitro calibration curve (see chapter 5 and ref. 23) was used to 
convert in vivo T1-relaxation rates (R1) of 19F-spins to pO2/tissue values. The standard errors of 
the intercept value and the slope of the calibration curve were propagated in the calculations of 
the SEM of absolute mean pO2/tissue values per tumor slice in experiments without carbogen 
breathing (n = 2) or were propagated in calculations of the SE of changes in the pO2/tissue values 
after 8 and 14 min carbogen breathing. For carbogen breathing experiments the average pO2/tissue 
changes of all tumors (n = 13) was analyzed with a paired t-test.
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Fast dynamic 1H-MRI studies of Gd_DTPA uptake. Cannulae (Neoflon 0  0.6/19mm, 24 G) 
were inserted in tail veins of 8 mice with tumors for on-line administration of tracer. 1H-MRI 
measurements were performed on a SISCO 200/400 spectrometer interfaced to a horizontal bore 
magnet (4.7 T). A home-built inductively coupled 1H-surface coil ( 0  3 cm) was used as 
transmitter and receiver. Global shimming was performed on the total tumor. For the position of 
a coronal slice through the center of the tumor parallel to the surface coil, multi-slice sagittal 
and coronal 1H-SE-images were made (TR = 0.3 s, TE = 0.023 s, matrix size 256 x 64, FOV 5 x 
5 cm, slice thickness = 1.5 mm). After positioning of the coronal slice, a fast RF-spoiled T 1- 
weighted FLASH sequence was used to obtain sensitivity to T1-relaxation time changes of water 
protons induced by the Gd_DTPA uptake in the extracellular space of tumor tissue. The uptake 
of Gd_DTPA causes a decrease of the T1-relaxation time of 1H spins of water in tumor tissue 
and consequently increases the signal intensity in T1-weighted 1H-MR FLASH images. It should 
be noted that the O2-component of carbogen can have a similar effect on the signal intensities in 
T1-weighted 1H-MR images, but we observed that the maximum decrease of T1-relaxation times 
was 6 % in the presence of carbogen. This decrease was much smaller than the T1-relaxation 
time decrease in the presence of Gd_DTPA at a dose of 0.1 mmol.kg-1, which was 
approximately 38 %.
A Gd_DTPA-uptake experiment consisted of 60 consecutive T1-weighted FLASH 
images with a total acquisition time of 50 s. An i.v. bolus injection (0.2 ml, duration: 2 s, 0.1 
mmol.kg1) of a Gd_DTPA solution in saline (Schering, Berlin, Germany) was given after 7 
precontrast images. The rate of bolus injection was constant for all experiments. After 4 images 
the precontrast signal intensity was in a steady state. The Gd_DTPA uptake has only been 
analyzed during 42 s after bolus administration, because the [Gd_DTPA] in the extracellular 
volume of the tumor region of interest decreases 1 min after bolus administration due to the 
Gd_DTPA clearance from the blood compartment (25). The acquisition parameters for the RF- 
spoiled T1-weighted FLASH were TR= 13 ms, TE= 4 ms, flip angle= 5o, matrix size= 64 x 64, 
FOV= 4 x 4 cm and slice thickness= 1.5 mm.
The experiments with carbogen breathing were carried out as follows: the series was 
started with a Gd_DTPA uptake experiment without carbogen breathing; the second Gd_DTPA 
uptake experiment was started 2 h later to allow clearance of the first Gd DTPA dose. After 2 h 
the signal intensity in T1-weighted FLASH images was similar to the 7th precontrast image of 
the first Gd_DTPA-uptake experiment. In the second experiment carbogen breathing was 
started 5 min before the second bolus contrast injection. For 3 mice the set of experiments was 
repeated without carbogen breathing in order to test the reproducibility of the Gd_DTPA uptake 
under identical experimental conditions.
Data analyses. In 60 consecutive T1-weighted FLASH images 1H-signal intensity changes 
were analyzed using ImageBrowser software (version 1.0, Spectroscopy Imaging Systems, CA, 
USA). Before the analyses per Gd_DTPA-uptake experiment the 7th precontrast FLASH image 
was subtracted from all images. For different regions of interest (ROI) in perfused tumor areas 
the mean signal intensity changes (postcontrast - precontrast signal intensity) were calculated in 
all 60 consecutive subtracted FLASH images and normalized to the maximum intensity change 
(100 %) in the series. Each ROI contains several pixels with different signal intensity changes; 
the standard deviation, as shown in Figure 7.3B-C, is taken as an indicator of the variation of 
pixel signal intensity changes per ROI. In the ROIs the pixels containing the skin as identified in 
H-SE images were left out. For the given doses the signal intensity increase in subtracted T1- 
weighted FLASH images was linearly related to [Gd_DTPA] (26, 27).
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P-MRS. The effects of carbogen breathing on the Pi/NTP ratio and pHmrs were measured by
31P-MRS in 5 mice with tumors and in muscle tissue of the hindlimb of 3 mice. These measu­
rements were performed on a Bruker spectrometer interfaced to a vertical bore magnet (4.7 T)
1 31employing a home-built H/ P double tunable 3 turn solenoid coil with an inner diameter of 13 
mm. The solenoid coil was fitted with a Faraday shield to eliminate spurious signals from 
normal tissue adjacent to the tumor. It should be noted that the Pi/NTP ratio reflects the average 
bioenergetic status of the tumor cells and the pHmrs is an approximate measure of the average
31intracellular pH in a volume sampled by the solenoid (= approximate tumor volume). P-MRS 
spectra were obtained with a one-pulse sequence with a hard pulse of ~12 ms (optimized for
31maximum signal intensity), TR = 3 s, NS = 320. The total acquisition time per P-MRS
31experiment was 16 min. One P-MRS experiment was completed before carbogen breathing 
was initiated, and 2 consecutive experiments were performed 5 min after the start of carbogen 
breathing.
Respiration of 100 % oxygen for 30 min reduced the T1-relaxation time of the inorganic 
phosphate (Pi) from ~ 4 s to ~ 3 s in tumors (28). With a pulse repetition time of 3 s and in the 
absence of carbogen (T1 of Pi ~ 4 s) the magnetization in the x-y plane has the following steady 
state value (29):
Mxy saturated = 0.53 * M0 (= (1-exp(-TR/T1)) * equilibrium z magnetization).
In the presence of carbogen (95 % O2) the extent of saturation decreases, because the T1- 
relaxation time decreases by approximately 1 s (see above): Mxy saturated = 0.63 * M0. No further 
effects of carbogen on the T1-relaxation times of NTP resonances were reported: thus, changes 
in the Pi/NTP ratio larger than about 119 % ({0.63 * M0/0 . 5 3  * M0} * 100) were related to 
changes in the bioenergetic status of tumor tissue.
Data analyses. Zero filling and the convolution difference technique with line 
broadenings of 30 and 1000 Hz were applied to the free induction decay. The peaks were fitted 
to Lorentzian line shapes with NMR1 software (New Methods Research, Inc., Syracuse, NY, 
USA). Per tumor the integral of the Pi peak was divided by the sum of the a  -, b - and g-NTP 
peak integrals. Pi/NTP ratio changes (D(Pi/NTP)) after the start of carbogen breathing were 
related to the Pi/NTP ratio without carbogen breathing (100 %). The mean Pi/NTP ratio changes 
of 5 tumors or 3 muscle tissues were analyzed with a paired t-test. The pH as measured with
31P-MRS (pHmrs ~ intracellular pH) was deduced from the chemical shift of the Pi signal with 
respect to the chemical shift of the phosphocreatine (PCr) signal or the a-NTP signal in the 
absence of a PCr resonance. A modified Henderson-Hasselbach equation was used with the 
following parameters for tumors: pK = 6.75, a(acid shift) = 3.29, b(base shift) = 5.7 (30, 31). 
For muscle tissue the parameters were as follows: pK = 6.75, a(acid shift) = 3.26, b(base shift) = 
5.75. Changes of the pHmrs in comparison with baseline values were analysed with a paired t- 
test.
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Results
Blood gas analyses of arterial blood samples before and after carbogen breathing.
Results of arterial blood gas analyses sampled before and 8 & 16 min after carbogen breathing 
are shown in Table 7.1. The normal pH value of whole blood (pHblood) in unanesthetized mice 
was 7.4 and is related to a pCO2blood value of ~ 40 mmHg as estimated from in vivo carbon 
dioxide dissociation curves for mammals (32, 33). The pHblood and pCO2blood values of 
anesthetized mice were 7.2 and 56 mmHg, respectively (see Table 7.1). The observed increase 
of the pCO2blood is compatible with the pHblood decrease as expected from the in vivo carbon 
dioxide dissociation curves. Carbogen breathing caused an additional pHblood shift of -0.05 
corresponding to a DpCO2blood of 16 mmHg (see Table 7.1). Next, carbogen breathing resulted 
in a 6.6 % increase of the hemoglobin saturation in arterial blood (SaO2). The average increase 
of dissolved oxygen in blood plasma (DpO2blood) was 347 mmHg.
Table 7.1 Results of arterial blood gas analyses (n = 5). Values are means ± SEM (Relative to baseline). The 
mean total hemoglobin concentration [tHb] of all blood samples was 10.4 ± 0.2 mM (= monomeric concentration) 
or 2.6 mM (= tetrameric concentration).
Base linea) 8 min carbogenb) 16 min carbogenb)
pHblood = 7.21 ± 0.04 DpHbiood = - 0.05 ± 0.004 DpHbiood = - 0.05 ± 0.009
pCÜ2biood = 56.4 ± 2.5 mmHg DpCÜ2biood = 16 ± 1.8 mmHg DpCÜ2biood = 16 ± 0.9 mmHg
SaO2C) = 94 ± 1.8 % SaÜ2 increase = 6.6 ± 0.7 % SaÜ2 increase = 6.6 ± 0.7 %
pÜ2bioodd) = 131 ± 7.2 mmHg DpÜ2biood = 338 ± 47 mmHg DpÜ2biood = 356 ± 49 mmHg
a) Anaesthesia: 2 % enflurane, 25 % O2, 73 % N2O
b) Anaesthesia + carbogen breathing: 2 % enflurane, 94 % O2, 4 % CO2 .
c) SaO2 = Hemoglobin (Hb) saturation (%).
d) pO2blood = Blood oxygen tension (mmHg).
Near infrared spectroscopy (NIRS) studies of concentration changes of oxy- and 
deoxyhemoglobin in tumor blood during breathing of different CO2/O2 gas mixtures.
Changes of the absorption characteristics of the oxygen-dependent chromophores in 
approximately the whole tumor blood volume of 14 mice have been observed with NIRS during 
25 min. Figure 7.1 shows mean concentration changes (mM) of oxyhemoglobin (O2Hb), 
deoxyhemoglobin (HHb) and the total hemoglobin (tHb). The CO2 content of the O2/CO2 gas 
mixture was increased in steps of 1 % with 5 min intervals. The mean concentration of O2Hb 
and HHb changed immediately after breathing the 99% O2 / 1% CO2 mixture. The total 
hemoglobin concentration remained constant (p > 0.05), but the mean O2Hb and HHb 
concentration changes in blood were highly significant (p < 0.001) for all gas mixtures in 
comparison with control experiments. The maximum change in the mean [O2Hb] and [HHb] 
was obtained at a gas mixture with 4 % CO2 : 46.3 ± 6.5 (SEM) mM and -34.9 ± 2.7 (SEM) mM, 
respectively. However, during the increase of the CO2 content from 1 % to 5 %, the maximum 
change of the mean concentration was only significant for HHb (p < 0.02) and was not 
significant for O2Hb (p > 0.05) in comparison with the 99% O2 / 1% CO2 mixture.
Further, no significant changes of the [O2Hb] and [HHb] were observed in 3 human glioma 
xenografts during breathing of 100 % O2 (results not shown here).
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time (min)
Figure 7.1 Mean concentration changes (|jM) ± SEM of oxygen-dependent chromophores in approximately the 
whole blood volume of 14 E49 tumors, as measured by near infrared spectroscopy, are shown when the CO2 content 
of the O2/CO2 gas mixtures was increased in steps of 1 % with 5 min intervals.
19F-MR relaxometry studies of the oxygen tension changes in tumor tissue during 
carbogen breathing.
For the interpretation of the in vivo 19F-MR relaxometry studies analyses of the PFC distribution 
within tumor slices is crucial. Figure 7.2A shows an example of a 19F-SE density image through 
the center of a representative tumor at the same location as the slice of the 19F-MR relaxometry 
measurement (see also Figure 5.1). In this image the distribution of PFCs was heterogeneous. In 
chapter 5 we observed spatial correlations between the perfused microvessel distribution and the 
PFC distribution in tumor tissue slices (23). In this chapter, the PFC distribution also appeared 
comparable with the Gd_DTPA distribution, see next paragraph. In all tumors, the PFC’s 
became sequestered in the perfused periphery of the tumor. Furthermore, pOtissue values as 
probed with Eppendorf O2-electrodes in the perfused periphery of the tumor corresponded to 
pO2tissue measured with19F-MR relaxometry. The pO2tissue values in necrotic regions as measured 
with Eppendorf O2-electrodes were much lower than the pO2tissue values observed with 19F-MR 
relaxometry. The latter indicates that PFC’s preferentially accumulate in perfused regions of the 
tumor, and not in necrotic regions of the tumor. Thus, slice-selective F-MR measurements 
probe average pO2/tissue values or changes in the average pO2/tissue in perfused regions of the 
tumor throughout the whole MR-slice.
In the absence of carbogen absolute pO2/tissue values varied from 0.32 ± 0.7 mmHg to 8.7 
± 2.7 mmHg (Chapter 5 and ref. 23). The changes of pO2/tissue relative to baseline (DpO2/tissue, 
mmHg) in slices through the center of 13 tumors after 8 min carbogen breathing are shown in 
Figure 7.2B (see also Table 5.1). The effect of carbogen showed large variations: the DpO2/tissue 
varied from approximately 0 to 15 mmHg. After 8 min of carbogen breathing the mean 
DpO2/tissue relative to baseline was 4.6 ± 1.3 mmHg (p < 0.01), and after 14 min carbogen 
breathing, the mean DpO2/tissue
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relative to basline was 1.7 ± 0.8 mmHg (p < 0.05). The mean DpO2/tissue tended to decrease with 
time, but the difference between the mean DpO2/tissue values was not significant (p > 0.05).
f>ULl
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Figure 7.2 The PFC distribution in a 19F-SE density image of a slice through the center of a representative tumor 
is shown in Fig. 7.2A. In Figure 7.2B, changes of the oxygen tension ± SE (DpO2/tissue, mmHg) after 8 min carbogen 
breathing in slices through the centers of 11 E49 tumors are shown. The numbers on the x-axis indicates individual 
mice.
Fast dynamic 1H-MRI studies of the Gd_DTPA uptake in perfused tumor regions in the 
absence and presence of carbogen.
The 1H-signal intensity in T1-weighted FLASH images increases when the T1-relaxation 
time of tissue water protons decreases due to the Gd_DTPA uptake in the extracellular space of 
perfused tumor regions. In all T1-weighted FLASH images of tumor tissue slices an increase of 
the 1H-signal intensity, or Gd_DTPA uptake, was observed in the well perfused periphery, but 
no changes were observed in the center during 42 s after bolus injection. Figure 7.3A shows a 
subtracted T1-weighted FLASH image (Signal Intensitypostcontrast - Signal Intensityprecontrast) of a 
slice through the center of a representative tumor 42 s after bolus injection of a Gd_DTPA 
solution in saline. In 5 mice two Gd_DTPA-uptake experiments were done: one without and 
another with carbogen breathing. The latter breathing condition was assessed two hours later to 
allow for Gd_DTPA clearance. For the regions of interest (ROIs) delineated in Figure 7.3A the 
mean relative signal intensity changes (mean DSI (%)) are shown in Figures 7.3B-C for both 
experiments. In all tumors the Gd_DTPA-uptake rate decreases in the perfused rim during 
carbogen breathing.
In subtracted T1-weighted FLASH images obtained 42 s after bolus injection in the 
presence of carbogen no detectable change of the perfused areas was observed in comparison 
with the same images without carbogen breathing. This was in agreement with the NIRS 
experiments where no significant change of the [tHb] was detected. Both observations indicate 
that the blood fraction in the volume of interest was not increased significantly due to carbogen 
breathing.
In 3 tumors the reproducibility of the Gd_DTPA-uptake experiments was tested. The 
bolus injection of a Gd_DTPA solution in saline was repeated after a time interval of 2 h in the 
absence of carbogen. The mean signal intensity changes in different regions of interest were
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highly reproducible in all tumors (results not shown). The signal intensity changes in the second 
experiment were all within the range of signal intensity changes of the first experiment ± 1.5 
SD.
A B
C
Figure 7.3A. Subtracted Ti-weighted 
FLASH images (SIpost - SIpre) of a slice 
through the center of an E49 tumor, 42 s 
after bolus administration of Gd_DTPA 
in saline (0.1 mmol.kg-1). Figure 7.3B- 
C. Changes of the mean relative signal 
intensity (DSI (%)) ± SD in the regions 
of interest delineated in Fig. 7.3A, 
without carbogen (■) and with 
carbogen breathing (□ ) two hours later.
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31P-MRS studies of changes in the bioenergetic status and pHmrs of tumor tissue during 
carbogen breathing.
31P-MR spectra of whole tumor volume were obtained without carbogen, 13 min and 29 min 
after initiation of carbogen breathing (Figure 7.4). The NTP and PCr peaks decreased and the Pi 
peak increased during carbogen breathing. Figure 7.5 shows mean Pi/NTP ratio changes (%) of 
5 tumors as a function of time (min) in comparison with baseline Pi/NTP ratios (100 %). Pi/NTP 
ratios started to increase and became significantly different from baseline values after 13-min 
carbogen breathing (see p-values in the legend of Fig. 7.5). Simultaneous with the increase of 
the Pi/NTP ratio, the pHmrs decreases significantly after 13 and 29 min carbogen breathing (see 
second y-axis of Fig. 7.5). In muscle tissue of the hindlimb (n = 3) no significant Pi/NTP ratio
1 24 Chapter 7
changes were observed (p > 0.1) for both time points. After 13 and 29 min carbogen breathing 
the mean A(Pi/NTP) of all experiments was 108 ± 5.7 %. The pHmrs decreased significantly after 
29 min carbogen breathing: the mean change of the pHmrs was - 0.14 ± 0.03 in muscle tissue.
t = 29 min
(ppm)
Figure 7.4 31P-MR spectra of an E49 tumor without carbogen: t = 0 (Fig. 7.4A), and during carbogen breathing
31at t = 13 min (Fig. 7.4B) and 29 min (Fig. 7.4C). Peak assignments of P-MR spectra: 1. Phosphomonoesters, 2. Pi, 
3. Phosphodiesters, 4. PCr, 5. g-phosphate of NTP, 6. a  -phosphate of NTP, 7. p-phosphate of NTP. NTP refers to 
the following nucleoside triphosphates: adenosine -, guanosine -, uridine - and cytidine-triphosphate. 31P-MRS 
cannot distinguish these nucleoside phosphates, because the phosphates groupes are all equivalent. The NTP peaks 
are predominantly the three phosphorus nuclei of ATP with smaller contributions from the others (49).
time after start carbogen 
breathing (min)
<Da>3
Figure 7.5 Changes of the mean Pi/NTP ratio in percentage ± SEM (%) (■) and mean pH™* ± SEM (□ ) in 5 
mice during carbogen breathing at t = 13 min and t = 29 min. The significant changes are indicated with an asterics. 
The p-values (paired t-test) are: t = 13 min, A (Pi/NTP) : p > 0.1, A pHmrs: p < 0.01, t = 29 min, A (Pi/NTP) : p < 
0.01, A pHmis: p < 0.05.
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Discussion
In this study a set of complementary noninvasive monitoring techniques have been used to 
probe the effects of carbogen breathing on the physiological profile of human glioma 
xenografts. The different methods were not used in sequence on the same individual tumor; 
however, experimental conditions, size and implantation site did not vary significantly among 
the different series. Therefore, average changes of physiological parameters in different tumors 
per series of experiments can be compared.
After carbogen breathing the oxygenation status of different blood and tissue 
compartments was ameliorated. Arterial blood gas analyses showed an increase of the 
hemoglobin saturation and the blood O2 tension during carbogen breathing. The increase of the 
arterial hemoglobin saturation is in agreement with NIRS measurements, which showed a 
significant increase of the mean [O2Hb] and simultaneously a decrease of the mean [HHb] in 
tumor blood for a range of different O2/CO2 mixtures. It should be noted that both methods 
measure different blood quantities: besides changes of the [O2Hb] in arterial blood, NIRS also 
detects modifications of the [O2Hb] in capillaries and venous blood (35). In other studies 
comparable effects of carbogen breathing on the oxyhemoglobin concentration of tumor blood 
have been observed. Using functional MR-imaging Robinson et al (13, 36) and Howe et al (37) 
reported large signal intensity increases in GH3 prolactinomas grown in the flank of rats after 5 
min carbogen breathing. A part of the signal intensity increase in tumor regions was attributed 
to an increase of the [O2Hb]. Further Fenton (5) observed cryo-spectrophotometrically in 
sarcoma and in squamous cell carcinoma xenografts an increase of the hemoglobin saturation in 
perfused tumor capillaries after 7-min carbogen breathing. In the present NIRS study a CO2 
content of 4 % in the breathing gas mixture seemed to be sufficient for a maximum effect on the 
mean [O2Hb]. This CO2 content is lower than the 5 % CO2 content of carbogen, which has been 
used as a standard mixture in other experimental and clinical studies (3-6, 13, 14).
When hemoglobin became completely saturated during carbogen breathing, the pO2 in 
arterial blood increased significantly. In oxygen-dependent phosphorescence quenching studies 
Torres Filho et al (38) found in blood vessels of human colon adenocarcinoma (grown in dorsal 
skin chambers) and in arterioles of subcutaneous tissue a pO2blood increase of ~ 150 % after 
carbogen breathing in comparison with baseline values in anesthetized mice. This is comparable 
to the increase of pO2blood observed in the present study. Furthermore, Cerniglia et al (39) 
showed with a similar technique an increase of the intravascular oxygen tension during 
carbogen breathing in subcutaneous 9L-Glioma tumors. The pO2blood increase varied among 
tumors and was greater with carbogen compared with 100 % oxygen. This is comparable to the 
results of the present NIRS studies where no detectable changes of the [O2Hb] in tumor blood 
were observed during breathing of 100 % O2. Breathing of a CO2/O2 gas mixture seems a more 
effective way of increasing the [O2Hb] and the pO2blood than breathing of 100 % O2.
Simultaneous to the increase of the [O2Hb] and pO2blood, the pO2/tissue as measured by 
19F-MR relaxometry increased significantly. It should be noted that the PFCs became 
sequestered in well-perfused regions of the tumor; thus, pO2/tissue changes were mainly observed 
in these regions (Chapter 5 and ref. 23). The oxygen tension in tissue depends on the balance 
between the O2 supply and O2-consumption rates of tumor cells; thus, a pO2/tissue increase can be 
due to an increase of the O2 supply, but may also be due to a decrease of O2-consumption rates. 
Given the fact that breathing of 100 % oxygen did not cause a significant increase of the 
[O2Hb], but a gas mixture of CO2 and O2 did, the CO2-component of carbogen may affect the 
pO2/tissue via modifications of the O2-consumption rates of tumor cells. A decline of the O2- 
consumption rate of cells may also result in an increase of the pO2/tissue and [O2Hb] in capillaries
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and venous blood.
The CO2-component of carbogen increased the CO2 blood tension (pCO2blood), which 
resulted in a drop of pHblood and pHmrs. During carbogen breathing a significant decrease of the 
Gd_DTPA-uptake rate in the extracellular space of perfused tumor regions was measured in all 
tumors studied. This uptake rate depends on tumor blood perfusion (TBP) in the perfused tumor 
microvessels, the permeability surface area (PS-product) of these vessels and the tracer 
distribution volume (40, 41). Can the observed acidification of tumor blood and tissue affect 
one of these parameters in such a way that the Gd_DTPA-uptake rate in perfused tumor regions 
decreases? Carbogen breathing is not expected to have any effect on the tracer distribution 
volume, which is a part of the extracellular volume in the region of interest containing perfused 
vessels. Furthermore, it is unlikely that the permeability of the tumor vessels altered by 
carbogen breathing. However, the CO2-component of carbogen has a vasodilating effect on 
vessels possessing responsive smooth musculature (13, 36); thus, carbogen may increase the 
surface area of perfused vessels (S). An increase in the surface area might result in a larger PS- 
product and thus in an increase of the Gd_DTPA uptake (41), but this was not observed in 
perfused tumor regions. Moreover, no detectable increase in perfused tumor areas was observed 
in subtracted T1-weighted FLASH images during carbogen breathing, which is in agreement 
with the results of the NIRS experiments, where no significant increase was observed in the 
[tHb] (~ blood volume). This probably means that populations of constricted tumor vessels, if 
present, are not strongly dilated by carbogen. In studies reported by Torress Filho et al (38) and 
Dewhirst et al (42) no important changes were observed in the mean tumor vessel diameter 
during carbogen breathing. The most plausible explanation for the decreased Gd_DTPA uptake 
in perfused tumor regions is a decreased blood perfusion. The tumor vasculature of 
subcutaneously or intramuscularly implanted rodent tumors in flank or hindlimb is mostly 
parallel to the host tissue vasculature (8). Vasodilator agents such as hydralazine and 
nitroglycerin were found to decrease the blood perfusion in such rodent tumors as measured by 
1H-MRI studies of the Gd_DTPA uptake (18, 43) and by laser Doppler flow studies (10). 
Simultaneously hydralazine was found to increase blood perfusion in muscle tissue (18, 43). 
The CO2-component of carbogen has a similar effect as the vasodilatory agents. A drop in 
pHblood and pHtissue mediates the vasodilating effect of this component on normal host 
vessels with responsive smooth muscle. The mode of action of these vasodilators is often 
referred to as the steal effect because, by dilating normal reactive vasculature, a drop in blood 
pressure will cause a lower blood flow through vessels which are in parallel to the host vascular 
bed and lack the contractile capability such as most tumor vessels (8-10).
Simultaneous to the decline of the TBP the Pi/NTP ratios of all tumors were found to 
increase. This increase was not significant during the first 13 min, in agreement with studies by 
Koutcher et al (44) and Howe et al (47), but became significant after 13-min carbogen 
breathing. Although, the effect of carbogen on TBP was only analyzed in the last 42 s of a 6 min 
carbogen breathing period, the constant increase of the Pi/NTP ratio during a breathing period of 
29 min suggests that the reduction of TBP is a more permanent effect of carbogen breathing. 
The reduction of the TBP (steal effect) may result in a decreased supply of substrates for energy 
metabolism in tumor cells, which leads to a decrease of the bioenergetic status of the whole 
tumor as expressed by an increase of the Pi/NTP ratio. In muscle tissue a decrease of the Pi/NTP 
ratio or improvement of the bioenergetic status due to an increased blood perfusion was not 
observed, because the blood perfusion was already adequate for the supply of substrates and O2. 
We speculate that tumor cells with an oxidative energy metabolism will consume less O2 when 
the supply of substrates such as glucose decreases. Consequently, in regions with oxygen 
consuming glioma cells the pO2/tissue and [O2Hb] in mainly venous blood may increase.
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In preliminary immunohistochemical studies we detected hypoxic regions at distances of 
approximately 100 mm from perfused capillaries, which indicates that populations of glioma 
cells in our tumor model consume oxygen (19, 45, 46). If tumor cells do not consume oxygen, 
then equilibrium between the oxygen tensions in blood and tissue will appear, and no hypoxic 
cells would be detectable.
Apart from a nutrient-limited decrease of oxidative energy metabolism in tumor cells, 
the reduction of the O2-consumption rate of tumor cells may also be due to another mechanism. 
Simultaneous to the increase of the Pi/NTP ratio the pHmrs decreases significantly. This 
acidification of the tumor may inhibit the glycolytic rate (11, 12) and can contribute to a 
decrease of O2-consumption rates of tumor cells with an oxidative energy metabolism, which 
may increase the Pi/NTP ratio. In addition, this acidification may also have an effect on the 
oxygen affinity of hemoglobin (Bohr effect); a lowering of the pH in blood and tissue shifts the 
blood oxygen dissociation to the right, so that the oxygen affinity is decreased, which favours 
oxygen unloading in tissue (47). In contrast, the [O2Hb] in tumor blood actually increased, 
indicating that the effect of the CO2-component on O2-consumption rates of tumor cells is more 
important.
Preliminary immunohistochemical analyses of the effect of carbogen on human larynx 
carcinoma xenografts transplanted in the same mice and location as the human glioma 
xenografts in the present study showed a strong decrease of hypoxic regions in whole tumor 
sections. Simultaneously, a significant decrease of perfused vessels and proliferating cells was 
observed (48). These results are in agreement with the decrease of TBP, bioenergetic status and 
simultaneous increase of the tumor tissue oxygenation observed in the present study.
Conclusions. The observation that oxyhemoglobin concentration in tumor blood and oxygen 
tensions in arterial blood and tumor tissue increase while tumor blood perfusion and 
bioenergetic status decrease during carbogen breathing may seem contradictory. It appears that 
this reflects different effects of the O2 - and CO2-components of carbogen on the physiology of 
the host and tumor. As 100 % O2 breathing alone did not result in a detectable increase of the 
[O2Hb] in tumor blood, the observed increase of the latter and the oxygen tension in tumor 
tissue during carbogen breathing appear to be mediated by the CO2-component of carbogen. 
Therefore, we speculate that the CO2-component of carbogen may have an indirect effect on the 
[O2Hb] and the tissue oxygen tension via an inhibition of oxidative energy metabolism. The 
latter may be explained by two different mechanisms: 1) The CO2-component has a vasodilating 
effect on host vessels. When the tumor vasculature lacks responsive smooth musculature and is 
in parallel to the vasculature of the host tissue, tumor blood perfusion reduces, which is known 
as the steal phenomenon. This causes a decrease of the substrate supply for oxidative energy 
metabolism and consequently reduces the O2-consumption rate of cells. 2) The acidification of 
tumor tissue may inhibit the glycolytic rate, which can have a similar effect on the O2- 
consumption rates of tumor cells.
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Summary
The aim of the study, described in this thesis, was to analyze physiological and biochemical 
parameters, which are related to the oxygenation status of human glioma xenografts. 
Noninvasive magnetic resonance (MR) methods and immunohistochemical analyses of the 
vascular architecture were used for this purpose. This information is important before the start 
of a radiotherapy treatment, since local oxygen tensions influence the radiosensitivity of a 
tumor. Furthermore, MR-techniques may help to develop and test treatment modulations in 
order to improve the oxygen tension in tumor tissue. The magnetic resonance studies 
included: 1) the direct analyses of the oxygen tension in tumor tissue, 2) the evaluation of 
physiological parameters, which determine the supply of oxygen, and finally 3) the analyses 
of biochemical parameters (e.g. bioenergetic status), which are related to the supply of 
oxygen. Most MR-experiments were followed by quantitative immunohistochemical analyses 
of the perfused and total vascular bed, hypoxic cells and necrotic regions. This unique 
comprehensive approach permits to compare physiological and biochemical parameters with 
quantitative morphometric analyses.
In chapter 1, the different parameters, which affect the local oxygen tension in tumor 
tissue, and the magnetic resonance methods and other techniques, which have been used in 
this thesis to probe these parameters are described.
In chapters 2-4, the tracer-uptake rates of the clinical diffusible tracer Gd and the 
freely diffusible tracer HDO have been analyzed in gliomas growing in rat brain or in the 
flank of nude mice. The tracer-uptake rate in tumor tissue is related to physiological 
processes, which determine the supply of oxygen and nutrients (tumor blood perfusion, 
diffusive transport across the capillary endothelium into the extravascular volume). Chapter
2 gives a short review of two pharmacokinetic models, which have been used for the 
interpretation of uptake rates of Gd and HDO in (tumor) tissue. The parameters of these 
models are only defined in regions with a high-density of perfused microvessels. In these 
regions, tracer-uptake rates can be related to physiological parameters such as tumor blood 
perfusion (TBP) and PSp-product, when pharmacokinetic models are fitted to tracer-uptake 
curves. The PS-product is a product of the vascular permeability (P) and the total perfused 
vascular surface-area (Sp), and determines the diffusive transport across the capillary 
endothelium. In chapter 3, Gd-uptake rates were analyzed with a high spatial and temporal 
resolution in 9L-gliomas growing in rat brain. The uptake rates had a positive correlation with 
the perfused microvessel density (Np) and vascular surface-area (Sp). The latter correlation 
indicates that variations in the TBP and/or vascular permeability did not affect the Gd-uptake 
rate in these glioma tumors. However, these parameters may still affect the Gd-uptake rate, 
when they are modulated. For instance, in chapter 7, a decrease of the TBP caused a large 
decline of the Gd-uptake rate. Without modulations of TBP and/or vascular permeability, Gd- 
uptake studies may be of additional value to pathology in the evaluation of a therapy, if the 
latter affects the perfused microvessel density or surface-area, such as an anti-angiogenic 
therapy.
Chapter 4 describes global H-MRS studies of HDO-uptake in the total volume of 2 
human glioma xenograft lines with a heterogeneously (E49) and homogeneously (E98) 
perfused vascular architecture. This MR-technique was introduced approximately 10 years 
ago, to measure tumor blood perfusion, but is difficult to apply in the clinic due to the low 
MR-sensitivity of H-spins and toxicity of high dose HDO. In chapter 4, the uptake of HDO 
has been measured with a high temporal resolution in the total tumor volume (global), and 
could not be detected locally in perfused regions of the tumor as in dynamic 1H-MRI studies
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of the Gd-uptake. Thus, the time to reach an equilibrium between the HDO concentration in 
the vascular and extravascular compartment was also controlled by diffusive transport of the 
tracer from perfused into nonperfused regions of the tumor. These processes were more 
dominant in heterogeneously perfused tumors with large distances between perfused 
microvessels. In such tumors, global HDO-uptake studies cannot be used to analyze TBP, but 
provide information on the diffusion geometry of a tumor. Here, the uptake rate of HDO is 
related to diffusion-limited supply of oxygen, nutrients and drugs to the tissue.
In general, tracer-uptake studies are related to the perfusion and diffusion-limited 
supply of oxygen and other substrates. However, direct measurements of the oxygen tension 
in tissue are still important, because the latter depends on the balance between the oxygen 
supply and demand of tumor cells, which is determined by the oxygen consumption rates.
Chapter 5 reports the characterization and validation of noninvasive oxygen tension 
measurements in the human glioma xenograft line E49 with slice-selective 19F-MR 
relaxometry. The perfluorocarbon compound perfluoro-15-crown-5-ether was used as oxygen 
sensor. De T1-relaxation rate of fluor spins in this oxygen sensor has a linear relationship with 
the local oxygen tension in regions of the tumor, in which the sensor accumulates. The 
distribution and accumulation of the sensor depends on the mode of injection: e.g. after i.v. 
injection perfluoro-15-crown-5-ether sequester in the perfused tumor rim. Thus, only in these 
perfused regions throughout the MR-slice oxygen tension and oxygen tension changes are 
measured. In perfused regions of the tumor, oxygen tensions as probed by F-MR 
relaxometry were comparable to oxygen tension values as measured with oxygen electrodes 
(Eppendorf). The latter method is the most frequently applied technique for detection of local 
and global oxygen tensions, and therefore it was used for validation of the oxygen tensions as 
detected by 19F-MR relaxometry.
Currently, perfluorocarbon compounds are not available for clinical use, but this 
situation may change in the near future.
The balance between the oxygen and nutrient supply via blood perfusion and diffusive 
transport in tissue, and the consumption of oxygen and nutrients by the cells determine the 
bioenergetic status of a tumor. The Pi/NTP ratio is a measure of the bioenergetic status, and
31can be detected with P-MRS. In heterogeneously perfused tumors many cells are not 
adjacent to functional capillaries, and have difficulties to maintain their bioenergetic status 
due to the lack of oxygen and nutrients. Therefore, the aim of the study presented in chapter 
6 was to analyze the correlation between the Pi/NTP ratio of the whole tumor, and distances 
between perfused capillaries (diffusion geometry) in the same heterogeneously (E49) and 
homogeneously perfused (E98) tumor lines as examined in other studies (chapter 4). A linear 
correlation was found between the Pi/NTP ratio and the percentage of intercapillary distances 
larger than 200 ^m. Calculations of the oxygen and glucose gradient length in glioma tissue 
using the Krogh cylinder model, and immunohistochemical analyses of distances between 
perfused and chronically hypoxic regions, suggested that the correlation between the Pi/NTP 
ratio and the percentage of intercapillary distances larger than 200 |im was possibly related to 
a transition of an aerobic energy metabolism to an anaerobic energy metabolism. The glioma 
cells with an aerobic energy metabolism tried to maintain their NTP synthesis via an 
intensified anaerobic glycolysis, which claimed the stock of glucose. These results indicate 
that the diffusion-limited supply of oxygen (and glucose) is the major determinant of the 
bioenergetic status in both tumor lines.
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31In a clinical setting, P-MRS measurements can be used to the study the global bioenergetic 
status of tumor and/or the local bioenergetic status in different regions of large tumor.
In chapter 7, the different MR-techniques presented in chapter 4, 5 and 6 were used and 
combined to study the effect of carbogen (5% CO2 and 95% O2) breathing on the 
physiological profile of the E49 tumor line. Carbogen breathing has been introduced to 
decrease the fraction of chronically hypoxic cells by increasing the saturation of hemoglobin 
with oxygen and by increasing the amount of dissolved oxygen in blood plasma. During 
carbogen breathing, we observed that the oxyhemoglobin concentration in tumor blood and 
oxygen tensions in arterial blood and tumor tissue increase, while simultaneously tumor blood 
perfusion and bioenergetic status decrease. It appears that this reflects different effects of the 
CO2-component of carbogen on the physiology of the host and the tumor.
We speculated that the CO2-component of carbogen might have an indirect effect on the 
[O2Hb] and the tissue oxygen tension via an inhibition of oxidative energy metabolism. The 
latter may be explained by two different mechanisms: 1) The CO2-component has a vasodilating 
effect on host vessels. When the tumor vasculature lacks responsive smooth musculature and is 
in parallel to the vasculature of the host tissue, tumor blood perfusion reduces, which is known 
as the steal phenomenon. This causes a decrease of the substrate supply for oxidative energy 
metabolism and consequently reduces the O2-consumption rate of cells. 2) The acidification of 
tumor tissue may inhibit the glycolytic rate, which can have a similar effect on the O2- 
consumption rates of tumor cells.
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Samenvatting
Het onderzoek dat is beschreven in dit proefschrift had als doel om fysiologische en 
biochemische parameters te analyseren, die gerelateerd zijn aan de oxygenatie status van 
primaire hersentumoren (gliomas). Voor dit doel is gebruik gemaakt van niet-invasieve 
magnetische resonantie (MR) technieken en immunohistochemische analyse methoden. 
Informatie over deze parameters is belangrijk, omdat lokale zuurstofspanningen de 
gevoeligheid van een tumor voor radiotherapie mede bepalen. Verder kunnen MR-technieken 
helpen bij de ontwikkeling en het testen van therapie modulaties, die ingezet kunnen worden 
voor de verbetering van de zuurstofspanning in tumorweefsel.
De MR-studies omvatten: 1) direkte bepalingen van de zuurstofspanning in tumorweefsel, 2) 
evaluaties van fysiologische parameters, die de zuurstof aanvoer in tumoren bepalen, en 
tenslotte 3) analyses van biochemische parameters (bioenergetische status) die gecorreleerd 
zijn met de aanvoer van zuurstof. De MR-studies werden in de meeste gevallen gevolgd door 
kwantitatieve immunohistochemische analysen van het geperfundeerde en totale vaatbed, 
hypoxische cellen en necrotische gebieden. Door deze unieke en uitgebreide aanpak werden 
fysiologische and biochemische parameters gerelateerd aan kwantitatieve morfologische 
analyses.
In hoofdstuk 1 wordt aangeven welke parameters de lokale zuurstofspanning in 
tumor weefsel bepalen en hoe deze gemeten zijn.
In hoofdstuk 2 t/m 4 worden tracer-opname studies in gliomas beschreven met 
diffundeerbare tracers, zoals het klinische contrast middel gadolinium (Gd) en zwaar-water. 
De tracer-opname snelheid in tumor weefsel is gerelateerd aan fysiologische processen, die de 
zuurstof en nutriënten aanvoer bepalen (bloed perfusie, diffusie transport over vaatendotheel 
naar extravasculaire ruimte). Hoofdstuk 2 geeft een overzicht van twee farmacokinetische 
modellen, die gebruikt zijn bij de interpretatie van de opname snelheden van Gd en zwaar- 
water in (tumor)weefsel. De parameters van deze farmacokinetische modellen zijn alleen 
bepaald in regio’s met een hoge dichtheid van geperfundeerde capillairen. Door een 
farmacokinetisch model te fitten aan een tracer-opname curve kunnen snelheidsconstanten 
van de curve gerelateerd worden aan fysiologische parameters, zoals tumor bloed perfusie 
(TBP) en het PSp-product. De laatste parameter is een product van de vaatpermeabiliteit (P) 
en het totale geperfundeerde vaatoppervlak (Sp), en bepaalt de tracer transportsnelheid door 
het vaatendotheel. In hoofdstuk 3, werden Gd-opname snelheden in 9L-glioma tumoren in 
ratten hersenen geanalyseerd met een hoge temporele en ruimtelijke resolutie. De opname 
snelheid van Gd heeft een positieve correlatie met de geperfundeerde vaatdichtheid (Np) en 
geperfundeerde vaatoppervlak (Sp). De laatste correlatie duidt erop dat variaties in de TBP en 
vaatpermeabiliteit (P) geen invloed hebben op de opname snelheid van Gd in deze gliomas. 
Echter, dat wil niet zeggen dat deze parameters niet de Gd-opname snelheid kunnen bepalen 
wanneer ze veranderd zouden worden. In hoofdstuk 7 werd een sterke afname van de Gd- 
opname snelheid veroorzaakt door een afname van de TBP. Zonder modulaties kunnen niet- 
invasieve Gd-opname studies in aanvulling op pathologisch onderzoek gebruikt worden om 
de effecten van een tumor therapie te meten, wanneer deze alleen invloed heeft op de 
geperfundeerde vaatdichtheid en oppervlak, zoals een anti-angiogenese therapie.
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Hoofdstuk 4 beschrijft globale H-MRS studies van zwaar-water (HDO) opname in het totale 
volume van 2 humane glioma xenograft lijnen met een heterogeen (E49) en homogeen (E98) 
geperfundeerde vaatverdeling. Deze MR-techniek werd ongeveer 10 jaar geleden 
geïntroduceerd om bloed perfusie te meten in tumoren, maar is ongeschikt voor klinische 
toepassingen o.a. door de lage MR-gevoeligheid van deuterium spins en de toxiciteit van 
HDO bij hoge dosis. Door de lage MR-gevoeligheid kon alleen de totale opname van HDO in 
het totale tumor volume (globaal) gemeten worden met een hoge temporele resolutie door 
gebruik van H-MRS. Dus de opname van HDO kon niet lokaal gemeten worden in 
geperfundeerde gebieden van de tumor met een hoge ruimtelijke en temporele resolutie, zoals 
bij dynamische H-MRI studies van de Gd-opname. Daarom werd de tijd om evenwicht te 
bereiken tussen de concentratie van HDO in de vasculaire en extravasculaire ruimte van het 
tumor weefsel ook bepaald door diffusie transport processen van de tracer vanuit 
geperfundeerde tumor gebieden naar niet-geperfundeerde gebieden. Deze processen speelde 
een grote rol in heterogeen geperfundeerde tumoren met lange diffusie afstanden tussen de 
geperfundeerde vaten. In deze tumoren, kan deze MR-techniek zeker niet gebruikt worden om 
bloed perfusie te meten, maar geeft wel inzicht in de diffusie geometrie van een tumor. De 
opname snelheid van HDO is gerelateerd aan diffusie-gelimiteerde opname van zuurstof, 
nutriënten en drugs in tumorweefsel.
In het algemeen geven tracer-opname studies indirect informatie over de aanvoer van 
zuurstof en substraten naar tumorweefsel. Echter directe bepalingen van de zuurstofspanning 
in weefsel blijven belangrijk, omdat deze niet alleen bepaald wordt door de zuurstof aanvoer, 
maar ook door de zuurstof vraag van de cellen ofwel zuurstof consumptie.
Hoofdstuk 5 beschrijft de karakterisatie en validatie van niet-invasieve 
zuurstofspanning metingen in de humaan glioma xenograft lijn E49 met behulp van plak- 
selektieve 19F-MR relaxometrie studies, waarbij perfluoro-15-crown-5-ether als 
zuurstofsensor was gebruikt. De Ti-relaxatie snelheid (Ti-1) van fluor spins van deze 
zuurstofsensor heeft een linaire relatie met de lokale zuurstofspanning in tumor gebieden 
waar deze sensor ophoopt. Deze ophoping is afhankelijk van de manier waarop injectie 
plaatst vindt. Bijvoorbeeld, perfluoro-15-crown-5-ether accumuleerde 3 dagen na i.v. injectie 
in geperfundeerde gebieden aan de rand van de tumor, zodat alleen in deze gebieden 
(verdeeld over de MR-plak) zuurstofspanningen of veranderingen in zuurstofspanningen 
gemeten kunnen worden (hoofdstuk 7). In geperfundeerde gebieden waren 
zuurstofspanningen, zoals gemeten met 19F-MR relaxometrie, vergelijkbaar met 
zuurstofspanningen gemeten met Eppendorf O2-elektroden. Deze laatste techniek wordt het 
meest gehanteerd om lokale zuurstofspanningen te meten en is daarom gebruikt om de 
zuurstofspanningen van de 19F-MR relaxometrie metingen te valideren.
Op dit moment zijn er nog geen zuurstofsensoren beschikbaar voor klinische 
toepassingen, maar verwacht wordt dat dit in de toekomst wel het geval zal zijn.
De balans tussen zuurstof en nutriënten aanvoer via bloed perfusie en diffusie 
transport in weefsel, en de consumptie van zuurstof en nutriënten door cellen bepaalt de 
bioenergetische status van een tumor. De Pi/NTP ratio is een maat voor de bioenergetische
31status van een tumor en kan bepaald worden met P-MRS.
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In heterogeen geperfundeerde tumoren, waarbij grote populaties cellen ver verwijderd zijn 
van functionele vaten, hebben veel cellen mogelijk moeite met het handhaven van hun 
bioenergetische status door gebrek aan zuurstof en substraten voor het energie metabolisme. 
Daarom werd in hoofdstuk 6 een correlatie onderzocht tussen Pi/NTP ratio van de hele tumor 
en intercapillairen afstanden tussen geperfundeerde capillairen (diffusie geometrie) in 
dezelfde heterogeen (E49) en meer homogeen geperfundeerde (E98) tumor lijnen uit 
hoofdstuk 4. Er werd een lineaire correlatie gevonden tussen de Pi/NTP ratio en het 
percentage intercapillaire afstanden boven de 200 mm. Door berekeningen van diffusie 
afstanden van zuurstof en glucose in glioma weefsel met behulp van een Krogh cilinder 
model en immunohistochemische analyses van afstanden tussen geperfundeerde gebieden en 
chronisch hypoxische gebieden, kon aannemelijk worden gemaakt dat de correlatie tussen de 
Pi/NTP ratio en het percentage intercapillaire afstanden boven de 200 mm mogelijk te maken 
heeft met een overgang van een aëroob naar anaëroob energie metabolisme. De glioma cellen 
met een aëroob energie metabolisme proberen waarschijnlijk de NTP synthese te handhaven 
via anaërobe glycolyse, waardoor de glucose voorraad sneller afneemt. Blijkbaar is diffusie- 
gelimiteerde opname van zuurstof (en glucose) de belangrijkste factor voor het handhaven 
van de bioenergetische status in de bestudeerde tumorlijnen.
31In de kliniek zijn P-MRS experimenten bruikbaar voor de bestudering van de 
globale bioenergetische status van een tumor, maar ook in voornamelijk grote tumoren 
kunnen lokale gebieden geanalyseerd worden.
In hoofdstuk 7 zijn de MR-technieken uit de hoofdstukken 4, 5 en 6 gebruikt en 
gecombineerd om de effecten van carbogeen (5% CO2, 95% O2) beademing op het 
fysiologische profiel van tumorlijn E49 te bestuderen. Carbogeen beademing werd 
geïntroduceerd met het doel om de fractie chronisch hypoxische cellen te laten afnemen door 
de hemoglobine saturatie met zuurstof en de hoeveelheid opgeloste zuurstof in het bloed 
plasma te verhogen. Tijdens carbogeen beademing, werd een toename gevonden van de 
oxyhemoglobine concentratie in tumor bloed en de zuurstofspanningen in weefsel, 
tegelijkertijd namen de tumor bloed perfusie en de bioenergetische status af. Het bleek dat dit 
veroorzaakt werd door verschillende effecten van de CO2-component van carbogeen op de 
fysiologie van de gastheer en de tumor.
We speculeerde dat de CO2-component van carbogeen mogelijk een indirect effect 
heeft op de oxyhemoglobine concentratie en de weefsel oxygenatie via een remming van de 
oxidatieve ademhaling. Dit werd uitgelegd via twee verschillende mechanisme: 1) De CO2- 
component heeft een vasodilaterende werking op de vaten van het gastweefsel. Wanneer de 
vaten van de tumor niet kunnen reageren op de CO2-component en wanneer ze parallel lopen 
met het vaatbed van de gastheer, dan zal de tumor bloed perfusie afnemen door een 
zogenaamd “steal effect” (bloed wordt gestolen uit de tumorvaten). Dit veroorzaakt een 
daling van substraat aanvoer voor het oxidatieve energie metabolisme en resulteert logische 
wijze in een afname van de zuurstofconsumptie van de tumorcellen. 2) De verzuring van het 
tumor weefsel kan mogelijk de glycolyse snelheid remmen wat eenzelfde effect heeft op de 
zuurstofconsumptie snelheid van de tumorcellen.
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